<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Market News &#38; Stocks to Watch from StraightStocks &#187; United States</title>
	<atom:link href="http://www.straightstocks.com/tag/united-states/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.straightstocks.com</link>
	<description>Leading Stock Market News, Opinions and Commentary</description>
	<lastBuildDate>Tue, 24 Nov 2009 22:03:44 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Nordstrom&#8217;s North Carolina Debut &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/nordstroms-north-carolina-debut-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/nordstroms-north-carolina-debut-analyst-blog/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 21:25:18 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Downtown Seattle store]]></category>
		<category><![CDATA[fashion specialty retailer]]></category>
		<category><![CDATA[Nordstrom Inc.]]></category>
		<category><![CDATA[North Carolina]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27600/Nordstrom%27s+North+Carolina+Debut+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Nordstrom Inc.</strong> (<a href="http://www.zacks.com/stock/quote/JWN">JWN</a>), a leading fashion specialty retailer, has recently announced plans to open a 33,000 square feet Nordstrom Rack in North Carolina, making its debut in the city.<br />
 <br />
Nordstrom Rack is the off-price division of Nordstrom Inc. The first Nordstrom Rack was opened in the basement of the Downtown Seattle store in 1975 as a clearance department. With a huge initial response, it has since grown into a separate division of the company. Currently, there are 69 Nordstrom Rack stores across 21 states in the U.S.<br />
 <br />
The new store, the first of its kind in North Carolina, is expected to open in the fall of 2010 at a prime location in the city. The store would offer merchandise at fire-sale prices with discounts of 50% &#8722; 60% to regular prices.<br />
 <br />
Currently, Nordstrom has about 184 stores spread across 28 states in the US, offering a selection of brand name and private label merchandise. The company sells its products through various channels including Nordstrom full-line stores, Nordstrom Rack off-price stores, Last Chance clearance stores, and Jeffrey boutiques, besides the catalog and the Internet.<br />
 <br />
Despite a reduction in disposable income and lower consumer discretionary spending due to the continued economic downturn, Nordstrom has continually opened new stores to attract more customer traffic. The company is upbeat about the upcoming holiday season and expects to bolster its sales through increased customer footfall.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=JWN">Read the full analyst report on "JWN"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/nordstroms-north-carolina-debut-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The New Crude Oil Benchmark That Could Change the Oil Market’s Price Dynamics</title>
		<link>http://www.straightstocks.com/investing-lessons/the-new-crude-oil-benchmark-that-could-change-the-oil-market%e2%80%99s-price-dynamics/</link>
		<comments>http://www.straightstocks.com/investing-lessons/the-new-crude-oil-benchmark-that-could-change-the-oil-market%e2%80%99s-price-dynamics/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 19:46:09 +0000</pubDate>
		<dc:creator>Investment U</dc:creator>
				<category><![CDATA[Contrarian Perspectives]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Argus Sour Crude Index (ASCI)]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[crude oil]]></category>
		<category><![CDATA[Cushing]]></category>
		<category><![CDATA[Dominant Player]]></category>
		<category><![CDATA[editor]]></category>
		<category><![CDATA[energy exchanges]]></category>
		<category><![CDATA[exxon mobil corp]]></category>
		<category><![CDATA[financial product]]></category>
		<category><![CDATA[fracturing]]></category>
		<category><![CDATA[Gulf Coast]]></category>
		<category><![CDATA[heavier crude  oil]]></category>
		<category><![CDATA[heavier oil]]></category>
		<category><![CDATA[heavy oil index]]></category>
		<category><![CDATA[heavy oil producers]]></category>
		<category><![CDATA[Hugo Chávez]]></category>
		<category><![CDATA[InvestmentU]]></category>
		<category><![CDATA[Keystone pipeline;]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[oil benchmark]]></category>
		<category><![CDATA[Oil Futures]]></category>
		<category><![CDATA[Oil Market]]></category>
		<category><![CDATA[Oil Price]]></category>
		<category><![CDATA[Oil Prices]]></category>
		<category><![CDATA[oil pricing]]></category>
		<category><![CDATA[oil producer]]></category>
		<category><![CDATA[oil producers]]></category>
		<category><![CDATA[Oil Trading]]></category>
		<category><![CDATA[Oklahoma]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Royal Dutch Shell plc]]></category>
		<category><![CDATA[Saudi Arabia]]></category>
		<category><![CDATA[Saudi Aramco]]></category>
		<category><![CDATA[Sheena Martin]]></category>
		<category><![CDATA[sweet crude oil]]></category>
		<category><![CDATA[U.S. Gulf Coast]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Valero Energy Corp]]></category>
		<category><![CDATA[Venezuela]]></category>
		<category><![CDATA[Western Europe]]></category>
		<category><![CDATA[Wti]]></category>

		<guid isPermaLink="false">http://www.investmentu.com/IUEL/2009/November/new-crude-oil-benchmark.html</guid>
		<description><![CDATA[The New Crude Oil Benchmark  That Could Change the Oil Market&#8217;s Price Dynamics
by Sheena Martin, Contributing Editor
Tuesday, November 24, 2009
Earlier this month, the  world&#8217;s largest oil producer set the table for a move away from traditional  light, sweet crude oil.
Saudi Aramco, the  state-owned company of Saudi Arabia has decided to drop [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/the-new-crude-oil-benchmark-that-could-change-the-oil-market%e2%80%99s-price-dynamics/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Dyax approaching its PDUFA Date (DYAX)</title>
		<link>http://www.straightstocks.com/stock-watch/dyax-approaching-its-pdufa-date-dyax/</link>
		<comments>http://www.straightstocks.com/stock-watch/dyax-approaching-its-pdufa-date-dyax/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 19:41:20 +0000</pubDate>
		<dc:creator>Jay Garcilazo</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Angioedema]]></category>
		<category><![CDATA[C1]]></category>
		<category><![CDATA[drug discovery technology;]]></category>
		<category><![CDATA[drug product;]]></category>
		<category><![CDATA[DX-88;]]></category>
		<category><![CDATA[Dyax Corp.]]></category>
		<category><![CDATA[FavStocks]]></category>
		<category><![CDATA[FDA Pulmonary]]></category>
		<category><![CDATA[FDA Pulmonary-Allergy Advisory Committee]]></category>
		<category><![CDATA[Gustav A. Christensen]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Hereditary Angioedema]]></category>
		<category><![CDATA[inflammation]]></category>
		<category><![CDATA[INH]]></category>
		<category><![CDATA[inherited disease]]></category>
		<category><![CDATA[life-threatening disease]]></category>
		<category><![CDATA[phage display technology]]></category>
		<category><![CDATA[president and chief executive officer]]></category>
		<category><![CDATA[stage biopharmaceutical;]]></category>
		<category><![CDATA[U.S. Food and Drug  Administration]]></category>
		<category><![CDATA[U.S. Food and Drug Administration]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://www.favstocks.com/?p=2178</guid>
		<description><![CDATA[   On 8 June 2009, Dyax Corp. (NASDAQ:DYAX), a clinical stage biopharmaceutical company that discovers, develops and commercializes biotherapeutics for inflammatory and oncology diseases, announced that it had obtained from the US Food ...]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/dyax-approaching-its-pdufa-date-dyax/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Earnings Preview for AutoZone &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/earnings-preview-for-autozone-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/earnings-preview-for-autozone-analyst-blog/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 19:30:31 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Autozone]]></category>
		<category><![CDATA[District Of Columbia]]></category>
		<category><![CDATA[leader]]></category>
		<category><![CDATA[Memphis]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[Puerto Rico]]></category>
		<category><![CDATA[retail]]></category>
		<category><![CDATA[retail market]]></category>
		<category><![CDATA[Tennessee]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27590/Earnings+Preview+for+AutoZone+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>AutoZone</strong> (<a href="http://www.zacks.com/stock/quote/AZO">AZO</a>) is expected to release its sales and earnings results for the fiscal first quarter before the opening bell on Dec 8. The Memphis, Tennessee-based retailer of automotive replacement parts reported a 3.1% year-over-year fall in its profit to $236.1 million or $4.43 per share for the fourth quarter of its fiscal 2009 ended Aug 29, 2009.<br />
 <br />
With this, AutoZone has managed to come close to the Zacks Consensus Estimate profit of $4.45 per share. For the first quarter, Zacks Consensus Estimate for the company is $2.68 per share, a decline of 40%, compared to the recorded earnings in the previous quarter.<br />
 <br />
AutoZone is one of the nation&#8217;s leading specialty retailers of automotive replacement parts and accessories, operating in the Do-It-Yourself (DIY) retail, Do-It-for-Me (DIFM) commercial and other customer markets. As of Aug 29, 2009, the retailer had 4,229 stores in 48 states, the District of Columbia and Puerto Rico in the U.S. and 188 stores in Mexico.<br />
 <br />
The company uses its significant cash flow to open new stores every year and maintain a mid-single-digit square footage growth rate. In fiscal 2009, the company opened 140 new stores in the U.S. and 40 in Mexico. AutoZone is also focused on growing same-store sales by expanding private label offerings, which now account for 25% of sales.<br />
 <br />
AutoZone is the leader in the DIY retail market in the U.S. with a 13% share. The average age of cars on the road is rising, which is raising the demand for auto parts necessitated by greater repair needs. In the DIFM commercial segment, the retailer has a meager 1.3% market share. However, management is of the belief that the company can increase its share in the segment by focusing on improving marketing initiatives to boost sales.<br />
 <br />
Nevertheless, AutoZone has a high degree of reliance on its private label brands, which could mar its performance in the commercial business. Consequently, the company could face increased costs on account of higher staffing levels at the stores on top of rising occupancy costs. Further, several of AutoZone&#8217;s vendors have merged in recent years. This could materially affect the prices at which the company purchases its products.<br />
 <br />
Thus, we maintain our Neutral recommendation on the stock.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AZO">Read the full analyst report on "AZO"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/earnings-preview-for-autozone-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Northrop Wins Military Contract &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/northrop-wins-military-contract-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/northrop-wins-military-contract-analyst-blog/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 19:11:54 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[aircraft systems;]]></category>
		<category><![CDATA[Beale Air Force Base]]></category>
		<category><![CDATA[Block 30]]></category>
		<category><![CDATA[Dayton;]]></category>
		<category><![CDATA[Edwards Air Force Base]]></category>
		<category><![CDATA[electro-optical/infrared and synthetic aperture radar imaging capabilities]]></category>
		<category><![CDATA[Maryland]]></category>
		<category><![CDATA[Northrop Grumman Corp.]]></category>
		<category><![CDATA[Ohio]]></category>
		<category><![CDATA[Patuxent River Naval Air Station]]></category>
		<category><![CDATA[Persian Gulf]]></category>
		<category><![CDATA[RQ-4 Global Hawk]]></category>
		<category><![CDATA[U S Air Force]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Wright Patterson AFB]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27589/Northrop+Wins+Military+Contract+-+Analyst+Blog</guid>
		<description><![CDATA[<p><strong>Northrop Grumman Corp.</strong> (<a href="http://www.zacks.com/stock/quote/NOC">NOC</a>) was awarded a $302.9 million fixed price incentive fee contract for five RQ-4 Global Hawk high-altitude, long-endurance (HALE) unmanned aircraft systems (UAS), by the U.S. Air Force. Earlier, the U.S. Air Force granted RQ-4 Global HALE with a military Airworthiness Certification (AWC), a significant milestone in the life of the aircraft system and a step on the path to routine unmanned flight within the United States.</p>
<p>Under the Lot 7 production contract, the company will build two Block 30 systems and three Block 40 systems for the Aeronautical Systems Group at Wright Patterson AFB in Dayton, Ohio. The award also includes a ground station consisting of a launch and recovery element and a mission control element, plus two additional sensor suites that will be retrofitted into previous production aircraft. The contract runs through 2011.</p>
<p>The company will deliver in 2010 the two Block 30 aircraft equipped with the Enhanced Integrated Sensor Suite (EISS) that provides electro-optical/infrared and synthetic aperture radar imaging capabilities. These aircraft will also be retrofitted to incorporate the production Airborne Signals Intelligence Payload.</p>
<p>The HALE UAS, Global Hawk can soar at altitudes of more than 60,000 feet for more than 32 hours and send near-real-time reconnaissance imagery and signals intelligence data to air, ground, and sea forces. It can fly three times as long and operates at a fraction of the cost per flight hour of its manned counterpart. Compared to other similar UAS, a single Global Hawk collects the same information as 18 smaller medium-altitude UAS.</p>
<p>Global Hawks are currently flown in four locations across the globe: Beale Air Force Base in Northern California, Edwards Air Force Base in Southern California, Patuxent River Naval Air Station in Maryland, and a forward operating location in support of Overseas Contingency Operations in the Persian Gulf.</p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=NOC">Read the full analyst report on "NOC"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/northrop-wins-military-contract-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report!  11/24/09, YRCW, CVAT, CTHR, TEN, RADS, SYNO</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-112409-yrcw-cvat-cthr-ten-rads-syno/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-112409-yrcw-cvat-cthr-ten-rads-syno/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 19:02:40 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[American Society of Plastic Surgeons]]></category>
		<category><![CDATA[Cavitation Technologies Inc.]]></category>
		<category><![CDATA[Charles & Colvard Ltd.]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[Distribution Inc]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[Intel]]></category>
		<category><![CDATA[Mobile Technology]]></category>
		<category><![CDATA[Nano Cavitation Technologies]]></category>
		<category><![CDATA[Patrick L. Horan]]></category>
		<category><![CDATA[President & Chief Executive Officer]]></category>
		<category><![CDATA[president and chief executive officer]]></category>
		<category><![CDATA[Radiant Systems Inc.;]]></category>
		<category><![CDATA[Randy N. McCullough]]></category>
		<category><![CDATA[retail industries]]></category>
		<category><![CDATA[Richard W. Kramp]]></category>
		<category><![CDATA[Seattle]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[surgeon]]></category>
		<category><![CDATA[Surgical Group]]></category>
		<category><![CDATA[Synovis Life Technologies Inc.]]></category>
		<category><![CDATA[Tenneco Inc.]]></category>
		<category><![CDATA[The Netherlands]]></category>
		<category><![CDATA[tissue  product]]></category>
		<category><![CDATA[Trade Partnership]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Veritas]]></category>
		<category><![CDATA[Vice President of Sales]]></category>
		<category><![CDATA[wall street]]></category>
		<category><![CDATA[Washington]]></category>
		<category><![CDATA[www.charlesandcolvard.com]]></category>
		<category><![CDATA[YRC Worldwide Inc.]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4955</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Tuesday Nov 24, 2009
DrStockPick.com Stock Report!
**************************************************************

Cavitation  Technologies, Inc. (OTC BB: CVAT.OB) has filed three new PCT patent  applications to protect our intellectual property worldwide. The patents are for  Flow-Through Cavitation Assisted Rapid Modification of Crude Oil, Modification  of Beverage Fluids, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-112409-yrcw-cvat-cthr-ten-rads-syno/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Some Options as the US Dollar Continues its Slide</title>
		<link>http://www.straightstocks.com/investing-lessons/some-options-as-the-us-dollar-continues-its-slide/</link>
		<comments>http://www.straightstocks.com/investing-lessons/some-options-as-the-us-dollar-continues-its-slide/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 18:56:56 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Caterpillar]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[physical base metal]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19509</guid>
		<description><![CDATA[Buying the dips has been a &#8220;buzz&#8221; word of late. As the stock market goes about its ups and downs, there is money to be made for those that care to pay attention and act. Acting is the operative word in this instance. The issue is, however, we as investors have been taught to buy [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/some-options-as-the-us-dollar-continues-its-slide/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>We Apologize for Interrupting the Gold Rally, But…</title>
		<link>http://www.straightstocks.com/investing-lessons/we-apologize-for-interrupting-the-gold-rally-but%e2%80%a6/</link>
		<comments>http://www.straightstocks.com/investing-lessons/we-apologize-for-interrupting-the-gold-rally-but%e2%80%a6/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 17:59:13 +0000</pubDate>
		<dc:creator>Investment U</dc:creator>
				<category><![CDATA[Contrarian Perspectives]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[bloomberg]]></category>
		<category><![CDATA[InvestmentU]]></category>
		<category><![CDATA[Robert Williams;]]></category>
		<category><![CDATA[Royal Mint]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[yellow metal]]></category>

		<guid isPermaLink="false">http://www.investmentu.com/IUEL/2009/November/gold-rally-interruption.html</guid>
		<description><![CDATA[We  Apologize for Interrupting the Gold Rally, But&#8230;
by Robert Williams, Publisher
Tuesday, November 24, 2009
The fascination with gold of late is incredible. Now, I&#8217;m  well aware of its abilities to hedge the risk of inflation and weakness in the  dollar. But based on the demand-side dynamics we&#8217;re witnessing, you&#8217;d think the  end [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/we-apologize-for-interrupting-the-gold-rally-but%e2%80%a6/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HZHI,  Exclusive Agreement With Exmovere Holdings Inc., for Mobility Aid and BioSensor Products  is Opening the Door to a Multi Million Dollar Industry for Horizon Health International</title>
		<link>http://www.straightstocks.com/stock-watch/hzhi-exclusive-agreement-with-exmovere-holdings-inc-for-mobility-aid-and-biosensor-products-is-opening-the-door-to-a-multi-million-dollar-industry-for-horizon-health-international/</link>
		<comments>http://www.straightstocks.com/stock-watch/hzhi-exclusive-agreement-with-exmovere-holdings-inc-for-mobility-aid-and-biosensor-products-is-opening-the-door-to-a-multi-million-dollar-industry-for-horizon-health-international/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 17:28:47 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[3-D]]></category>
		<category><![CDATA[604-998-3385]]></category>
		<category><![CDATA[advertisment services]]></category>
		<category><![CDATA[assistive technology]]></category>
		<category><![CDATA[British Columbia]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[cellular telephone]]></category>
		<category><![CDATA[Company Director]]></category>
		<category><![CDATA[consumer applications]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[Delbert G. Blewett]]></category>
		<category><![CDATA[disability products;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[e - commerce]]></category>
		<category><![CDATA[e-commerce system]]></category>
		<category><![CDATA[emergency services;]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[ergonomic solutions]]></category>
		<category><![CDATA[Exmovere Holdings Inc.]]></category>
		<category><![CDATA[forward to a long beneficial relationship]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[Horizon Health International Corp.]]></category>
		<category><![CDATA[Jeff Hoogveld]]></category>
		<category><![CDATA[mobility device]]></category>
		<category><![CDATA[mobility devices]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[North Vancouver;]]></category>
		<category><![CDATA[online data centers]]></category>
		<category><![CDATA[personal mobility device]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[Retail Stores]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[wearable device]]></category>
		<category><![CDATA[Workplace Medical Equipment Specialist]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.exmovere.com]]></category>
		<category><![CDATA[www.horizonhealthandsafety.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[Xplosivestocks.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4954</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

Tuesday Nov 24, 2009
DrStockPick.com Stock Report!
**************************************************************
 HZHI, Horizon Health International Corp., HZHI.PK
Horizon Health International Corp. Enters Into an Exclusive Agreement With Exmovere Holdings Inc., for Mobility Aid and BioSensor Products, Opening the Door to a Multi Million Dollar Industry
NORTH VANCOUVER, BRITISH COLUMBIA&#8211;(CRWENEWSWIRE) - HORIZON [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/hzhi-exclusive-agreement-with-exmovere-holdings-inc-for-mobility-aid-and-biosensor-products-is-opening-the-door-to-a-multi-million-dollar-industry-for-horizon-health-international/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 11/24/09, PSFT, IVFH, HTDS, CW, HUM, RPC</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-112409-psft-ivfh-htds-cw-hum-rpc/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-112409-psft-ivfh-htds-cw-hum-rpc/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 17:23:39 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[Amplification Technologies Inc.]]></category>
		<category><![CDATA[Atlanta]]></category>
		<category><![CDATA[Atlanta Community Food Bank]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cell-renewing skin  care products]]></category>
		<category><![CDATA[Commission of European Communities;]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[Curtiss-Wright Corporation]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[food  pantries seeking help]]></category>
		<category><![CDATA[Glenn E. Tynan]]></category>
		<category><![CDATA[Gourmet Food Products]]></category>
		<category><![CDATA[Humana Foundation]]></category>
		<category><![CDATA[Humana Inc.]]></category>
		<category><![CDATA[Innovative Food Holdings Inc.]]></category>
		<category><![CDATA[National Aeronautics and Space Administration]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[New York City]]></category>
		<category><![CDATA[North Georgia]]></category>
		<category><![CDATA[nutritious food]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[PowerSafe Technology Corporation]]></category>
		<category><![CDATA[Radient Pharmaceuticals Corporation]]></category>
		<category><![CDATA[Second Annual Gabelli & Company]]></category>
		<category><![CDATA[Securities And Exchange Commission]]></category>
		<category><![CDATA[Slavica Bio Chem]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[The Grand Hyatt Hotel]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vice President and CFO]]></category>
		<category><![CDATA[www.ampti.net]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4950</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Tuesday Nov 24, 2009
DrStockPick.com Stock Report!
**************************************************************

PowerSafe Technology  Corporation (Other OTC: PSFT.PK), announced today that two Small  Business Innovation Research (SBIR) projects submitted by its wholly owned  subsidiary Amplification Technologies Inc. (www.ampti.net) (ATI) have been competitively  selected by NASA. Phase I [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-112409-psft-ivfh-htds-cw-hum-rpc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Brightpoint Wins WiMAX Contract &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/brightpoint-wins-wimax-contract-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/brightpoint-wins-wimax-contract-analyst-blog/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 17:01:22 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[3g]]></category>
		<category><![CDATA[3G/4G wireless devices]]></category>
		<category><![CDATA[4G WiMax]]></category>
		<category><![CDATA[4G WiMAX mobile broadband services]]></category>
		<category><![CDATA[activation services]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Brightpoint Inc.]]></category>
		<category><![CDATA[broadband]]></category>
		<category><![CDATA[broadband network]]></category>
		<category><![CDATA[Internet speed]]></category>
		<category><![CDATA[inventory management;]]></category>
		<category><![CDATA[mobile broadband network]]></category>
		<category><![CDATA[mobile broadband services;]]></category>
		<category><![CDATA[North Carolina]]></category>
		<category><![CDATA[PDA]]></category>
		<category><![CDATA[Road Runner]]></category>
		<category><![CDATA[streamlined supply chain solution]]></category>
		<category><![CDATA[Time Warner Cable Inc.]]></category>
		<category><![CDATA[transportation management]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[wireless data card]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27582/Brightpoint+Wins+WiMAX+Contract+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Brightpoint Inc.</strong> (<a href="http://www.zacks.com/stock/quote/CELL">CELL</a>) received a shot on its arm as the company received a major contract to provide an integrated supply chain management system for the next-generation (4G) WiMAX network. Yesterday, the company announced that it has entered into an agreement with <strong>Time Warner Cable Inc. </strong>(<a href="http://www.zacks.com/stock/quote/TWC">TWC</a>) to provide transportation management, inventory management, device customization, fulfillment, and reverse logistics for the latter&#8217;s upcoming WiMAX venture.<br />
 <br />
Time Warner Cable, the second largest cable MSO in the U.S., will launch its 4G WiMAX mobile broadband services in three North Carolina markets from Dec 1. Under the brand name of &#8220;Road Runner Mobile", this super-fast mobile broadband network will support Internet speed of 6 Mbps. The &#8220;Road Runner Mobile" service will provide its subscribers the convenience of mobility so that the customers can enjoy the WiMAX services on their devices anywhere they go within their service circle.<br />
 <br />
Brightpoint will provide a streamlined supply chain solution to Time Warner Cable to support the launch of Road Runner Mobile including wireless data card, accessory and collateral fulfillment and returns, triage and repairs. Brightpoint has enhanced its portfolio of product offerings with a full range of sales &#38; distribution, logistics, and activation services. The company has a solid global customer base. Management continues to seek new operational initiatives that foster improved customer handling of handsets, in particular PDA&#8217;s, data and 3G/4G wireless devices.<br /><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=CELL">Read the full analyst report on "CELL"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=TWC">Read the full analyst report on "TWC"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/brightpoint-wins-wimax-contract-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>3Q GDP Growth Revised to 2.8% &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/3q-gdp-growth-revised-to-2-8-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/3q-gdp-growth-revised-to-2-8-analyst-blog/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 16:29:18 +0000</pubDate>
		<dc:creator>Dirk Van Dijk</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Congress]]></category>
		<category><![CDATA[Fannie]]></category>
		<category><![CDATA[Federal Government]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[Freddie]]></category>
		<category><![CDATA[Kicker]]></category>
		<category><![CDATA[Medicare]]></category>
		<category><![CDATA[New Century Financial]]></category>
		<category><![CDATA[Pentagon]]></category>
		<category><![CDATA[Real Estate]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Washington]]></category>
		<category><![CDATA[Washington Mutual]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27597/3Q+GDP+Growth+Revised+to+2.8%25+-+Analyst+Blog</guid>
		<description><![CDATA[<p class="MsoNormal"><em><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial;font-style: italic"><br />
This is a revision to the post I put up when the first cut at the GDP report came out on 10/30.  In it the new numbers are in <strong><span style="font-weight: bold">bold</span></strong> and the original estimates are put in parentheses, thus a number in parentheses does not mean that it has a negative value (those will have a minus sign in front of them, numbers relating to the first or second quarters are left unchanged.  New text will be in italics. This should give the reader a clear sense of not only how strong GDP and its components, but also how the latest numbers match up. </span></font></em></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial">The recession is over! In the third quarter GDP grew by <strong><span style="font-weight: bold">2.8%</span></strong> (3.5%), <em><span style="font-style: italic">slightly below (</span></em>comfortably ahead) of expectations for <strong><span style="font-weight: bold">2.9%</span></strong> (3.0%) growth. This is a huge improvement over the 0.7% decline in the second quarter and the 6.4% plunge in the first quarter.
<p>The internals of the report were strong as well, although it appears that much of the growth came from things like the Cash for Clunkers program and the extraordinary levels of support that are currently being given to the housing sector.</p>
<p>I will first go over the percentage growth rates for the main components of GDP, and then how much each part contributed to, or subtracted from, the <strong><span style="font-weight: bold">2.8% </span></strong>(3.5%) growth rate. This is probably the more important part since the size of the different parts of GDP are very different, and a small percentage change in a big component can have more impact than a large change in a small component. Just as a reminder: GDP is equal to the sum of Consumer spending, Investment spending, Government spending and net exports, or Y = C + I + G + (X &#8211; M) and I will be using that framework for the discussion.</p>
</span></font></p>
<p class="MsoNormal"><strong><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial;font-weight: bold"><em>Growth Rates</em><br />
<br />
</span></font></strong></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial">The overall<strong><span style="font-weight: bold"> 2.8%</span></strong> (3.5%) growth of GDP was almost matched by its biggest component, Personal Consumption expenditures, or PCE, which grew <strong><span style="font-weight: bold">2.9% (</span></strong>3.4%), a big improvement over the 0.9% decline in the second quarter and the 0.6% increase in the first three months of the year.<br />
<br />
<p>It is important to note that during the recession, consumer spending declined far less than did overall GDP, especially in the first quarter, so the consumer was becoming a much bigger part of the overall economy. This is not healthy over the long run, but at this point I think people are happy to get some growth where ever we can find it</p>
<p>Consumers spend on both goods and services, and goods are broken down into durable and non durable goods. The big mover in the third quarter were goods, which increased by <strong><span style="font-weight: bold">7.2% </span></strong>(8.1%) following a decline of 3.1% in the 2Q and an increase of 2.5% in the 1Q. Spending on durable goods was the real driver, growing at an annualized rate of <strong><span style="font-weight: bold">20.1% (</span></strong>22.3%) in the 3Q, following a 5.6% decline in the 2Q and a 3.9% increase in the 1Q.</p>
<p>Spending on non-durable goods tends to be much more stable than spending on durable goods. Non-durable goods spending rose by <strong><span style="font-weight: bold">1.7%</span></strong> (2.0%) reversing a 1.9% decline in the 2Q, which was in turn a reversal of a 1.9% increase in the 1Q. Spending on services tends to be even more stable than spending on non-durable goods. Service spending grew at an annualized rate of <strong><span style="font-weight: bold">1.0% (</span></strong>1.2%) in the 2Q up from a 0.2% increase in the 2Q and a 0.3% decline in the 1Q</p>
<p>Historically, spending on durable goods has been one of the key drivers to getting us out of a recession, and not spending on durable goods one of the key reasons for falling into recessions. It is the volatility in the sector that makes it important more than its absolute size.</p>
</span></font></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial"> </span></font></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial">
<p>Now, you might wonder, what caused the recession to be so nasty last winter when Consumer spending wasn&#8217;t really all that bad? The answer is that Investment really fell of a cliff. The good news is that it is starting to come back.</p>
<p>Overall Gross Private Domestic investment grew at an <strong><span style="font-weight: bold">8.4% (</span></strong>11.5%) annualized rate in the 3Q, but it still has a lot of lost ground to make up from the earlier part of the year. In the second quarter overall investment spending fell at a 23.7% annualized rate</p>
<p>Now here is the kicker -- that was actually a dramatic improvement over the 1Q when investment spending absolutely collapsed, falling 50.5%. Clearly the biggest collapse in investment spending since the Great Depression (and it came on the heels of a 24.2% decline in the 4Q of 2008). To anyone who understood what was going on, those were really terrifying times, and the turnaround from them is absolutely spectacular</p>
<p>There are two basic types of investment: fixed and inventory, and right now we are concerned with fixed investment (I will cover inventory later in the contributions to GDP part).</p>
</span></font></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial"> </span></font></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial">Fixed investment is broken into two parts, Non-Residential or business investment and Residential investment, which is mostly homebuilding.<br />
<br />
<p>Overall Fixed investment rose by <strong><span style="font-weight: bold">0.3% (</span></strong>2.3%) following declines of 12.5% in the 2Q and 39.0% in the 1Q. Business investment, however, continued to decline, but at a much slower rate, falling <strong><span style="font-weight: bold">4.1% (</span></strong>2.5%) after 9.6% and 39.2% declines in the 2Q and 1Q, respectively. With massive amounts of unused capacity it is not surprising that businesses are cutting back on their capital spending still.</p>
<p>Business investment comes in two flavors, spending on structures like building new factories, malls and office buildings and spending on equipment and software to go into them. Spending on structures continues to be very weak, falling at a <strong><span style="font-weight: bold">15.1% </span></strong>(9.0%) annualized rate in the 3Q, but that marks an improvement over the 17.3% decline in the 2Q and the 43.6% collapse in the 1Q. With massive amounts of space sitting idle in offices and empty strip malls littering the landscape, look for new investment in commercial real estate to continue to decline in coming quarters.</p>
<p>Moody&#8217;s has estimated that the value of commercial real estate has plunged by 41% since the peak a little over a year ago, and that is hardly an inducement to build more. If a business needs the space, it's far cheaper to just buy some existing space.</p>
</span></font></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial"> </span></font></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial">Spending on Equipment and Software (E&#38;S) on the other hand is starting to come back, if only feebly, rising <strong><span style="font-weight: bold">2.3%</span></strong> (1.1%) after a 4.9% decline in the 2Q and a 36.4% plunge in the 1Q. Look for some stability in this line going forward as the new Microsoft operating system will probably generate a new PC cycle, but with capacity utilization still around 70% I would not expect a boom in orders for new factory equipment.<br />
<br />
<p>The real star of fixed investment though came on the residential side, which rose <strong><span style="font-weight: bold">19.5% (</span></strong>23.4%). This is the first increase in almost four years, and follows declines of 23.3% in the 2Q and 38.2% in the 1Q. The long string of declines had brought residential investment to a record low share of GDP. The extraordinary support of the housing sector by the government, including the first time buyer tax credit, the Fed buying up $1.25 Trillion of <strong>Fannie</strong> (<a href="http://www.zacks.com/stock/quote/fnm">FNM</a>) and <strong>Freddie</strong> (<a href="http://www.zacks.com/stock/quote/fre">FRE</a>) backed paper to artificially suppress mortgage rates and the FHA acting like the old New Century Financial or Washington Mutual on their worst days have played a big role in the turnaround. I seriously question the sustainability of it after the support is removed, and I don&#8217;t think the support can continue indefinitely.</p>
</span></font></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial"> </span></font></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial">Government spending grew by <strong><span style="font-weight: bold">3.1% (</span></strong>2.3%) in the 3Q, a big slowdown from the 6.7% increase in the 2Q, but more than the 2.6% decline in the 1Q. It was all at the Federal level where spending rose at an annual rate of  <strong><span style="font-weight: bold">8.3% (</span></strong>7.9%) down from a 11.4% increase in the 2Q, but up from the 4.3% decline in the 1Q.<br />
<br />
<p>Remember this measure of government spending does not include spending on transfer payments like Social Security and Medicare, which are largely captured in the consumption numbers. Defense spending was the big driver -- we are still a nation fighting two wars. It grew at an annual rate of <strong><span style="font-weight: bold">8.3%</span></strong> (8.4%) down from a 14.0% rate of increase in the 2Q but up from a 5.1% decline in the 1Q.</p>
<p class="MsoNormal">Non-defense spending rose at a <strong><span style="font-weight: bold">6.9% (</span></strong>6.8%) annual rate following a 6.1% increase in the 2Q and a 2.5% decline in the 1Q. State and local spending on the other hand is constrained by balanced budget laws and falling tax revenues. It declined <strong><span style="font-weight: bold">0.1% (</span></strong>1.1%) in the 3Q following a 3.9% increase in the 2Q and a 1.5% decline in the 1Q. They were able to increase spending in the 2Q due to support for the Federal government as part of the stimulus package. Now that support looks like it is being overwhelmed by the plunge in property, income and sales taxes.<font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial"><br />
<br />
</span></font></p>
</span></font></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial">
<p>International trade has started to rebound, and we saw an increase in both imports and exports. Increasing exports are good for GDP and increases in Imports are bad for GDP, and unfortunately imports rose more than did exports. We were able to improve our overseas sales by <strong><span style="font-weight: bold">17.0% (</span></strong>14.7%) in the 3Q -- a nice turnaround from the 4.1% decline in the 2Q and the 29.9% plunge in the 1Q. Unfortunately we also increase what we bought from overseas by <strong><span style="font-weight: bold">20.8% (</span></strong>16.4%), a big turnaround from the 14.7% decline in the 2Q and the 36.4% plunge in the first three months of the year. Keep in mind that we import a lot more than we export, so not only was the percentage increase bigger for imports, it was coming off a higher base.</p>
</span></font></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial"> </span></font></p>
<p class="MsoNormal"><em><strong><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial;font-weight: bold">Contributions to Growth</span></font></strong></em></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial">Not all components of GDP are created equal.  Some are very big, and others relatively small. Some tend to be very stable over time, and some tend to swing violently from quarter to quarter. The bigger and more volatile they are, the more they will impact the overall growth rate of GDP. Thus looking at just the percentage changes in the componenets does not tell the full story. Of the <strong><span style="font-weight: bold">2.8%</span></strong> (3.5%) total growth, how many points were added or subtracted by each part of the economy?</span></font></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial">  </span></font></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial">The biggest part of the economy is the Consumer or PCE, over all it contributed <strong><span style="font-weight: bold">2.07</span></strong> (2.36) of the <strong><span style="font-weight: bold">2.80</span></strong> (3.50) points of total growth. In the second quarter it caused 0.62 of the 0.70 total decline in the 2Q. In the first quarter it actually offset 0.44 points of the 6.40 total decline. In other words, excluding the consumer the economy would have contracted 6.84% rather than 6.40%.<br />
<br />
<p>Within consumer spending, spending on goods added <strong><span style="font-weight: bold">1.60 (</span></strong>1.79) points after subtracting 0.71 points in the 2Q and adding 0.56 points in the 1Q. Spending on durables was the main driver, adding <strong><span style="font-weight: bold">1.34</span></strong> (1.47) points after subtracting 0.41 points in the 2Q and adding 0.28 in the 1Q.  Non durable goods added 0.26 (0.31) points after subtracting 0.29 in the 2Q and adding 0.29 in the 1Q.</p>
<p class="MsoNormal">While spending on services is much more stable than spending on goods, it is also a much larger portion of the consumer wallet. Service spending added <strong><span style="font-weight: bold">0.47 </span></strong>(0.57) points to the overall GDP growth in the 2Q, up from adding 0.09 points in the 2Q and subtracting 0.13 in the 1Q. It is the volatility that gives durable goods there importance to the economy not the overall size. In the third quarter total spending on durable goods was at a $1.055 Trillion annual rate, just 15.4% of the $6.852 Trillion spent on services, but durables goods had an impact on economic growth that was 158% bigger.<br />
<font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial"> <br />
</span></font></p>
</span></font></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial">Investment spending was a big swing factor in the 3Q.  It added <strong><span style="font-weight: bold">0.91</span></strong> (1.22) points to overall growth. That is a HUGE improvement over the 3.10 point subtraction in the 2Q and the 8.98 point implosion in the 1Q.  Unfortunately. <strong><span style="font-weight: bold">0.87 </span></strong>(0.94) points of that contribution came from inventories. Inventory investment is the &#8220;worst" type of GDP growth since large increases in one quarter are usually reversed in the next quarter, or in this case, large declines being reversed upwards. <br />
<br />
<p>In the 2Q inventory investment subtracted 1.42 points from overall growth and in the 1Q they subtracted 2.36 points.  Even in the 4Q they subtracted 0.64 points from growth.  Three straight quarters of sharply lower inventories is highly unusual and we were due for a bounce.  Perhaps we have one more quarter of a solid contribution from inventory investment, but I would not expect it to last much beyond that. </p>
</span></font></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial"> </span></font></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial">Overall fixed investment added just <strong><span style="font-weight: bold">0.04 (</span></strong>0.28) points to growth, but that sure was a nice improvement over the 1.68 point subtraction and the 6.62 point disaster that was the 1Q. <br />
<br />
<p>However, it was not coming from the business side.  Business investment subtracted <strong><span style="font-weight: bold">0.40</span></strong> (0.24) growth points in the 3Q, so it is still very soft, but at least it is not imploding like it was earlier in the year.  In the 2Q it subtracted 1.01 points and in the 1Q it took away 5.29 growth points.  Within business investment it was spending on structures that caused the problem with a deduction of <strong><span style="font-weight: bold">0.55 </span></strong>(0.32) growth points while spending on E&#38;S offset 0.15 (0.08) points of that.  In the 2Q both sides of business investment were drags on the economy with investment in Commercial real estate subtracting 0.69 growth points and spending on equipment deducting 0.32 points.  The 2Q was in turn a major improvement over the 1Q disaster where spending on structures subtracted 2.28 growth points and equipment spending subtracted 3.01 points.</p>
</span></font></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial"> </span></font></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial">
<p>Housing finally helped the economy in the 3Q, adding <strong><span style="font-weight: bold">0.45</span></strong> (0.53) points to growth, after a string of 15 straight quarters where it was a drag on the economy.  In the 2Q it was a 0.67 point drag and in the 1Q it was a 1.33 point drag.  The long decline has, however, made housing a much smaller share of the overall economy.  In the 3Q residential investment totaled only $360.9 billion, or 2.52% of the overall economy.  At the peak of the housing bubble it represented 6.34% of the overall economy.  Thus the <strong><span style="font-weight: bold">19.5 </span></strong>(23.3%) increase in residential investment had far less of an overall impact than it did in the past.</p>
<p>While residential investment is still near a record low share of the overall economy, I have serious questions about the sustainability of the increase.  The extension and expansion of the tax credit as is now moving through the Congress might keep things going for the next few quarters, but after that things are likely to fall apart again. <em><span style="font-style: italic">Most of the tax credit is going to those who buy existing homes, rather than new homes, and thus it is a very inefficient way of increasing residential investment.  It is however, an open question if we really want to be directing resources into housing given the glut of housing units in the country.</span></em>  Just like we saw with the Cash for Clunkers program, it is probably just encouraging those folks who might have bought later to buy now. <em><span style="font-style: italic">Cash for clunkers was a much smaller program, totaling only $3.0 billion, yet is had a huge impact on the economy, most of the improvement in consumer durable goods came from autos. <br />
<br />
</span></em></p>
<p class="MsoNormal">The tax credit is also tricking people into thinking that the house is more affordable that it really is, just the way that teaser rate ARM&#8217;s did, and we saw just how well that worked out.  The FHA is handing out mortgages with only 3.5% down and people can use the tax credit for that ridiculously small down payment.  This has future disaster of biblical proportions written all over it.  The next bailouts will not be of the banks like <strong>Bank of America</strong> (<a href="http://www.zacks.com/stock/quote/bac">BAC</a>) and <strong>Citigroup</strong> (<a href="http://www.zacks.com/stock/quote/c">C</a>) but of the FDIC and the FHA<font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial">.<br />
<br />
</span></font></p>
</span></font></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial">Direct government spending had a small but positive impact on overall growth in the 3Q, adding <strong><span style="font-weight: bold">0.63 </span></strong>(0.48) points a fairly significant slowdown from the 1.33 contribution in the 2Q, but better than the 0.52 point drag in the 1Q.  All the help came from  Washington , not city hall or the statehouse. <br />
<br />
<p>The Federal government added <strong><span style="font-weight: bold">0.65</span></strong> (0.62) growth points, down from 0.85 points in the 2Q but up from a 0.33 point drag in the 1Q.  The Pentagon was the main factor in all three quarters, with defense spending adding <strong><span style="font-weight: bold">0.48</span></strong> (0.45) points in the 3Q following a 0.70 addition in the 2Q and a 0.27 point drag in the 1Q.  Non-defense spending was sort of a non issue, adding just <strong><span style="font-weight: bold">0.17 </span></strong>(0.17) points in the 3Q, not much difference from the 0.15 point contribution in the 2Q, and up a little bit from the slight 0.06 point drag in the 1Q.</p>
</span></font></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial"> </span></font></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial">
<p>State and Local governments are not allowed to run operating deficits, and so when faced with declining tax revenues they have to cut back, unless Uncle Sam helps them out.  Well  Washington is helping, but its not enough and S&#38;L spending was a <strong><span style="font-weight: bold">0.02</span></strong> (0.14) point drag in the 3Q.  The Federal help was enough in the 2Q and so the contribution to growth in the 2Q was a positive 0.48 points.  In the 1Q, before the stimulus package could get much traction S&#38;L spending was a 0.19 point drag.</p>
</span></font></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial"> </span></font></p>
<p class="MsoNormal"><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial">
<p>Net exports had been just about the only bright spot in the first half of the year, even though it came the wrong way, from both imports and exports plunging, only with imports falling more than exports did.  That reversed in the 3Q as both showed a nice expansion, but our appetite for foreign goods outstripping the desire for  U.S. goods and services abroad.  The increase in exports added <strong><span style="font-weight: bold">1.71</span></strong> (1.49) points to growth, but the increase in imports was a <strong><span style="font-weight: bold">2.53 </span></strong>(2.01) point drag, for a net negative contribution from net exports of <strong><span style="font-weight: bold">0.82 </span></strong>(0.52) points. In the 2Q falling exports subtracted 0.45 points but plunging imports added 2.09 points, for a net imports net help to the economy of 1.64 points.</p>
<p class="MsoNormal">In the first quarter, as world trade came to a near standstill, net exports were just about the only positive you could find for the economy. Yes, plunging exports subtracted an awful 3.95 points of growth, but the fact that we were buying practically nothing from overseas added 6.58 growth points for a net aid to the economy of 2.85 points. In other words, if the  U.S.  were a closed economy in the first quarter, growth would have fallen not at a 6.4% rate, but at a 9.25% rate.<font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial"><br />
<br />
</span></font></p>
</span></font></p>
<p class="MsoNormal"><em><strong><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial;font-weight: bold">Overall</span></font></strong></em></p>
<p class="MsoNormal"><em><font size="2" face="Arial"><span style="font-size: 10pt;font-family: Arial;font-style: italic">
<p>Relative to the first cut at the data, the downward revisions were broad based, with smaller contributions from all major areas of the economy, with the exception of the government.  Of particular concern is that fixed investments contribution to growth virtually disappeared.</p>
<p>Investment&#8217;s share of GDP is near all time low&#8217;s and that is not a good thing for the future of the country. Inventory investment really does not count in this regard.   The trade deficit (net exports) continues to be a major problem.  While consumption spending growth was revised lower, it still grew faster than overall GDP, indicating that it continues to grow as a share of the economy.</p>
<p>This country needs to move its economy towards one that is focused on investment and exports, not one dominated by consumption, and consumption of imported goods in particular.   Still, even though it was not as good a report as the original, it sure is an improvement over the second quarter, and especially over the fourth quarter.</p>
</span></font></em></p>
<p class="MsoNormal"><font size="3" face="Times New Roman"><span style="font-size: 12pt"> <br />
<em>Dirk van Dijk, CFA is the Chief Equity Strategist for Zacks.com. With more than 25 years investment experience he has become a popular commentator appearing in the Wall Street Journal and on CNBC. Dirk is also the Editor in charge of the market-beating <a href="http://www.zacks.com/registration/strategicinvestor/welcome/?adid=SI_online_commentary_dvd">Zacks Strategic Investor</a> service.</em><br />
</span></font></p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=FNM">Read the full analyst report on "FNM"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=FRE">Read the full analyst report on "FRE"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=C">Read the full analyst report on "C"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BAC">Read the full analyst report on "BAC"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/3q-gdp-growth-revised-to-2-8-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>People&#8217;s United Eyes Acquisition &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/peoples-united-eyes-acquisition-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/peoples-united-eyes-acquisition-analyst-blog/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 16:20:46 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[equipment finance businesses]]></category>
		<category><![CDATA[exclusive financial advisor]]></category>
		<category><![CDATA[Financial Federal Corporation]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[People's United Financial Inc.]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27578/People%27s+United+Eyes+Acquisition+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>People's United Financial Inc</strong>. (<a href="http://www.zacks.com/stock/quote/PBCT">PBCT</a>) said on Monday that it is eyeing the acquisition of <strong>Financial Federal Corporation</strong> (<a href="http://www.zacks.com/stock/quote/FIF">FIF</a>) for about $738 million in stock and cash. <br />
<br />
People's United, the holding company for People's United Bank, expects the acquisition to be completed in the first quarter of 2010. This acquisition is expected to be significantly accretive to People's United&#8217;s operating earnings in 2010 without diluting its capital ratios and have an IRR greater than 20%. <br />
<br />
Under the terms of the acquisition, Financial Federal shareholders will receive $11.27 in cash and one share of People's United common stock. Calculated with the closing price of People's United shares on Nov 20, the transaction is valued at $27.74 per Financial Federal share. The receipt of People's United stock by shareholders of Financial Federal is expected to be tax-free. <br />
<br />
According to the People's United management, this acquisition offers opportunities for the company to grow its highly-profitable equipment financing business with experienced staff in new markets throughout the country. The combined portfolio will rank People's United 13th among U.S. bank-owned equipment finance businesses. <br />
<br />
<strong>Morgan Stanley</strong> (<a href="http://www.zacks.com/stock/quote/MS">MS</a>) acted as exclusive financial advisor to People's United and Keefe Bruyette &#38; Woods acted as exclusive financial advisor to Financial Federal Corporation. <br />
<br />
Financial Federal&#8217;s fourth quarter fiscal 2009 (ended Jul 31) earnings of 35 cents per share came in two cents short of the Zacks Consensus Estimate. The earnings for the quarter were also down 29% from 49 cents in the prior-year quarter. Results were negatively impacted primarily by fewer originations, higher provision for credit losses and increased expenses. However, a significant improvement in net interest margin, decreased cost of debt, and strong liquidity were impressive during the quarter<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PBCT">Read the full analyst report on "PBCT"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=FIF">Read the full analyst report on "FIF"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=MS">Read the full analyst report on "MS"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/peoples-united-eyes-acquisition-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PWRM, MRK, DrStockPick.com Stock Report! Power 3 Medical Products Inc. and  Merck  Co. Inc.</title>
		<link>http://www.straightstocks.com/stock-watch/pwrm-mrk-drstockpick-com-stock-report-power-3-medical-products-inc-and-merck-co-inc/</link>
		<comments>http://www.straightstocks.com/stock-watch/pwrm-mrk-drstockpick-com-stock-report-power-3-medical-products-inc-and-merck-co-inc/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 16:20:33 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[actual disease]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[alendronate sodium]]></category>
		<category><![CDATA[ALS]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[diagnostic tests]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[human health pharmaceutical products]]></category>
		<category><![CDATA[Ira L. Goldknopf]]></category>
		<category><![CDATA[John F. Keenan]]></category>
		<category><![CDATA[judge]]></category>
		<category><![CDATA[Merck & Co. Inc.]]></category>
		<category><![CDATA[MRK]]></category>
		<category><![CDATA[neurodegenerative disease;]]></category>
		<category><![CDATA[neurological disorders]]></category>
		<category><![CDATA[Power 3 Medical Products Inc.]]></category>
		<category><![CDATA[Power3;]]></category>
		<category><![CDATA[President and Chief Scientific Officer]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[PWRM]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[U.S. District Court]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[www.BestOTC.com]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.merck.com]]></category>
		<category><![CDATA[www.PennyOmega.com]]></category>
		<category><![CDATA[www.power3medical.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[www.stock-pr.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4946</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

Tuesday Nov 24, 2009
DrStockPick.com Stock Report!
PWRM, MRK
**************************************************************
PWRM, Power 3 Medical Products Inc, PWRM.OB
PWRM is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. PWRM’s patent-pending [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/pwrm-mrk-drstockpick-com-stock-report-power-3-medical-products-inc-and-merck-co-inc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MetroPCS Upgraded to Neutral &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/metropcs-upgraded-to-neutral-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/metropcs-upgraded-to-neutral-analyst-blog/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 16:00:11 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[4G Long Term Evolution (LTE)]]></category>
		<category><![CDATA[4G Long Term Evolution (LTE) wireless broadband service]]></category>
		<category><![CDATA[America Movil]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[AT&T]]></category>
		<category><![CDATA[Atlanta]]></category>
		<category><![CDATA[Dallas]]></category>
		<category><![CDATA[Ericsson]]></category>
		<category><![CDATA[Las Vegas]]></category>
		<category><![CDATA[Los Angeles]]></category>
		<category><![CDATA[MetroPCS Communications]]></category>
		<category><![CDATA[Northeastern]]></category>
		<category><![CDATA[prepaid wireless segment]]></category>
		<category><![CDATA[product/services]]></category>
		<category><![CDATA[Samsung]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Sprint Nextel]]></category>
		<category><![CDATA[ultra high-bandwidth multimedia data applications]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Verizon]]></category>
		<category><![CDATA[wireless broadband]]></category>
		<category><![CDATA[wireless broadband service;]]></category>
		<category><![CDATA[wireless carriers]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27577/MetroPCS+Upgraded+to+Neutral+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
We upgrade our recommendation for <strong>MetroPCS Communications</strong> (<a href="http://www.zacks.com/stock/quote/PCS">PCS)</a> to Neutral following the company&#8217;s better-than-expected operating results in the last quarter. Reported earnings have outpaced the Zacks Consensus Estimate fueled by healthy revenue growth across the company&#8217;s Core and Northeast markets. MetroPCS is benefiting from its new unlimited international calling plan which is driving revenue per user. <br />
<br />
MetroPCS remains a leading low-cost service provider in the unlimited prepaid market in the US and will continue to benefit from the ongoing wireline replacement trend. The company is increasingly focused on strengthening its position in the unlimited prepaid segment by broadening its portfolio of discounted service plans.<br />
<br />
MetroPCS has initiated several steps to counter intense competition and drive subscriber accretion. The company is rolling out new product/services, upgrading network infrastructure and entering additional markets for growth. <br />
<br />
The company is currently enjoying meaningful traction in the Northeast region, which is evidenced by healthy subscriber growth. Gains from the Northeastern markets continue to offset declines in Core markets (including Atlanta, Dallas, Las Vegas, Los Angeles and San Francisco). A significant part of MetroPCS&#8217; network infrastructure deployment initiatives is centered on the lucrative Northeast region. <br />
<br />
MetroPCS has joined the league of the top-tier US wireless carriers such as <strong>Verizon</strong> (<a href="http://www.zacks.com/stock/quote/VZ">VZ</a>) and <strong>AT&#38;T</strong> (<a href="http://www.zacks.com/stock/quote/T">T</a>) as the company recently declared vendors for its 4G Long Term Evolution (LTE) wireless broadband service. MetroPCS has selected <strong>Ericsson </strong>(<a href="http://www.zacks.com/stock/quote/ERIC">ERIC</a>) as network infrastructure vendor and Samsung as the supplier of LTE enabled handsets. <br />
<br />
The company plans to launch 4G LTE service and several dual-mode smartphones across its metropolitan markets in second-half 2010. The ultra high bandwidth multimedia data applications supported by the 4G LTE network will boost revenue per user through increased minutes of use. <br />
<br />
However, despite these encouraging growth prospects, MetroPCS contends with subscriber retention problems as customer accretion continues to decelerate on a sequential basis due to intense competition in the prepaid wireless segment. The company is experiencing sustained customer attrition in its legacy Core markets. <br />
<br />
Churn (customer switch) level remains high due to increased customer defection as the company&#8217;s larger peers in the prepaid market such as <strong>Sprint Nextel</strong> (<a href="http://www.zacks.com/stock/quote/S">S</a>) and <strong>America Movil&#8217;s</strong> (<a href="http://www.zacks.com/stock/quote/AMX">AMX</a>) Tracfone continue to lure subscribers with competitive service plans and better product offerings.<br />
 <br />
While expansion into the Northeastern markets is expected to drive future growth, we feel that associated capital expenditures will strain balance sheet moving forward.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PCS">Read the full analyst report on "PCS"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=VZ">Read the full analyst report on "VZ"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=T">Read the full analyst report on "T"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ERIC">Read the full analyst report on "ERIC"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=S">Read the full analyst report on "S"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AMX">Read the full analyst report on "AMX"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/metropcs-upgraded-to-neutral-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>AlumniFuel Power Corp. (AFPW.OB) Subsidiary Turns Heads with Technology at Naval Energy Forum</title>
		<link>http://www.straightstocks.com/investing-lessons/alumnifuel-power-corp-afpw-ob-subsidiary-turns-heads-with-technology-at-naval-energy-forum/</link>
		<comments>http://www.straightstocks.com/investing-lessons/alumnifuel-power-corp-afpw-ob-subsidiary-turns-heads-with-technology-at-naval-energy-forum/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 15:02:46 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Admiral]]></category>
		<category><![CDATA[AlumniFuel Power Incorporated]]></category>
		<category><![CDATA[American Power Corporation]]></category>
		<category><![CDATA[AmericanFuel Power Corporation]]></category>
		<category><![CDATA[chief]]></category>
		<category><![CDATA[David Cade]]></category>
		<category><![CDATA[Department of Defense]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Gary Roughead]]></category>
		<category><![CDATA[hydrogen gas]]></category>
		<category><![CDATA[life gas]]></category>
		<category><![CDATA[Navy Ray Mabus]]></category>
		<category><![CDATA[niche applications]]></category>
		<category><![CDATA[owned operating subsidiary]]></category>
		<category><![CDATA[President and CEO]]></category>
		<category><![CDATA[Secretary of Navy Ray Mabus]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[United States Marine Corps;]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Virginia]]></category>
		<category><![CDATA[wall street]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19497</guid>
		<description><![CDATA[One company that has been turning the heads of investors of late is AlumniFuel Power Incorporated.  A Philadelphia based company, AlumniFuel Power (API) is the wholly owned operating subsidiary of American Power Corporation and is an early-stage alternative energy company that utilizes state-of-the-art technology to generate hydrogen gas and steam for multiple niche applications [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/alumnifuel-power-corp-afpw-ob-subsidiary-turns-heads-with-technology-at-naval-energy-forum/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cameron Completes NATCO Deal &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/cameron-completes-natco-deal-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/cameron-completes-natco-deal-analyst-blog/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 15:00:00 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Cameron International Corp;]]></category>
		<category><![CDATA[Cooper Cameron Corporation]]></category>
		<category><![CDATA[Dual Frequency electrostatic]]></category>
		<category><![CDATA[Dual Frequency electrostatic technology]]></category>
		<category><![CDATA[electrostatic technology]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[NATCO Group]]></category>
		<category><![CDATA[Oil And Gas]]></category>
		<category><![CDATA[oil drilling equipment maker]]></category>
		<category><![CDATA[pressure control equipment]]></category>
		<category><![CDATA[refinery desalter products]]></category>
		<category><![CDATA[separation and processing solutions]]></category>
		<category><![CDATA[subsea applications]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[U.S. Department of Justice]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27575/Cameron+Completes+NATCO+Deal+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Last week, oil drilling equipment maker <strong>Cameron International Corp.</strong> (<a href="http://www.zacks.com/stock/quote/CAM">CAM</a>) closed the previously announced acquisition of Texas-based fellow oilfield service provider NATCO Group for approximately $780 million, following the approval by NATCO&#8217;s shareholders. <br />
<br />
In relation to the acquisition, Cameron reached an agreement with the U.S. Department of Justice (DOJ) to divest its Edge refinery desalter business and will license, on a non-exclusive basis, NATCO's Dual Frequency electrostatic technology for refinery desalter products. This was based on the DOJ&#8217;s antitrust division&#8217;s view that the acquisition as originally proposed would significantly hamper U.S. refinery desalter manufacturing competition, resulting in higher prices and lower quality, service, and innovation. <br />
<br />
Incidentally, Cameron and NATCO are the top two domestic refinery desalter suppliers. The acquiistion involved an all-stock transaction whereby, NATCO stakeholders exchanged each of their shares for 1.185 Cameron common stocks and will receive cash reflecting the value of any fractional shares. Additionally, Cameron has issued about 23.7 million shares associated with this acquisition. <br />
<br />
The agreement was previously unanimously approved by the boards of both the companies. We believe that the NATCO acquisition will transform Houston-based Cameron into a leading supplier of separation and processing solutions worldwide as well as boost its subsea development capabilities. The new &#8216;Cameron&#8217; will have enhanced worldwide presence, broad product offerings in both upstream and downstream markets, and additional manufacturing capabilities. <br />
<br />
Cameron expects the transaction to add to its profitability in 2010, after adjusting for any integration costs. Cameron recently posted better-than-expected third-quarter 2009 results despite pricing pressure and reduced order flow. A healthy backlog of $5.1 billion, coupled with Cameron&#8217;s strong financial health, growing international operations, and the still favorable outlook for the deepwater offshore markets should help the company weather the current downturn better than most of its peers. <br />
<br />
However, the industry-wide slump still continues to weigh on the company&#8217;s profits and the scenario is unlikely to change much during the next few quarters. Consequently, we see the stock performing in line with the broader market and rate it as Neutral. <br />
<br />
Houston, Texas-based Cameron International Corporation, previously known as Cooper Cameron Corporation, is a leading manufacturer of pressure control equipment used in onshore, offshore, and subsea applications for oil and gas drilling, production, and transmission.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=CAM">Read the full analyst report on "CAM"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/cameron-completes-natco-deal-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Royal Standard Minerals, Inc. (RYSMF) Goldwedge Underground Program Nye County, Nevada</title>
		<link>http://www.straightstocks.com/investing-lessons/royal-standard-minerals-inc-rysmf-goldwedge-underground-program-nye-county-nevada/</link>
		<comments>http://www.straightstocks.com/investing-lessons/royal-standard-minerals-inc-rysmf-goldwedge-underground-program-nye-county-nevada/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 14:59:02 +0000</pubDate>
		<dc:creator>Stuart T. Smith</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[(775) 487-2454]]></category>
		<category><![CDATA[800-631-8127]]></category>
		<category><![CDATA[domestic producer]]></category>
		<category><![CDATA[gold  mining industry]]></category>
		<category><![CDATA[MANHATTAN NV]]></category>
		<category><![CDATA[Nevada]]></category>
		<category><![CDATA[Nye County]]></category>
		<category><![CDATA[precious metal properties]]></category>
		<category><![CDATA[producer]]></category>
		<category><![CDATA[Roland Larsen]]></category>
		<category><![CDATA[Royal Standard Minerals Inc.]]></category>
		<category><![CDATA[smallcapvoice]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[www.royalstandardminerals.com]]></category>

		<guid isPermaLink="false">http://smallcapvoice.com/blog/?p=3186</guid>
		<description><![CDATA[MANHATTAN, NV &#8212; (Marketwire) &#8212; 11/24/09 &#8212; Royal Standard Minerals , Inc. (OTCBB: RYSMF) has continued with the evaluation of the underground development program on the 100% owned Goldwedge property located in Nye County, Nevada. For our new shareholders, currently there are essentially two areas of development the &#8216;A&#8217; zone and the &#8216;B&#8217; zone in [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/royal-standard-minerals-inc-rysmf-goldwedge-underground-program-nye-county-nevada/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Williams Completes 2nd Phase &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/williams-completes-2nd-phase-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/williams-completes-2nd-phase-analyst-blog/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 14:40:00 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[clean burning natural gas;]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[energy needs]]></category>
		<category><![CDATA[gas pipeline]]></category>
		<category><![CDATA[Natural Gas]]></category>
		<category><![CDATA[natural gas pipeline]]></category>
		<category><![CDATA[natural gas pipeline system]]></category>
		<category><![CDATA[New Jersey]]></category>
		<category><![CDATA[Pennsylvania]]></category>
		<category><![CDATA[Sentinel]]></category>
		<category><![CDATA[the Sentinel]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Williams Companies Inc.]]></category>
		<category><![CDATA[Williams Completes]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27573/Williams+Completes+2nd+Phase+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>The Williams Companies</strong> (<a href="http://www.zacks.com/stock/quote/WMB">WMB</a>) announced that it has placed the second phase of the Sentinel expansion project on its interstate Transco natural gas pipeline system into service, as a result increasing firm transportation capacity into the northeastern U.S. by 102 thousand dekatherms per day (Mdt/d). <br />
<br />
The first portion of the project (Phase I), which provided an additional 40 Mdt/d, was placed into service in December 2008. Phase II construction included the addition/replacement of approximately 14 miles of 42-inch pipe, along with 8 compressor station upgrades at various locations in Pennsylvania and New Jersey . <br />
<br />
The Transco natural gas pipeline is a 10,500-mile pipeline system that carries natural gas to markets all over the northeastern and southeastern U.S. The current expansion is expected to boost the total system capacity to approximately 8.6 billion cubic feet per day and will allow Williams to continue meeting the region's growing energy needs by providing clean-burning natural gas in time for the winter heating season. <br />
<br />
The Williams Companies, Inc. is an energy firm that primarily finds, produces, gathers, processes, and transports natural gas. The company divides its business into four segments: Exploration &#38; Production (E&#38;P), Midstream Gas &#38; Liquids, Gas Pipeline, and Gas Marketing Services.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=WMB">Read the full analyst report on "WMB"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/williams-completes-2nd-phase-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Stock Market News for November 24, 2009 &#8211; Market News</title>
		<link>http://www.straightstocks.com/stock-watch/stock-market-news-for-november-24-2009-market-news/</link>
		<comments>http://www.straightstocks.com/stock-watch/stock-market-news-for-november-24-2009-market-news/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 14:32:41 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Apple]]></category>
		<category><![CDATA[AT&T]]></category>
		<category><![CDATA[Barnes and Noble]]></category>
		<category><![CDATA[Borders]]></category>
		<category><![CDATA[Chevron]]></category>
		<category><![CDATA[consumer services]]></category>
		<category><![CDATA[Dollar Tree;]]></category>
		<category><![CDATA[Dow 30]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[General Electric]]></category>
		<category><![CDATA[Heinz]]></category>
		<category><![CDATA[Hewlett-Packard]]></category>
		<category><![CDATA[Hormel;]]></category>
		<category><![CDATA[Iphone]]></category>
		<category><![CDATA[Nasdaq Composite]]></category>
		<category><![CDATA[Oil And Gas]]></category>
		<category><![CDATA[Sp 500]]></category>
		<category><![CDATA[telecommunications]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Verizon]]></category>
		<category><![CDATA[wall street]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27579/Stock+Market+News+for+November+24%2C+2009+-+Market+News</guid>
		<description><![CDATA[<p align="justify">U.S. stocks closed broadly higher Monday, ending a three-day losing run, as a strong housing report reassured investors&#8217; faith in the economy.  A weak dollar helped lift gold to another record high and sent shares of commodity-related companies higher.  Calls for central banks around the world to continue stimulus measures also hurt the dollar even as speculation grew that the Federal Reserve will keep interest rates at a record low.</p>
<p align="justify">On Monday, the 30-stock Dow Jones industrial average surged 132.79 points, or 1.29%, to 10,450.95.  The broad Standard &#38; Poor's 500-stock index rose 14.86 points, or 1.36%, at 1,106.24 and the tech-heavy Nasdaq composite index jumped 29.97 points, or 1.40%, to 2,176.01. Trading volume was light, with NYSE volume less than 1 billion shares, as advancing shares outran decliners by a four-to-one margin.  Wall Street&#8217;s fear gauge, the CBOE Vix, plummeted 4.6% to 21.16.</p>
<p align="justify">Treasuries lost ground as investors&#8217; risk appetite grew.  A number of analyst upgrades also helped shares yesterday and after the close Hewlett-Packard (NYSE:HPQ) came out with strong numbers and also announced plans to triple its repurchase plan.</p>
<p align="justify">Among the DJIA components, all but two gained, led by Verizon (NYSE:VZ), up 3.0%, AT&#38;T (NYSE:T), up 2.9%, General Electric (NYSE:GE), up 2.9%, and Chevron (NYSE:CVX), up 2.6%.  A Barron's article suggested AT&#38;T (NYSE:T) shares undervalued due to concerns its exclusive iPhone contract with Apple (NASDAQ:AAPL) might not be extended next year; Verizon (NYSE:VZ) shares jumped shot up on hopes the exclusivity agreement might not be extended.  And Chevron (NYSE:CVX) shares gained from the dollar&#8217;s retreat.</p>
<p align="justify">All ten S&#38;P 500 industry groups advanced, led by consumer services and telecommunications, both up 2.7%, oil and gas, up 1.6%, and industrial and tech shares, both up 1.5%.</p>
<p align="justify">Gold prices jumped to fresh highs yesterday, before giving up some ground to settle at $1164.70, up $17.90.  Meanwhile, the greenback dropped 0.7% to 75.13 against a basket of currencies.  This afternoon's FOMC meeting minutes will be scrutinised by investors for any evidence of a timing change for its asset purchase programs.  Such considerations are also key to the trajectory for gold pricing, viewed as an inflation hedge.</p>
<p align="justify">Earnings reports are due from Barnes and Noble (NYSE:BKS), Borders (NYSE:BGP), Dollar Tree (NASDAQ:DLTR), Heinz (NYSE:HNZ) and Hormel (NYSE:HRL).</p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/stock-market-news-for-november-24-2009-market-news/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zacks Bull and Bear of the Day Highlights: Petrobras, St. Jude Medical, Motorola Inc., Sprint Nextel Corp. and Alcatel-Lucent &#8211; Press Releases</title>
		<link>http://www.straightstocks.com/stock-watch/zacks-bull-and-bear-of-the-day-highlights-petrobras-st-jude-medical-motorola-inc-sprint-nextel-corp-and-alcatel-lucent-press-releases/</link>
		<comments>http://www.straightstocks.com/stock-watch/zacks-bull-and-bear-of-the-day-highlights-petrobras-st-jude-medical-motorola-inc-sprint-nextel-corp-and-alcatel-lucent-press-releases/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 12:39:50 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Alcatel Lucent]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[base station products]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Brazil]]></category>
		<category><![CDATA[Cell Phones]]></category>
		<category><![CDATA[cellular telephone]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[Crm]]></category>
		<category><![CDATA[general]]></category>
		<category><![CDATA[huge pre-salt oil reserves]]></category>
		<category><![CDATA[iDEN]]></category>
		<category><![CDATA[iDEN technology]]></category>
		<category><![CDATA[iDEN-based base station products]]></category>
		<category><![CDATA[integrated energy]]></category>
		<category><![CDATA[IPTV specialist]]></category>
		<category><![CDATA[Leonard Zacks;]]></category>
		<category><![CDATA[LTE chip]]></category>
		<category><![CDATA[Motorola Inc.]]></category>
		<category><![CDATA[Paris]]></category>
		<category><![CDATA[Petrobras]]></category>
		<category><![CDATA[proposed new oil]]></category>
		<category><![CDATA[RadioFrame Networks Inc.]]></category>
		<category><![CDATA[Sprint Nextel Corp.]]></category>
		<category><![CDATA[St Jude Medical]]></category>
		<category><![CDATA[This technology;]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[wireless carriers]]></category>
		<category><![CDATA[wireless operators]]></category>
		<category><![CDATA[Zacks Equity Research]]></category>
		<category><![CDATA[Zacks Investment Research Inc.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27568/Zacks+Bull+and+Bear+of+the+Day+Highlights%3A+Petrobras%2C+St.+Jude+Medical%2C+Motorola+Inc.%2C+Sprint+Nextel+Corp.+and+Alcatel-Lucent+-+Press+Releases</guid>
		<description><![CDATA[<p align="left"><strong>For Immediate Release</strong></p>
<p align="left">Chicago, IL &#8211; November 24, 2009 &#8211; Zacks Equity Research highlights <strong>Petrobras </strong>(<a href="http://www.zacks.com/stock/quote/PBR">PBR</a>) as the Bull of the Day and <strong>St. Jude Medical </strong>(<a href="http://www.zacks.com/stock/quote/STJ">STJ</a>) the Bear of the Day. In addition, Zacks Equity Research provides analysis on <strong>Motorola Inc.</strong>(<a href="http://www.zacks.com/stock/quote/MOT">MOT</a>), <strong>Sprint Nextel Corp.</strong>(<a href="http://www.zacks.com/stock/quote/S">S</a>) and <strong>Alcatel-Lucent </strong>(<a href="http://www.zacks.com/stock/quote/ALU">ALU</a>).</p>
<p align="left">Full analysis of all these stocks is available at <a href="http://at.zacks.com/?id=5506">http://at.zacks.com/?id=5506</a></p>
<p align="left">Here is a synopsis of all five stocks:</p>
<p align="left"><a href="http://www.zacks.com/newsroom/commentary/index.php?type_id=6">Bull of the Day</a>:</p>
<p align="left"><strong>Petrobras </strong>(<a href="http://www.zacks.com/stock/quote/PBR">PBR</a>), the largest integrated energy firm in Brazil, stands to benefit from its country's economic growth and huge pre-salt oil reserves. The company recently reported a better-than-expected third-quarter, helped by strong downstream results that more than offset the sharp decline in commodity prices.</p>
<p align="left">Near- to medium-term concerns include the uncertain commodity-price scenario, significant capital investment requirements, and Brazil's proposed new oil and gas regulatory framework. However, given its strong pipeline of development projects and impressive recent exploration successes, the company's long-term outlook looks compelling.</p>
<p align="left">As such, we recommend an Outperform rating for Petrobras ADRs. Our six-month target price is $55 per share.</p>
<p><a href="http://www.zacks.com/newsroom/commentary/index.php?type_id=7">Bear of the Day</a>:</p>
<p align="left">We look for global demographic trends -- aging populations in developed nations and the rapid urbanization of developing countries -- to fuel long-term growth of <strong>St. Jude Medical </strong>(<a href="http://www.zacks.com/stock/quote/STJ">STJ</a>). These trends give rise to growing demand for cardiovascular health care.</p>
<p align="left">However, recent weaknesses in the CRM segment, particularly in the U.S., are headwinds for St. Jude in the near-term. This might force the company to lose market share to its competitors.</p>
<p align="left">Earnings per share in the third quarter reached $0.59, beating the Zacks Consensus Estimate by one cent. However, we have chosen to downgrade the stock to an Underperform with a target price of $31.</p>
<p>Latest Posts on the Zacks <a href="http://www.zacks.com/stock/news/AnalystBlog">Analyst Blog</a>:</p>
<p align="left"><em>Motorola Boosts iDEN Business</em></p>
<p align="left"><strong>Motorola Inc.</strong>(<a href="http://www.zacks.com/stock/quote/MOT">MOT</a>) has decided to purchase iDEN base station assets of the privately held RadioFrame Networks Inc. The iDEN (Integrated Digital Enhanced Network) technology allows cell phone calls to move on the same network as communication from two-way radios. In general, this technology resembles walkie-talkie features on cell phones. Financial terms of this deal have not been disclosed so far. Motorola itself is the pioneer of the iDEN technology that RadioFrame had licensed for its base station products.</p>
<p align="left">The main reason for this acquisition is the superior iDEN-based base station products of RadioFrame that are lower cost and more power efficient. This proposed acquisition will enhance Motorola's portfolio of multi-channel base stations products that are optimized to support non-contiguous spectrum allocations in the special mobile radio business. Motorola may use RadioFrame&#8217;s lower-cost iDEN architecture into entirely separated spectrum bands that are allocated to the wireless carriers in the international (outside the U.S.) markets. RadioFrame has a solid client base for its base station products, notable among them being <strong>Sprint Nextel Corp.</strong>(<a href="http://www.zacks.com/stock/quote/S">S</a>).</p>
<p align="left">RadioFrame&#8217;s base station products will be a part of Motorola&#8217;s Home and Network Mobility segment. This segment makes equipment for cable and wireless operators. Recently, industry rumors indicated that the company has decided to sell this segment for more than $4.5 billion. As of now, Home and Network Mobility is the largest segment of Motorola. In the third quarter of 2009, this segment generated more than $2 billion revenue and $199 million operating profit.</p>
<p align="left">Earlier this month, Motorola&#8217;s Home and Network Mobility segment decided to purchase IPTV specialist BitBand and will do venture funding to the LTE chip making business of Sequans Communications together with <strong>Alcatel-Lucent </strong>(<a href="http://www.zacks.com/stock/quote/ALU">ALU</a>). BitBand has more than 60 commercial IPTV deployments throughout the world and Paris based Sequans Communications has intended to demonstrate its first LTE chipset in early 2010. Whether Motorola sells its Home and Network Mobility segment or not, it seems that the company is increasingly focusing on optimizing the resources of its largest business segment.</p>
<p align="left">Get the full analysis of all these stocks by going to <a href="http://at.zacks.com/?id=5507">http://at.zacks.com/?id=5507</a>.</p>
<p align="left"><strong>About the Bull and Bear of the Day</strong></p>
<p align="left">Every day, the analysts at Zacks Equity Research select two stocks that are likely to outperform (Bull) or underperform (Bear) the markets over the next 3-6 months.</p>
<p align="left"><strong>About the Analyst Blog</strong></p>
<p align="left">Updated throughout every trading day, the <a href="http://www.zacks.com/stock/news/AnalystBlog">Analyst Blog</a> provides analysis from Zacks Equity Research about the latest news and events impacting stocks and the financial markets.</p>
<p align="left"><strong>About Zacks Equity Research</strong></p>
<p align="left">Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.</p>
<p align="left">Continuous analyst coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.</p>
<p align="left">Zacks <a href="http://at.zacks.com/?id=5508">"Profit from the Pros"</a> e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today by visiting <a href="http://at.zacks.com/?id=5508">http://at.zacks.com/?id=5508</a>.</p>
<p align="left"><strong>About Zacks </strong></p>
<p align="left">Zacks.com is a property of <a href="http://www.zacks.com/">Zacks Investment Research</a>, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the <a href="http://www.zacks.com/rank/index.php">Zacks Rank</a>, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at <a href="http://at.zacks.com/?id=5509">http://at.zacks.com/?id=5509</a>.</p>
<p align="left">Visit <a href="http://www.zacks.com/performance">http://www.zacks.com/performance</a> for information about the performance numbers displayed in this press release.</p>
<p align="left">Follow us on Twitter: <a href="http://twitter.com/zacksresearch">http://twitter.com/zacksresearch</a></p>
<p align="left">Join us on Facebook: <a href="http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts">http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts</a></p>
<p align="left">Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.</p>
<p align="left">Contact:<br />
Mark Vickery<br />
Web Content Editor<br />
312-265-9380<br />
Visit: <a href="www.zacks.com">www.zacks.com </a></p>
<p align="left"> </p>
<p align="left"> </p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/zacks-bull-and-bear-of-the-day-highlights-petrobras-st-jude-medical-motorola-inc-sprint-nextel-corp-and-alcatel-lucent-press-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zacks Analyst Blog Highlights: Halliburton Company, Schlumberger Limited, Smith International Inc., National-Oilwell Varco and Weatherford International Ltd. &#8211; Press Releases</title>
		<link>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-halliburton-company-schlumberger-limited-smith-international-inc-national-oilwell-varco-and-weatherford-international-ltd-press-releases/</link>
		<comments>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-halliburton-company-schlumberger-limited-smith-international-inc-national-oilwell-varco-and-weatherford-international-ltd-press-releases/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 12:10:56 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[back oil]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[Energy Demand]]></category>
		<category><![CDATA[energy service firms]]></category>
		<category><![CDATA[halliburton company]]></category>
		<category><![CDATA[Leonard Zacks;]]></category>
		<category><![CDATA[National Oilwell Varco]]></category>
		<category><![CDATA[National-Oilwell]]></category>
		<category><![CDATA[Natural Gas]]></category>
		<category><![CDATA[natural gas woes]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[oil rigs;]]></category>
		<category><![CDATA[Schlumberger Limited]]></category>
		<category><![CDATA[Smith International Inc]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Weatherford International Ltd.;]]></category>
		<category><![CDATA[Zacks Investment Research Inc.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27565/Zacks+Analyst+Blog+Highlights%3A+Halliburton+Company%2C+Schlumberger+Limited%2C+Smith+International+Inc.%2C+National-Oilwell+Varco+and+Weatherford+International+Ltd.+-+Press+Releases</guid>
		<description><![CDATA[<p align="left"><strong>For Immediate Release</strong></p>
<p align="left">Chicago, IL &#8211; November 24, 2009 &#8211; Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: <strong>Halliburton Company </strong>(<a href="void(0)">HAL</a>), <strong>Schlumberger Limited </strong>(<a href="void(0)">SLB</a>), <strong>Smith International Inc.</strong> (<a href="void(0)">SII</a>), <strong>National-Oilwell Varco </strong>(<a href="void(0)">NOV</a>) and <strong>Weatherford International Ltd.</strong> (<a href="void(0)">WFT</a>).</p>
<p align="left">Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5513">http://at.zacks.com/?id=5513</a></p>
<p align="left"><strong>Here are highlights from Monday&#8217;s Analyst Blog: </strong></p>
<p align="left"><strong>U.S. Rig Count Hits 8-Month High </strong></p>
<p align="left">Producers had scaled back oil and gas drilling operations over the past several months in the midst of falling commodity prices and tighter access to credit. However, during recent weeks, there have been signs that the companies were beginning to bring rigs back on line (especially oil rigs) amid signs of economic stabilization that could drive up energy demand. This pushed the nationwide rig count above 1,100 working units for the week ended Nov. 13, the first time since March.</p>
<p align="left">The overall picture, though, remains weak, particularly for natural gas, whose inventories have recently hit a new record high of 3.83 trillion cubic feet (Tcf) and is threatening to test the maximum capacity of 3.89 Tcf. The supply picture is expected to reverse in the coming months as producers bet on colder weather and the lagging effect of the sharp drop in domestic drilling activity takes hold.</p>
<p align="left">Until then, we believe that natural gas woes (especially in North America) will continue to haunt energy service firms like <strong>Halliburton Company </strong>(<a href="void(0)">HAL</a>), <strong>Schlumberger Limited </strong>(<a href="void(0)">SLB</a>), <strong>Smith International Inc.</strong> (<a href="void(0)">SII</a>), <strong>National-Oilwell Varco </strong>(<a href="void(0)">NOV</a>) and <strong>Weatherford International Ltd.</strong> (<a href="void(0)">WFT</a>). These oilfield service names have seen their revenues and earnings plunge in the last few quarters on the back of lower volumes and a very competitive pricing environment. We have Neutral recommendations on all the above-mentioned companies.</p>
<p align="left">Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5515">http://at.zacks.com/?id=5515</a>.</p>
<p align="left"><strong>About Zacks Equity Research</strong></p>
<p align="left">Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.</p>
<p align="left">Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.</p>
<p align="left">Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: <a href="http://at.zacks.com/?id=5517">http://at.zacks.com/?id=5517</a></p>
<p align="left"><strong>About Zacks </strong></p>
<p align="left">Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at <a href="http://at.zacks.com/?id=5518">http://at.zacks.com/?id=5518</a>.</p>
<p align="left">Visit <a href="http://www.zacks.com/performance">http://www.zacks.com/performance</a> for information about the performance numbers displayed in this press release.</p>
<p align="left">Follow us on Twitter: <a href="http://twitter.com/zacksresearch">http://twitter.com/zacksresearch</a></p>
<p align="left">Join us on Facebook: <a href="http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts">http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts</a></p>
<p align="left">Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.</p>
<p align="left">Contact:<br />
Mark Vickery<br />
Web Content Editor<br />
312-265-9380<br />
Visit: <a href="www.zacks.com">www.zacks.com </a></p>
<p align="left"> </p>
<p align="left"> </p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-halliburton-company-schlumberger-limited-smith-international-inc-national-oilwell-varco-and-weatherford-international-ltd-press-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>WealthTrack: Robert Kleinschmidt – reveling in contrarian investment philosophy</title>
		<link>http://www.straightstocks.com/investing-lessons/wealthtrack-robert-kleinschmidt-%e2%80%93-reveling-in-contrarian-investment-philosophy/</link>
		<comments>http://www.straightstocks.com/investing-lessons/wealthtrack-robert-kleinschmidt-%e2%80%93-reveling-in-contrarian-investment-philosophy/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 10:04:23 +0000</pubDate>
		<dc:creator>Prieur du Plessis</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Consuelo Mack]]></category>
		<category><![CDATA[investment postcards]]></category>
		<category><![CDATA[Portfolio Manager]]></category>
		<category><![CDATA[president and chief investment officer]]></category>
		<category><![CDATA[Robert Kleinschmidt]]></category>
		<category><![CDATA[Tocqueville Asset Management]]></category>
		<category><![CDATA[Tocqueville Fund]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Us Government]]></category>

		<guid isPermaLink="false">http://www.investmentpostcards.com/?p=14118</guid>
		<description><![CDATA[This week Consuelo Mack is joined on WealthTrack by Robert Kleinschmidt, president and chief investment officer of Tocqueville Asset Management and portfolio manager of its flagship Tocqueville Fund. Kleinschmidt discusses where his contrarian investment philosophy is leading him now and why investors should be concerned about US government debt and the future of the dollar. ]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/wealthtrack-robert-kleinschmidt-%e2%80%93-reveling-in-contrarian-investment-philosophy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>How do retail sales stack up in an atypical recovery?</title>
		<link>http://www.straightstocks.com/investing-lessons/how-do-retail-sales-stack-up-in-an-atypical-recovery/</link>
		<comments>http://www.straightstocks.com/investing-lessons/how-do-retail-sales-stack-up-in-an-atypical-recovery/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 09:24:40 +0000</pubDate>
		<dc:creator>Contrarian Profits</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[contrarian profits]]></category>
		<category><![CDATA[editor]]></category>
		<category><![CDATA[overall retail sales momentum]]></category>
		<category><![CDATA[overall retail sales;]]></category>
		<category><![CDATA[Retail Sales]]></category>
		<category><![CDATA[retail sales ex-gas]]></category>
		<category><![CDATA[Rob Parenteau;]]></category>
		<category><![CDATA[The Richebacher]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://www.contrarianprofits.com/?p=21135</guid>
		<description><![CDATA[Rob Parenteau, currency and credit markets expert, and editor of The Richebacher letter, analyzes the current state of the economy, as represented by retail sales.  Can retail really drive the recovery?]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/how-do-retail-sales-stack-up-in-an-atypical-recovery/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Top Growth Equity Funds &#8211; Mutual Fund Commentary</title>
		<link>http://www.straightstocks.com/stock-watch/top-growth-equity-funds-mutual-fund-commentary-8/</link>
		<comments>http://www.straightstocks.com/stock-watch/top-growth-equity-funds-mutual-fund-commentary-8/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 06:03:15 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Barrett Associates]]></category>
		<category><![CDATA[Blue Chip Growth Fund;]]></category>
		<category><![CDATA[Brockenbrough & Company Inc]]></category>
		<category><![CDATA[Charles M. Caravati]]></category>
		<category><![CDATA[Coleman;]]></category>
		<category><![CDATA[General Partner]]></category>
		<category><![CDATA[III;]]></category>
		<category><![CDATA[Jamestown Equity Fund]]></category>
		<category><![CDATA[lead manager]]></category>
		<category><![CDATA[manager of the fund]]></category>
		<category><![CDATA[Managing Director]]></category>
		<category><![CDATA[Rank Growth Equity Funds;]]></category>
		<category><![CDATA[Reynolds Blue Chip Growth Fund;]]></category>
		<category><![CDATA[Robert J. Milnamow]]></category>
		<category><![CDATA[Robertson;]]></category>
		<category><![CDATA[Siebel/Montgomery Securities]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vice President]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27561/Top+Growth+Equity+Funds+-+Mutual+Fund+Commentary</guid>
		<description><![CDATA[<p>Today we are featuring top-performing &#8220;Growth" equity mutual funds, which primarily invest in equity securities of companies in search of long-term growth.</p>
<p>Investors can find such funds by checking out the entire list of the <a href="http://www.zacks.com/funds/mutualfund/allmfs.php?rank_in=ALL&#38;TableType=1Y&#38;fundtype=Equity - Growth">Zacks #1 Rank Growth Equity Funds</a>.</p>
<p><strong>3 Burgeoning Picks</strong></p>
<p><strong>Barrett Growth Fund </strong>A (<a href="http://www.zacks.com/funds/mfrank/quotes.php?t=BGRWX&#38;type=main">BGRWX</a>) seeks to achieve long-term capital appreciation and to maximize after tax returns. It was incepted in October 2002.</p>
<p>The fund invests in common stocks of high quality companies that it believes have superior growth potential and stocks that can be purchased at reasonable prices. The fund generally undertakes a 'buy and hold' investment strategy in order to reduce turnover and maximize after-tax returns.</p>
<p>The fund has an expense ratio of 1.25%. It distributes dividends and capital gains, if any, annually.</p>
<p>Robert J. Milnamow has been lead manager of the fund since January 2004. Milnamow has been with Barrett Associates since 2003 and is a managing director with the firm.</p>
<p><strong>Reynolds Blue Chip Growth Fund </strong>(<a href="http://www.zacks.com/funds/mfrank/quotes.php?t=RBCGX&#38;type=main">RBCGX</a>) was incepted in August 1988. It seeks long-term capital appreciation and, to a lesser extent current income.</p>
<p>The fund invests in common stocks of United States companies. Under normal market conditions, the fund primarily invests in common stocks of 'blue chip' companies. In seeking to achieve its secondary objective of current income, the fund invests in dividend-paying common stocks.</p>
<p>Shareholders have to make a minimum initial investment of $1,000 to enter this Zacks#1 Rank (&#8220;Strong Buy") fund. As of June 2009, it has a portfolio turnover of 516%.</p>
<p>Frederick L. Reynolds has been lead manager of the fund since August 1988. Previously, Reynolds spent 14 years as a general partner with Robertson, Coleman and Siebel/Montgomery Securities.</p>
<p><strong>Jamestown Equity Fund </strong>(<a href="http://www.zacks.com/funds/mfrank/quotes.php?t=JAMEX&#38;type=main">JAMEX</a>) seeks long term growth of capital. It was incepted in December 1992.</p>
<p>The fund invests primarily in common stocks, preferred stocks, convertible preferred stocks and convertible bonds. Equity investments are made using fundamental analysis, proprietary models and qualitative, judgmental evaluation as selection criteria. The fund seeks financially strong, relatively large companies, which offer above average earnings and relatively modest valuations.</p>
<p>Shareholders have to make a minimum initial investment of $5,000 to enter this Zacks#1 Rank (&#8220;Strong Buy") fund. It has an expense ratio of 1.10%.</p>
<p>Charles M. Caravati, III has been lead manager of the fund since December 1992. Caravati joined Lowe, Brockenbrough &#38; Company, Inc in 1992 and is a vice president with the firm.</p>
<p><strong>Discover Many More Funds</strong></p>
<p>Learn more about the new Zacks Mutual Fund Rank and discover some of the best market-beating mutual funds by browsing our <a href="http://www.zacks.com/funds/mutualfund/">mutual funds section</a>. This part of Zacks.com offers a variety of tools, including mutual fund research, a new mutual fund screener, helpful answers to frequently asked questions and quick access to prospectuses and other information.</p>
<p>By applying the Zacks Rank to mutual funds, investors can find funds that not only outpaced the market in the past but are also expected to outperform going forward.</p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/top-growth-equity-funds-mutual-fund-commentary-8/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>St. Jude Medical (STJ) &#8211; Bear of the Day</title>
		<link>http://www.straightstocks.com/stock-watch/st-jude-medical-stj-bear-of-the-day/</link>
		<comments>http://www.straightstocks.com/stock-watch/st-jude-medical-stj-bear-of-the-day/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 05:00:00 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Crm]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/commentary/12842/St.+Jude+Medical+%28STJ%29+-+Bear+of+the+Day</guid>
		<description><![CDATA[We look for global demographic trends -- aging populations in developed nations and the rapid urbanization of developing countries -- to fuel long-term growth of St. Jude Medical (<a href="http://www.zacks.com/stock/quote/stj">STJ</a>). These trends give rise to growing demand for cardiovascular health care.
<p ALIGN="left">
However, recent weaknesses in the CRM segment, particularly in the U.S., are headwinds for St. Jude in the near-term. This might force the company to lose market share to its competitors.
</p><p ALIGN="left">
Earnings per share in the third quarter reached $0.59, beating the Zacks Consensus Estimate by one cent. However, we have chosen to downgrade the stock to an Underperform with a target price of $31.<a href="http://www.zacks.com">Zacks Investment Research</a><br /></p>]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/st-jude-medical-stj-bear-of-the-day/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Arena Resources Inc. &#8211; Momentum &#8211; Zacks Rank Buy</title>
		<link>http://www.straightstocks.com/stock-watch/arena-resources-inc-momentum-zacks-rank-buy/</link>
		<comments>http://www.straightstocks.com/stock-watch/arena-resources-inc-momentum-zacks-rank-buy/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 05:00:00 +0000</pubDate>
		<dc:creator>Michael Vodicka</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[ARD]]></category>
		<category><![CDATA[Arena Resources Inc;]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Natural Gas Properties]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/commentary/12838/Arena+Resources+Inc.+-+Momentum+-+Zacks+Rank+Buy</guid>
		<description><![CDATA[<b>Arena Resources Inc.</b> (<a href="http://www.zacks.com/stock/quote/ARD">ARD</a>) has posted big gains over the last 8 months on strong earnings and elevated energy prices.  
<p ALIGN="left">
<b>Company Description</b>
</p><p ALIGN="left">
Arena Resources, Inc. engages in the exploration and production of oil and natural gas properties in the united States. The company was founded in 200 and has a market cap of $1.58 billion. 
</p><p ALIGN="left">
With crude trading at elevated prices, exploration companies have fallen back into favor. This dynamic and strong third-quarter results, reported on Nov 5, has helped push shares of ARD back to the 52-week high. 
</p><p ALIGN="left">
<b>Third-Quarter Results</b>
</p><p ALIGN="left">
Earnings for the quarter came in at 31 cents per share, 5 cents ahead of the Zacks Consensus Estimate. The company has beat in each of the last four quarters by an average of 2 cents, or 10%. 
</p><p ALIGN="left">
In a bid to expand its enhance and expand its operations, the Board of Directors approved a $27 million increase in its capital budget for 2009 to $107 million. 
</p><p ALIGN="left">
<b>Estimates Rising</b> 
</p><p ALIGN="left">
Estimates have generally been on the rise for the last few months. The current-year estimate has added 13 cents to $1.12. The next-year estimate is bullish, pegged at $1.75, a 57% growth projection. 
</p><p ALIGN="left">
<b>Valuation</b>
</p><p ALIGN="left">
After the recent run up, shares do look a bit pricey, trading at 36X projected current-year earnings. The bullish next-year estimate helps temper the valuation a bit though. 
</p><p ALIGN="left">
<b>The Chart</b>
</p><p ALIGN="left">
Shares of ARD have posted big gains over the last 8 months after bottoming out around $20 in early March. The 52-weke high is close at hand at $44.40, take a look below. 
</p><p ALIGN="left">
</p><p ALIGN="left">
<img src="http://www.zacks.com/images/upload_dir/1259000176.JPG" width="609" height="310"/>
<a href="http://www.zacks.com">Zacks Investment Research</a><br /></p>]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/arena-resources-inc-momentum-zacks-rank-buy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Debt and Interest Rates: Some Empirical Evidence and Implications</title>
		<link>http://www.straightstocks.com/investing-lessons/debt-and-interest-rates-some-empirical-evidence-and-implications/</link>
		<comments>http://www.straightstocks.com/investing-lessons/debt-and-interest-rates-some-empirical-evidence-and-implications/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 02:00:08 +0000</pubDate>
		<dc:creator>Menzie Chinn</dc:creator>
				<category><![CDATA[Economics]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[bank purchases;]]></category>
		<category><![CDATA[bush administration]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[Jeff Frankel]]></category>
		<category><![CDATA[Medicare]]></category>
		<category><![CDATA[Oecd]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Us Treasury]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.econbrowser.com/archives/2009/11/debt_and_intere.html</guid>
		<description><![CDATA[<p>Today's <a href="http://www.nytimes.com/2009/11/23/business/23rates.html"><i>NYT</i> article</a> suggests apocalypse (very) soon:</p>
<blockquote><p>...the government faces a payment shock similar to those that sent legions of overstretched homeowners into default on their mortgages.</p></blockquote>
<p>Do we really need to worry so much in the short term?</p>

<br />

<img alt="gs10.gif" src="http://www.econbrowser.com/archives/2009/11/gs10.gif" />

<br /><b>Figure 1:</b> Ten year constant maturity Treasury yields (blue line), and observation for 11/19 (red square). NBER defined recessions shaded gray; assumes last recession ends June 2009. Source: St. Louis Fed FREDII and NBER.


<p>Six years ago, Jeff Frankel and I examined the implications of the borrow-and-spend policies of the Bush Administration <a href="http://www.ssc.wisc.edu/~mchinn/intratepap7.pdf">[PDF]</a>. We estimated the following relationship:</p>

<p>(1) <i>i<sub>t</sub> <sup>long</sup> = 0.001 + 1 &#215; &#960;<sub>t</sub> + 0.077 E(d<sub>t+2</sub>) + 0.280 (y<sub>t</sub>-y<sub>t</sub><sup>FE</sup>) + 0.005 i<sub>t</sub><sup>*</sup> - 0.574 int<sub>t</sub></i></p>

<p>Adj.-R<sup>2</sup> = 0.51, N=17, Smpl 1988-2004. <i>i</i> is the long term interest rate on ten year bonds, &#960; is the y/y inflation rate, <i>E(d<sub>t+2</sub>)</i> is the two-year ahead expected debt-to-GDP ratio and <i>(y<sub>t</sub>-y<sub>t</sub><sup>FE</sup>)</i> is the output gap (both according to OECD), and <i>i<sup>*</sup></i> is the foreign interest rate, and <i>int</i> is foreign purchases of US Treasury debt. (This specification was also discussed in <a href="http://www.econbrowser.com/archives/2007/03/wmds_in_iraq_la.html">this March 2007 post</a>.)</p>

<p>We can use these estimates to do a back of the envelope calculation of what happens in a year, going from end FY2009 to end FY2010, by taking the total differential of equation (1). The change will be given by:</p>

<p>(2) <i>&#916; i = &#916; &#960; + 0.077 &#916; E(d<sub>t+2</sub>) + 0.280 &#916; (y<sub>t</sub>-y<sub>t</sub><sup>FE</sup>) - 0.574 &#916; int </i></p>

<p>According to the <a href="http://www.cbo.gov/ftpdocs/105xx/doc10521/2009BudgetUpdate_Summary.pdf">August CBO <i>Economic and Budget Outlook</i></a>, public debt held by the public two years ahead will rise from 65.2 to 65.9 ppts of GDP (that is, end FY 2011 to end FY2012, in Summary Table 1). The OECD November <a href="http://www.oecd.org/document/18/0,3343,en_2649_34109_20347538_1_1_1_37443,00.html"><i>Economic Outlook</i></a> reports that the output gap in 2009 was -4.92 ppts of GDP, and is projected to be -5.36 in 2010. If East Asian bank purchases of Treasuries remain constant, then one finds that the inflation adjusted interest rate will rise by:</p>

<p>(0.659-0.652)&#215;0.077 + (-0.0536+0.0492)&#215;0.280 = 0.0005-0.0012 = <b>-0.0007</b></p>

<p>That is, the interest rate would <i>fall</i> by 7 bps (holding expected inflation constant). In other words, real interest rates would stay roughly constant, <i>ceteris paribus</i>.</p>
<p>Now, what about foreign purchases of US treasury bills and notes? These ran about $333 billion through September <a href="http://www.latimes.com/business/la-fi-foreign18-2009nov18,0,7902212.story">[1]</a>, or about 2.3% of nominal GDP. Suppose this went to zero (!). <i>Then</i> real rates would rise 1.3%. Of course, one needs net foreign purchases to drop to <b>zero</b>, which seems to me unlikely.</p>

<p>Some caveats: These estimates were obtained using data that spanned a period without extraordinary Federal Reserve credit easing, and in the face of an unprecedented financial collapse. And, the relationship is not precisely estimated. But they're the estimates we -- or at least I -- have.</p>

<p>By the way, <a href="http://www.cbo.gov/ftpdocs/105xx/doc10521/08-25-BudgetUpdate.pdf">CBO predicts</a> only a 0.8 ppts increase in the ten year rate going from 2009 to 2010, and an additional 0.3 ppts by 2011 (Summary Table 2).</p>


<p>I'll further observe that the article gives the impression that the jump in Federal debt was due to the stimulus bill. But in fact, as shown in <a href="http://www.econbrowser.com/archives/2009/08/the_lasting_leg.html">this post</a>, most of the debt accumulation has been accounted for by the decline in tax revenues associated with the recession.</p>

<p>No doubt, trouble on the fiscal front is real, and has long been brewing -- from the tax cuts of 2001 (if extended) to <a href="http://www.econbrowser.com/archives/2006/01/fiscal_exposure.html">Medicare Part D</a>. And, indeed, I argued for a lot more fiscal restraint when we were near full employment. <a href="http://www.econbrowser.com/archives/2006/10/the_us_macroeco.html">[2]</a> But, in my view, apocalypse not quite yet.</p> 
]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/debt-and-interest-rates-some-empirical-evidence-and-implications/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Abbott Deals for Drug Candidate &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/abbott-deals-for-drug-candidate-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/abbott-deals-for-drug-candidate-analyst-blog/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 21:20:20 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Abbott Labs]]></category>
		<category><![CDATA[Abbott;]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Commission of European Communities;]]></category>
		<category><![CDATA[Cox]]></category>
		<category><![CDATA[Date]]></category>
		<category><![CDATA[Drug Candidate]]></category>
		<category><![CDATA[lower back pain]]></category>
		<category><![CDATA[osteoarthritis]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[pain candidate]]></category>
		<category><![CDATA[PanGenetics BV]]></category>
		<category><![CDATA[PG110]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27556/Abbott+Deals+for+Drug+Candidate+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Abbott Labs</strong> (<a href="http://www.zacks.com/stock/quote/abt">ABT</a>) recently signed a definitive agreement with PanGenetics BV for a pain candidate, PG110. Under the terms of the agreement, Abbott will acquire global rights to PG110 which is a novel biologic that targets Nerve Growth Factor (NGF) for the treatment of chronic pain.<br />
<br />
PanGenetics will receive an upfront payment of $170 million and $20 million in milestone payments. This agreement should allow Abbott to expand its pain product portfolio and leverage its expertise in biologics. The commercial opportunity in the pain market is significant. There is major demand for the development of a treatment that would provide relief from pain without the potential of addiction and abuse.<br />
<br />
It is estimated that there are about 72 million diagnosed chronic pain patients in the U.S. and EU, and up to 30% of chronic pain patients get inadequate relief. Current treatments include non-steroidal anti-inflammatory drugs (NSAIDs), certain Cox-II inhibitors, opioids and other drugs that may have various tolerability and safety issues, including the potential for abuse and addiction.<br />
<br />
PG110 is currently in a phase I study in patients with osteoarthritis. The successful completion of this study would allow Abbott to explore the candidate&#8217;s potential in other pain indications like chronic lower back pain, cancer pain and diabetic neuropathic pain.<br />
<br />
The deal is scheduled to close by year end. Abbott maintained its previously announced guidance for 2009.<br />
<br />
We currently have a Neutral rating on Abbott. While economic weakness has slowed sales of a number of products in 2009, Abbott is weathering the storm relatively well. Abbott&#8217;s strong business segments, contributions from recent acquisitions and impressive late-stage pipeline should help fortify long-term earnings growth.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ABT">Read the full analyst report on "ABT"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/abbott-deals-for-drug-candidate-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>November 23rd CEOcast Weekly Newsletter</title>
		<link>http://www.straightstocks.com/investing-lessons/november-23rd-ceocast-weekly-newsletter/</link>
		<comments>http://www.straightstocks.com/investing-lessons/november-23rd-ceocast-weekly-newsletter/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 20:51:54 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Advanced Cell Technologies]]></category>
		<category><![CDATA[advertising campaigns]]></category>
		<category><![CDATA[advertising mediums]]></category>
		<category><![CDATA[ALS]]></category>
		<category><![CDATA[Americas Holdings]]></category>
		<category><![CDATA[amyotrophic lateral sclerosis]]></category>
		<category><![CDATA[Anaheim]]></category>
		<category><![CDATA[Asia Pacific]]></category>
		<category><![CDATA[Barnes & Noble]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[bird flu]]></category>
		<category><![CDATA[blindness]]></category>
		<category><![CDATA[book vacation travel]]></category>
		<category><![CDATA[Brain Cancer]]></category>
		<category><![CDATA[cable systems]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cancers]]></category>
		<category><![CDATA[Casey Eye Institute]]></category>
		<category><![CDATA[CEL-SCI Corporation]]></category>
		<category><![CDATA[cell therapy]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[central nervous system diseases]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[chief technology officer]]></category>
		<category><![CDATA[clinical trial protocol]]></category>
		<category><![CDATA[colorectal cancer]]></category>
		<category><![CDATA[Control Group]]></category>
		<category><![CDATA[Deere]]></category>
		<category><![CDATA[Dell]]></category>
		<category><![CDATA[Destron Fearing]]></category>
		<category><![CDATA[diagnostic tool]]></category>
		<category><![CDATA[diagnostic/clinical response products]]></category>
		<category><![CDATA[Digital Angel Corporation]]></category>
		<category><![CDATA[electronic media]]></category>
		<category><![CDATA[Emery University]]></category>
		<category><![CDATA[Enzo Biochem]]></category>
		<category><![CDATA[eye disease]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[founder]]></category>
		<category><![CDATA[Gap Limited]]></category>
		<category><![CDATA[glioblastoma;]]></category>
		<category><![CDATA[green process manufacturer]]></category>
		<category><![CDATA[Griffin Securities;]]></category>
		<category><![CDATA[H.J. Heinz;]]></category>
		<category><![CDATA[H1N1]]></category>
		<category><![CDATA[health and security identification tools]]></category>
		<category><![CDATA[health care products]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[Healthy Living Channel]]></category>
		<category><![CDATA[Hewlett-Packard]]></category>
		<category><![CDATA[higher advertising spending;]]></category>
		<category><![CDATA[ICT-107]]></category>
		<category><![CDATA[ImmunoCellular Therapeutics Ltd.;]]></category>
		<category><![CDATA[in-vivo glucose sensing microchip technology]]></category>
		<category><![CDATA[Indiana]]></category>
		<category><![CDATA[industry-focused media outlets]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[integrated biotechnology;]]></category>
		<category><![CDATA[interactive applications]]></category>
		<category><![CDATA[interactive media company specializing]]></category>
		<category><![CDATA[interactive TV]]></category>
		<category><![CDATA[Investigational New Drug (IND)]]></category>
		<category><![CDATA[Investigational New Drug (IND) application]]></category>
		<category><![CDATA[investigational therapy]]></category>
		<category><![CDATA[leader]]></category>
		<category><![CDATA[Lou Gehrig]]></category>
		<category><![CDATA[macular degeneration]]></category>
		<category><![CDATA[Mad Cow Disease]]></category>
		<category><![CDATA[Massachusetts]]></category>
		<category><![CDATA[Media Channels]]></category>
		<category><![CDATA[Medtronic]]></category>
		<category><![CDATA[Michigan]]></category>
		<category><![CDATA[Nasdaq 100]]></category>
		<category><![CDATA[Neuralstem;]]></category>
		<category><![CDATA[New Jersey]]></category>
		<category><![CDATA[New Jersey Medical School]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[newark]]></category>
		<category><![CDATA[notable travel]]></category>
		<category><![CDATA[Omnicomm Systems Inc]]></category>
		<category><![CDATA[ONE Bio Corp.]]></category>
		<category><![CDATA[ONE Holdings]]></category>
		<category><![CDATA[One Interactive]]></category>
		<category><![CDATA[Oregon]]></category>
		<category><![CDATA[Orphan disease]]></category>
		<category><![CDATA[Otc Bulletin Board]]></category>
		<category><![CDATA[PCE]]></category>
		<category><![CDATA[pharmaceutical research corridor]]></category>
		<category><![CDATA[Portland]]></category>
		<category><![CDATA[PositiveID Corp]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Randolph K. Geissler]]></category>
		<category><![CDATA[real estate lineup]]></category>
		<category><![CDATA[recent media interest]]></category>
		<category><![CDATA[RECEPTORS LLC;]]></category>
		<category><![CDATA[related real estate broker]]></category>
		<category><![CDATA[Residence TV]]></category>
		<category><![CDATA[Resort]]></category>
		<category><![CDATA[Retinal Disease]]></category>
		<category><![CDATA[Robert Wendt]]></category>
		<category><![CDATA[Rutgers]]></category>
		<category><![CDATA[S&P]]></category>
		<category><![CDATA[sample device]]></category>
		<category><![CDATA[Sears Holdings]]></category>
		<category><![CDATA[solar cell technologies]]></category>
		<category><![CDATA[source food safety products]]></category>
		<category><![CDATA[specialist in managing companies]]></category>
		<category><![CDATA[stem cell developer]]></category>
		<category><![CDATA[Stem Cells]]></category>
		<category><![CDATA[target]]></category>
		<category><![CDATA[targeted lifestyle transactional television networks]]></category>
		<category><![CDATA[technology professionals]]></category>
		<category><![CDATA[Thanksgiving]]></category>
		<category><![CDATA[The Johns Hopkins University School of Medicine]]></category>
		<category><![CDATA[the University of Michigan]]></category>
		<category><![CDATA[thin film solar cell device]]></category>
		<category><![CDATA[Tom Armstrong]]></category>
		<category><![CDATA[Toronto]]></category>
		<category><![CDATA[travel industry]]></category>
		<category><![CDATA[treatment for eye disease]]></category>
		<category><![CDATA[treatment of brain and other cancers]]></category>
		<category><![CDATA[treatment of infectious diseases]]></category>
		<category><![CDATA[TrialMaster EDC]]></category>
		<category><![CDATA[TrialMaster EDC solution]]></category>
		<category><![CDATA[Turner Media Group]]></category>
		<category><![CDATA[Tyson Foods]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[University of Massachusetts Memorial Medical Center]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[vice president of advertising sales]]></category>
		<category><![CDATA[VP of Marketing]]></category>
		<category><![CDATA[Wendy Borow Johnson]]></category>
		<category><![CDATA[Willie Nelson]]></category>
		<category><![CDATA[Worcester]]></category>
		<category><![CDATA[XsunX;]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19489</guid>
		<description><![CDATA[Companies featured in this edition of the newsletter: ACTC, CUR, CVM, DKAM, ENZ, IMUC, MFGD, NXOI, OMCM, ONEZ, PSID, XSNX
Markets continued to carry momentum during the early stages of last week, as the absence of significant economic news led to a continuation of the upward trend characterizing the past few weeks, until an earnings miss [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/november-23rd-ceocast-weekly-newsletter/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Duke Realty Renews Credit Facility  &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/duke-realty-renews-credit-facility-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/duke-realty-renews-credit-facility-analyst-blog/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 20:37:53 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Duke Realty Corporation]]></category>
		<category><![CDATA[premier]]></category>
		<category><![CDATA[Real Estate]]></category>
		<category><![CDATA[real estate investment trust]]></category>
		<category><![CDATA[real estate markets]]></category>
		<category><![CDATA[Renews Credit Facility]]></category>
		<category><![CDATA[traded real estate developer]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27547/Duke+Realty+Renews+Credit+Facility++-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Duke Realty Corporation</strong> (<a href="http://www.zacks.com/stock/quote/DRE">DRE</a>), a real estate investment trust (REIT) engaged in owning, managing and developing industrial, health care and office properties across the U.S, has recently renewed its unsecured revolving credit facility to enhance its operating flexibility in the current credit-constrained market.<br />
 <br />
The credit facility, which was originally scheduled to mature in Jan 2010, has been currently extended to Feb 2013. Under the terms of the renewal, the credit facility would offer a borrowing capacity of $850 million at an interest rate of 275 basis points over the applicable LIBOR rate. In addition, Duke Realty also has an option to increase the credit facility to $1.05 billion.<br />
 <br />
Duke Realty maintains a balanced and flexible capital structure and has increased its liquidity by diligently managing overhead expenses and reducing dividend payments. With the renewal of the credit facility, the company has further strengthened its balance sheet that provides an operating flexibility to protect and enhance market positions and emerge stronger once the real estate markets fully recover.<br />
 <br />
Duke Realty is one of the largest commercial real estate companies in the U.S. For over 35 years, the company has leveraged its local presence and its integrated platform to drive returns, establishing itself as a premier publicly traded real estate developer in the country.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=DRE">Read the full analyst report on "DRE"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/duke-realty-renews-credit-facility-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HZHI, CVAT, PWRM, HCEI, PSFT, TAXS, CSRH, AQNM, Stocks at a Glance. DrStockPick.com Report!</title>
		<link>http://www.straightstocks.com/stock-watch/hzhi-cvat-pwrm-hcei-psft-taxs-csrh-aqnm-stocks-at-a-glance-drstockpick-com-report/</link>
		<comments>http://www.straightstocks.com/stock-watch/hzhi-cvat-pwrm-hcei-psft-taxs-csrh-aqnm-stocks-at-a-glance-drstockpick-com-report/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 20:26:57 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[(718) 951-8021]]></category>
		<category><![CDATA[(818) 718-0905]]></category>
		<category><![CDATA[(951) 657-8832]]></category>
		<category><![CDATA[+1 866 824 8854]]></category>
		<category><![CDATA[3-D]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[advertisment services]]></category>
		<category><![CDATA[ALS]]></category>
		<category><![CDATA[Amplification Technologies Inc.]]></category>
		<category><![CDATA[Aquentium Inc.;]]></category>
		<category><![CDATA[assistive technology]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[beverage]]></category>
		<category><![CDATA[BioMedReports.com]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cavitation Technologies Inc.]]></category>
		<category><![CDATA[cellular telephone]]></category>
		<category><![CDATA[chemical industries]]></category>
		<category><![CDATA[chemical sensors]]></category>
		<category><![CDATA[Consorteum Holdings Inc.;]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[crude oil]]></category>
		<category><![CDATA[CSRH]]></category>
		<category><![CDATA[diagnostic tests]]></category>
		<category><![CDATA[disability products;]]></category>
		<category><![CDATA[Distribution Inc]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[drug development]]></category>
		<category><![CDATA[e - commerce]]></category>
		<category><![CDATA[emergency services;]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Energy Drinks]]></category>
		<category><![CDATA[environmental friendly technology]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[ergonomic solutions]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Exmovere Holdings Inc.]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[Food Safety]]></category>
		<category><![CDATA[General Counsel for TAXS]]></category>
		<category><![CDATA[green technologies;]]></category>
		<category><![CDATA[Healthy Coffee International Inc.]]></category>
		<category><![CDATA[Healthy Coffee USA Inc.]]></category>
		<category><![CDATA[high-energy physics]]></category>
		<category><![CDATA[Homeland Security]]></category>
		<category><![CDATA[Horizon Health International Corp.]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[Indiana]]></category>
		<category><![CDATA[InGaAs/InP technologies]]></category>
		<category><![CDATA[Internet-driven international business model]]></category>
		<category><![CDATA[Jack Mayer]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Krishna Linga]]></category>
		<category><![CDATA[leader in the development]]></category>
		<category><![CDATA[light level imaging]]></category>
		<category><![CDATA[Mark Taggatz;]]></category>
		<category><![CDATA[medical diagnostics]]></category>
		<category><![CDATA[medical imaging]]></category>
		<category><![CDATA[Michael Sharp]]></category>
		<category><![CDATA[Michael Wallace]]></category>
		<category><![CDATA[mining]]></category>
		<category><![CDATA[mobility devices]]></category>
		<category><![CDATA[motivational speaker]]></category>
		<category><![CDATA[Nano Cavitation Technologies]]></category>
		<category><![CDATA[neurodegenerative disease;]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[New Zealand]]></category>
		<category><![CDATA[news portal;]]></category>
		<category><![CDATA[non-chemical sanitation equipment]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[online data centers]]></category>
		<category><![CDATA[Palm Springs]]></category>
		<category><![CDATA[personal mobility device]]></category>
		<category><![CDATA[physical and chemical refining]]></category>
		<category><![CDATA[Pilipinas]]></category>
		<category><![CDATA[PK Healthy Coffee INTL]]></category>
		<category><![CDATA[platform semiconductor]]></category>
		<category><![CDATA[platform semiconductor technology]]></category>
		<category><![CDATA[Power 3 Medical Products Inc.]]></category>
		<category><![CDATA[Power3 Medical Products Inc.;]]></category>
		<category><![CDATA[PowerSafe Technology Corp.]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[President & COO]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[PSFT]]></category>
		<category><![CDATA[Quent Rickerby;]]></category>
		<category><![CDATA[Retail Stores]]></category>
		<category><![CDATA[Savi Ranch Parkway business complex]]></category>
		<category><![CDATA[scientific instrumentation]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[semiconductor]]></category>
		<category><![CDATA[speaker]]></category>
		<category><![CDATA[spectroscopy]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[Sweden]]></category>
		<category><![CDATA[TaxMasters Inc.]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[vegetable oil refining]]></category>
		<category><![CDATA[Waste To Energy]]></category>
		<category><![CDATA[wearable device]]></category>
		<category><![CDATA[workflow management software application]]></category>
		<category><![CDATA[Workplace Medical Equipment Specialist]]></category>
		<category><![CDATA[www.amplificationtechnologies.com]]></category>
		<category><![CDATA[www.aquentium.com]]></category>
		<category><![CDATA[www.consorteum.com]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.HCEI.biz]]></category>
		<category><![CDATA[www.HealthyCoffee.com]]></category>
		<category><![CDATA[www.power3medical.com]]></category>
		<category><![CDATA[www.psftinc.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[www.txmstr.com]]></category>
		<category><![CDATA[Xplosivestocks.com]]></category>
		<category><![CDATA[Yorba Linda]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4937</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

Monday November 23, 2009
DrStockPick.com Stock Report!
HZHI CVAT, PWRM, HCEI, PSFT, TAXS, CSRH, AQNM
**************************************************************
 HCEI, Healthy Coffee International Inc., HCEI.PK
HCEI is well positioned in the market place at the intersection of three mega-billion dollar industries: coffee, wellness and energy drinks, and has quickly established offices [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/hzhi-cvat-pwrm-hcei-psft-taxs-csrh-aqnm-stocks-at-a-glance-drstockpick-com-report/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TV to Launch Wireless Service &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/tv-to-launch-wireless-service-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/tv-to-launch-wireless-service-analyst-blog/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 20:02:53 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[America Movil S.A.B. de C.V.]]></category>
		<category><![CDATA[broadband]]></category>
		<category><![CDATA[broadband Internet connection;]]></category>
		<category><![CDATA[cable operator]]></category>
		<category><![CDATA[Cable Tv]]></category>
		<category><![CDATA[Cablevision]]></category>
		<category><![CDATA[cellular telephone]]></category>
		<category><![CDATA[digital cable television services]]></category>
		<category><![CDATA[Dominant Player]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[fiber optic network;]]></category>
		<category><![CDATA[fixed telephony services]]></category>
		<category><![CDATA[high-definition television services]]></category>
		<category><![CDATA[I.R.I.S. s.a. TG3Z3510AFCS Headset]]></category>
		<category><![CDATA[long-distance services solutions]]></category>
		<category><![CDATA[media]]></category>
		<category><![CDATA[Megacable]]></category>
		<category><![CDATA[Mexican Ministry of Communication and Transportation]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[mobile phone services;]]></category>
		<category><![CDATA[telecommunications service providers]]></category>
		<category><![CDATA[Telefonica S.A.]]></category>
		<category><![CDATA[Televisa]]></category>
		<category><![CDATA[television network]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[video-on-demand products]]></category>
		<category><![CDATA[wireless communications]]></category>
		<category><![CDATA[wireless services market]]></category>
		<category><![CDATA[wireless services venture]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27544/TV+to+Launch+Wireless+Service+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Grupo Televisa S.A. </strong>(<a href="http://www.zacks.com/stock/quote/TV">TV</a>) has decided to explore the wireless communications market. Televisa is the largest media company in Mexico as well as in the Spanish-speaking world. Its cable TV subsidiary Cablevision will start providing mobile phone services in Mexico from the first quarter of 2010. Televisa has already started its own telecom business. On May 9, 2007, the Mexican Ministry of Communication and Transportation granted Cablevision permission to offer fixed telephony services through its network. As of now, Cablevision offers digital cable television services, broadband Internet connection, high-definition television services and video-on-demand products.<br />
 <br />
Televisa is a dominant force in the Mexican media business. The company is almost a monopoly with around 70% of the Mexican open television market. Televisa has a stable customer base in many different areas, including television broadcasting, pay television network, publishing, and radio. Cablevision will try to leverage this long-established customer base to explore its new wireless services venture. Furthermore, Televisa has been expanding to more stable and developed markets in the U.S. and in Europe. <br />
<br />
The Mexican wireless services market is highly competitive. <strong>America Movil S.A.B. de C.V.</strong> (<a href="http://www.zacks.com/stock/quote/AMX">AMX</a>) is the dominant player in this market commanding approximately 70% share. <strong>Telefonica S.A.</strong> (<a href="http://www.zacks.com/stock/quote/TEF">TEF</a>) is the other major competitor. Mexican cable operator Megacable also decided to enter this market in early 2010. Cablevision already provides data and long-distance services solutions to carriers and other telecommunications service providers through its fiber-optic network in Mexico and the U.S.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=TV">Read the full analyst report on "TV"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AMX">Read the full analyst report on "AMX"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=TEF">Read the full analyst report on "TEF"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/tv-to-launch-wireless-service-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Motorola Boosts iDEN Business &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/motorola-boosts-iden-business-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/motorola-boosts-iden-business-analyst-blog/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 19:45:20 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Alcatel Lucent]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[base station products]]></category>
		<category><![CDATA[Cell Phones]]></category>
		<category><![CDATA[cellular telephone]]></category>
		<category><![CDATA[general]]></category>
		<category><![CDATA[iDEN]]></category>
		<category><![CDATA[iDEN technology]]></category>
		<category><![CDATA[iDEN-based base station products]]></category>
		<category><![CDATA[IPTV specialist]]></category>
		<category><![CDATA[LTE chip]]></category>
		<category><![CDATA[Motorola Inc.]]></category>
		<category><![CDATA[Paris]]></category>
		<category><![CDATA[RadioFrame Networks Inc.]]></category>
		<category><![CDATA[Sprint Nextel Corp.]]></category>
		<category><![CDATA[This technology;]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[wireless carriers]]></category>
		<category><![CDATA[wireless operators]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27542/Motorola+Boosts+iDEN+Business+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Motorola Inc.</strong> (<a href="http://www.zacks.com/stock/quote/MOT">MOT</a>) has decided to purchase iDEN base station assets of the privately held RadioFrame Networks Inc. The iDEN (Integrated Digital Enhanced Network) technology allows cell phone calls to move on the same network as communication from two-way radios. In general, this technology resembles walkie-talkie features on cell phones. Financial terms of this deal have not been disclosed so far. Motorola itself is the pioneer of the iDEN technology that RadioFrame had licensed for its base station products. <br />
 <br />
The main reason for this acquisition is the superior iDEN-based base station products of RadioFrame that are lower cost and more power efficient. This proposed acquisition will enhance Motorola's portfolio of multi-channel base stations products that are optimized to support non-contiguous spectrum allocations in the special mobile radio business. Motorola may use RadioFrame&#8217;s lower-cost iDEN architecture into entirely separated spectrum bands that are allocated to the wireless carriers in the international (outside the U.S.) markets. RadioFrame has a solid client base for its base station products, notable among them being <strong>Sprint Nextel Corp.</strong> (<a href="http://www.zacks.com/stock/quote/S">S</a>).<br />
 <br />
RadioFrame&#8217;s base station products will be a part of Motorola&#8217;s Home and Network Mobility segment. This segment makes equipment for cable and wireless operators. Recently, industry rumors indicated that the company has decided to sell this segment for more than $4.5 billion. As of now, Home and Network Mobility is the largest segment of Motorola. In the third quarter of 2009, this segment generated more than $2 billion revenue and $199 million operating profit.<br />
 <br />
Earlier this month, Motorola&#8217;s Home and Network Mobility segment decided to purchase IPTV specialist BitBand and will do venture funding to the LTE chip making business of Sequans Communications together with <strong>Alcatel-Lucent </strong>(<a href="http://www.zacks.com/stock/quote/ALU">ALU</a>). BitBand has more than 60 commercial IPTV deployments throughout the world and Paris based Sequans Communications has intended to demonstrate its first LTE chipset in early 2010. Whether Motorola sells its Home and Network Mobility segment or not, it seems that the company is increasingly focusing on optimizing the resources of its largest business segment.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=MOT">Read the full analyst report on "MOT"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=S">Read the full analyst report on "S"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ALU">Read the full analyst report on "ALU"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/motorola-boosts-iden-business-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 11/23/09, CVAT, AVOE, CSC, PRU, AJG, TRAK</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-112309-cvat-avoe-csc-pru-ajg-trak/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-112309-cvat-avoe-csc-pru-ajg-trak/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 19:41:02 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[ALG]]></category>
		<category><![CDATA[Arthur J Gallagher Co]]></category>
		<category><![CDATA[automotive retail  industry]]></category>
		<category><![CDATA[Avro Energy Inc.]]></category>
		<category><![CDATA[Cavitation Technologies Inc.]]></category>
		<category><![CDATA[Concord;]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[CSC]]></category>
		<category><![CDATA[DealerTrack Holdings Inc]]></category>
		<category><![CDATA[director]]></category>
		<category><![CDATA[Distribution Inc]]></category>
		<category><![CDATA[Donny Fitzgerald]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[Duane Street]]></category>
		<category><![CDATA[Honda]]></category>
		<category><![CDATA[Inc. in Concord]]></category>
		<category><![CDATA[manager for Duane Street]]></category>
		<category><![CDATA[Manager of  Operations]]></category>
		<category><![CDATA[Manager of  Operations and Director]]></category>
		<category><![CDATA[Nano Cavitation Technologies]]></category>
		<category><![CDATA[North Carolina]]></category>
		<category><![CDATA[on-demand software;]]></category>
		<category><![CDATA[Prudential Financial Inc]]></category>
		<category><![CDATA[replacement manager]]></category>
		<category><![CDATA[Shuford Insurance Agency Inc.]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Toyota]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[wall street]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4933</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Monday Nov 23, 2009
DrStockPick.com Stock Report!
**************************************************************

Cavitation Technologies,  Inc. (OTC BB: CVAT.OB) has filed three new PCT patent applications to  protect our intellectual property worldwide. The patents are for Flow-Through  Cavitation Assisted Rapid Modification of Crude Oil, Modification of Beverage  Fluids, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-112309-cvat-avoe-csc-pru-ajg-trak/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HCEI, Healthy Coffee International is Well Positioned in the Market Place at the Intersection of Three Mega-billion Dollar Industries</title>
		<link>http://www.straightstocks.com/stock-watch/hcei-healthy-coffee-international-is-well-positioned-in-the-market-place-at-the-intersection-of-three-mega-billion-dollar-industries/</link>
		<comments>http://www.straightstocks.com/stock-watch/hcei-healthy-coffee-international-is-well-positioned-in-the-market-place-at-the-intersection-of-three-mega-billion-dollar-industries/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 19:25:57 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[(949) 209-8850]]></category>
		<category><![CDATA[advertisment services]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[corporate site]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[Energy Drinks]]></category>
		<category><![CDATA[Establishing Offices Worldwide]]></category>
		<category><![CDATA[Healthy Coffee International Inc.]]></category>
		<category><![CDATA[Healthy Coffee USA Inc.]]></category>
		<category><![CDATA[Internet-driven international business model]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[New Zealand]]></category>
		<category><![CDATA[Orleans Arena]]></category>
		<category><![CDATA[Pilipinas]]></category>
		<category><![CDATA[PK Healthy Coffee INTL]]></category>
		<category><![CDATA[Rick Aguiluz]]></category>
		<category><![CDATA[Savi Ranch Parkway business complex]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Sweden]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[www.HCEI.biz]]></category>
		<category><![CDATA[www.HealthyCoffee.com]]></category>
		<category><![CDATA[www.healthycoffee.us]]></category>
		<category><![CDATA[Xplosivestocks.com]]></category>
		<category><![CDATA[Yorba Linda]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4932</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Monday Nov 23, 2009
DrStockPick.com Stock Report!
**************************************************************
 HCEI, Healthy Coffee International Inc., HCEI.PK
HCEI’s proprietary formulas combine the health benefits of Ginseng, Reishi Mushroom, and other top quality ingredients with the world’s finest coffee beans to create a line of deliciously healthy instant gourmet coffee drinks.
Last [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/hcei-healthy-coffee-international-is-well-positioned-in-the-market-place-at-the-intersection-of-three-mega-billion-dollar-industries/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Decision scheduled for Santarus (SNTS)</title>
		<link>http://www.straightstocks.com/stock-watch/fda-decision-scheduled-for-santarus-snts/</link>
		<comments>http://www.straightstocks.com/stock-watch/fda-decision-scheduled-for-santarus-snts/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 19:19:25 +0000</pubDate>
		<dc:creator>Jay Garcilazo</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[diarrhea]]></category>
		<category><![CDATA[DM-1796]]></category>
		<category><![CDATA[FavStocks]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[induction of remission]]></category>
		<category><![CDATA[metformin hydrochloride]]></category>
		<category><![CDATA[Santarus Inc;]]></category>
		<category><![CDATA[sodium bicarbonate;]]></category>
		<category><![CDATA[tablet product]]></category>
		<category><![CDATA[treatment of certain upper GI diseases]]></category>
		<category><![CDATA[ulcerative colitis;]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[www.santarus.com]]></category>
		<category><![CDATA[Zegerid tablet]]></category>
		<category><![CDATA[Zegerid;]]></category>

		<guid isPermaLink="false">http://www.favstocks.com/?p=2144</guid>
		<description><![CDATA[   Santarus, Inc. (NASDAQ:SNTS) expects the FDA to decide by December 4, 2009 regarding its NDA for ZEGERID tablet product. A NDA (New Drug Application) for DM-1796 is also expected to be filed with ...]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/fda-decision-scheduled-for-santarus-snts/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Decision scheduled for Santarus (SNTS)</title>
		<link>http://www.straightstocks.com/stock-watch/fda-decision-scheduled-for-santarus-snts/</link>
		<comments>http://www.straightstocks.com/stock-watch/fda-decision-scheduled-for-santarus-snts/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 19:19:25 +0000</pubDate>
		<dc:creator>Jay Garcilazo</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[diarrhea]]></category>
		<category><![CDATA[DM-1796]]></category>
		<category><![CDATA[FavStocks]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[induction of remission]]></category>
		<category><![CDATA[metformin hydrochloride]]></category>
		<category><![CDATA[Santarus Inc;]]></category>
		<category><![CDATA[sodium bicarbonate;]]></category>
		<category><![CDATA[tablet product]]></category>
		<category><![CDATA[treatment of certain upper GI diseases]]></category>
		<category><![CDATA[ulcerative colitis;]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[www.santarus.com]]></category>
		<category><![CDATA[Zegerid tablet]]></category>
		<category><![CDATA[Zegerid;]]></category>

		<guid isPermaLink="false">http://www.favstocks.com/?p=2144</guid>
		<description><![CDATA[   Santarus, Inc. (NASDAQ:SNTS) expects the FDA to decide by December 4, 2009 regarding its NDA for ZEGERID tablet product. A NDA (New Drug Application) for DM-1796 is also expected to be filed with ...]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/fda-decision-scheduled-for-santarus-snts/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CytRx Technical Breakout on Pending News (NASDAQ:CYTR)</title>
		<link>http://www.straightstocks.com/stock-watch/cytrx-technical-breakout-on-pending-news-nasdaqcytr-2/</link>
		<comments>http://www.straightstocks.com/stock-watch/cytrx-technical-breakout-on-pending-news-nasdaqcytr-2/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 18:58:25 +0000</pubDate>
		<dc:creator>Jay Garcilazo</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Am-80]]></category>
		<category><![CDATA[APL]]></category>
		<category><![CDATA[bone marrow transplant]]></category>
		<category><![CDATA[CytRx Corporation]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[European Medicines Agency]]></category>
		<category><![CDATA[FavStocks]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[leukemia]]></category>
		<category><![CDATA[MiV Investments Inc.]]></category>
		<category><![CDATA[STAR-1]]></category>
		<category><![CDATA[The star]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.favstocks.com/?p=2165</guid>
		<description><![CDATA[   Miv Investments Inc. has initiated an independent bullish technical trading alert for 11/23/09 on CytRx Corporation (NASDAQ:CYTR). Shares of the company finished trading during 11/20/09 at $1.35 per share, up 20.18% from ...]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/cytrx-technical-breakout-on-pending-news-nasdaqcytr-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Despite What the News Tells You, Crude Oil Prices Set to Fall</title>
		<link>http://www.straightstocks.com/investing-lessons/despite-what-the-news-tells-you-crude-oil-prices-set-to-fall/</link>
		<comments>http://www.straightstocks.com/investing-lessons/despite-what-the-news-tells-you-crude-oil-prices-set-to-fall/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 18:57:31 +0000</pubDate>
		<dc:creator>Investment U</dc:creator>
				<category><![CDATA[Contrarian Perspectives]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[crude oil]]></category>
		<category><![CDATA[Crude Oil Prices]]></category>
		<category><![CDATA[crude-oil inventories]]></category>
		<category><![CDATA[Department of Energy]]></category>
		<category><![CDATA[editor]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[InvestmentU]]></category>
		<category><![CDATA[New Jersey]]></category>
		<category><![CDATA[New Jersey refinery]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[oil demand]]></category>
		<category><![CDATA[Oil Market]]></category>
		<category><![CDATA[Oil Prices]]></category>
		<category><![CDATA[Oil Refineries]]></category>
		<category><![CDATA[Printing Presses]]></category>
		<category><![CDATA[Sheena Martin]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.investmentu.com/IUEL/2009/November/crude-oil-prices-set-to-fall.html</guid>
		<description><![CDATA[Despite What the News Tells You, Crude Oil Prices Set to Fall
by Sheena Martin,  Contributing Editor
Monday, November 23, 2009
Is the price of oil headed  for $100 per barrel again?
Many say it is. But to be  frank, the &#8220;fair price&#8221; is much lower than the current range of $75-$83 per  barrel.
If you [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/despite-what-the-news-tells-you-crude-oil-prices-set-to-fall/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Akeena Solar, Inc. (AKNS) Partners with Highland Solar Achieving Canadian Market Penetration</title>
		<link>http://www.straightstocks.com/investing-lessons/akeena-solar-inc-akns-partners-with-highland-solar-achieving-canadian-market-penetration/</link>
		<comments>http://www.straightstocks.com/investing-lessons/akeena-solar-inc-akns-partners-with-highland-solar-achieving-canadian-market-penetration/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 17:51:38 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Akeena Solar Inc]]></category>
		<category><![CDATA[AKNA Barry Cinnamon]]></category>
		<category><![CDATA[Andalay AC]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[D. C.]]></category>
		<category><![CDATA[D.C.]]></category>
		<category><![CDATA[Electrical Systems]]></category>
		<category><![CDATA[electricity bills]]></category>
		<category><![CDATA[generous new renewable energy programs]]></category>
		<category><![CDATA[Highland Solar]]></category>
		<category><![CDATA[home owner]]></category>
		<category><![CDATA[Ontario]]></category>
		<category><![CDATA[Popular Mechanics]]></category>
		<category><![CDATA[power systems]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[renewable energy]]></category>
		<category><![CDATA[rooftop solar systems]]></category>
		<category><![CDATA[Sean McCrane]]></category>
		<category><![CDATA[Solar Systems]]></category>
		<category><![CDATA[stand-alone solar systems]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19483</guid>
		<description><![CDATA[Akeena Solar Inc (AKNS), well-known for their Andalay AC power systems, which are stand-alone solar systems designed for the average home, announced a partnership with Highland Solar (HS) today, Monday, Nov. 23. 
HS, located in Ontario, will move at least 1.75 megawatts (MW) of the Andalay AC solar panels through 2010, via its local installers [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/akeena-solar-inc-akns-partners-with-highland-solar-achieving-canadian-market-penetration/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cardio Vascular Medical Device Corp. (CVSL.OB) Applying for Patents in Europe, Canada, and Far East</title>
		<link>http://www.straightstocks.com/investing-lessons/cardio-vascular-medical-device-corp-cvsl-ob-applying-for-patents-in-europe-canada-and-far-east/</link>
		<comments>http://www.straightstocks.com/investing-lessons/cardio-vascular-medical-device-corp-cvsl-ob-applying-for-patents-in-europe-canada-and-far-east/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 17:44:25 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[angioplasty]]></category>
		<category><![CDATA[bypass surgery]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Cardio Vascular Medical Device Corp.]]></category>
		<category><![CDATA[cardiovascular surgery]]></category>
		<category><![CDATA[cardiovascular surgery technologies]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[developer]]></category>
		<category><![CDATA[Eli Gonen]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Far East]]></category>
		<category><![CDATA[heart attacks;]]></category>
		<category><![CDATA[Heart Disease]]></category>
		<category><![CDATA[neurosurgeon]]></category>
		<category><![CDATA[principal product]]></category>
		<category><![CDATA[steerable guidewire product]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19481</guid>
		<description><![CDATA[Cardio Vascular Medical Device Corp., an Israeli based developer of advanced cardiovascular surgery technologies, has announced that it will apply for additional patents for its proprietary steerable guidewire product for use in angioplasty procedures. The company already holds a U.S. patent for its innovative guidewire, but wants to obtain patents in Europe, Canada, and the [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/cardio-vascular-medical-device-corp-cvsl-ob-applying-for-patents-in-europe-canada-and-far-east/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Encouraging Data on J&amp;J Drug &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/encouraging-data-on-jj-drug-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/encouraging-data-on-jj-drug-analyst-blog/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 16:44:53 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[American College of Rheumatology]]></category>
		<category><![CDATA[ankylosing spondylitis;]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[european commission]]></category>
		<category><![CDATA[GO-FORWARD]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[necrosis]]></category>
		<category><![CDATA[psoriatic arthritis;]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>
		<category><![CDATA[Schering Plough]]></category>
		<category><![CDATA[Simponi]]></category>
		<category><![CDATA[tumor]]></category>
		<category><![CDATA[U.S. Food and Drug Administration]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27534/Encouraging+Data+on+J%26J+Drug+-+Analyst+Blog</guid>
		<description><![CDATA[<p><strong>Johnson and Johnson</strong> (<a href="http://www.zacks.com/stock/quote/JNJ">JNJ</a>) recently presented long-term data from two phase III clinical trials of Simponi (golimumab), carried out on rheumatoid arthritis (RA) patients. It was observed that patients taking Simponi every four weeks achieved sustained improvements through one year. The data were presented at the 2009 American College of Rheumatology (ACR) Annual Scientific Meeting held last month.</p>
<p>Data from the first trial &#8211; GOlimumab After Former anti-TNF (tumor necrosis factor) Therapy Evaluated in RA (GO-AFTER) revealed that patients previously treated with TNF inhibitors (adalimumab, etanercept or infliximab) responded as well as showed continued response to the drug for an entire year. At week 52, data measured by American College of Rheumatology (ACR 20) response found a 20% improvement in arthritis symptoms in 63% of patients receiving the drug while 41% of the patients achieved a 50% improvement in arthritis symptoms measured by ACR 50 response.</p>
<p>Results from the second trial - GOlimumab FOR subjects With Active RA Despite Methotrexate (GO-FORWARD) study proved the effectiveness of Simponi in patients with active RA despite prior treatment with methotrexate. Like the earlier trial, this trial also presented positive results for Simponi. At week 52, 64% of patients taking the drug and methotrexate achieved ACR 20 response while 25% achieved a 70% improvement in arthritis symptoms as measured by ACR 70 response. Both these studies were carried out with Simponi in 50 mg dosage as a once-monthly subcutaneous injection.</p>
<p>Earlier in April 2009, Simponi received approval from the US Food and Drug Administration and Health Canada approved Simponi for the treatment of moderate to severe active RA, active psoriatic arthritis (PsA) and active ankylosing spondylitis. Thereafter, in October 2009, the drug received approval from the European Commission as well.</p>
<p>As a reminder, on May 27, 2009 Johnson &#38; Johnson announced an arbitration demand against Schering-Plough (now a part of <strong>Merck</strong>, <a href="http://www.zacks.com/stock/quote/MRK">MRK</a>) requesting a ruling regarding the ex-US rights of Remicade and Simponi. J&#38;J developed both compounds and licensed marketing rights outside the US to Schering-Plough. However, J&#38;J contends that the merger between Schering-Plough and Merck has triggered a change of control provision in the licensing agreement, resulting in its termination, thereby returning full rights to the compounds to J&#38;J.<br />
 <br />
Remicade is approved for 15 indications in the US alone including RA. Remicade generated almost $5.9 billion in worldwide revenues in 2008, including $2.1 billion in sales outside the US, which Schering-Plough booked as revenues. The pending case is of great importance to both companies given the sales contribution from the product. We are Neutral on J&#38;J.</p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=JNJ">Read the full analyst report on "JNJ"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=MRK">Read the full analyst report on "MRK"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/encouraging-data-on-jj-drug-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PWRM, STEM, DrStockPick.com Stock Report! Power 3 Medical Products Inc. and StemCells Inc.</title>
		<link>http://www.straightstocks.com/stock-watch/pwrm-stem-drstockpick-com-stock-report-power-3-medical-products-inc-and-stemcells-inc-2/</link>
		<comments>http://www.straightstocks.com/stock-watch/pwrm-stem-drstockpick-com-stock-report-power-3-medical-products-inc-and-stemcells-inc-2/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 16:28:33 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[actual disease]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[ALS]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cell-based technologies]]></category>
		<category><![CDATA[Children’s Hospital]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[diagnostic tests]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[HuCNS-SC®]]></category>
		<category><![CDATA[Ira L. Goldknopf]]></category>
		<category><![CDATA[lead product candidate]]></category>
		<category><![CDATA[neurodegenerative disease;]]></category>
		<category><![CDATA[neurodegenerative disorders;]]></category>
		<category><![CDATA[neurological disorder]]></category>
		<category><![CDATA[neurological disorders]]></category>
		<category><![CDATA[Neurosurgery]]></category>
		<category><![CDATA[Pelizaeus-Merzbacher Disease]]></category>
		<category><![CDATA[Power 3 Medical Products Inc.]]></category>
		<category><![CDATA[Power3;]]></category>
		<category><![CDATA[President and Chief Scientific Officer]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[PWRM]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[Stem Cells]]></category>
		<category><![CDATA[StemCells Inc.]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[treatment of two fatal neurodegenerative disorders]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[University of California]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[www.BestOTC.com]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.PennyOmega.com]]></category>
		<category><![CDATA[www.power3medical.com]]></category>
		<category><![CDATA[www.stemcellsinc.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[www.stock-pr.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4916</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

Monday Nov 23, 2009
DrStockPick.com Stock Report!
PWRM, STEM
**************************************************************
PWRM, Power 3 Medical Products Inc, PWRM.OB
PWRM is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. PWRM’s patent-pending [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/pwrm-stem-drstockpick-com-stock-report-power-3-medical-products-inc-and-stemcells-inc-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nike Increases Quarterly Dividend &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/nike-increases-quarterly-dividend-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/nike-increases-quarterly-dividend-analyst-blog/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 16:23:16 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[leading designer]]></category>
		<category><![CDATA[massive and well-established network]]></category>
		<category><![CDATA[Nike Inc]]></category>
		<category><![CDATA[Retail Accounts]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27533/Nike+Increases+Quarterly+Dividend+-+Analyst+Blog</guid>
		<description><![CDATA[<strong><br />
Nike Inc.</strong> (<a href="http://www.zacks.com/stock/quote/NKE">NKE</a>), the world&#8217;s leading designer, marketer and distributor of athletic footwear, apparel, equipment and accessories, has recently increased its quarterly dividend by 8% to 27 cents per share from 25 cents.<br />
 <br />
Amid a challenging macroeconomic environment, when most companies are either reducing or temporarily withdrawing dividend payments, Nike has decided to increase its dividend for the eighth year in a row. The company has paid over $1.8 billion as dividends to shareholders in the last five years, and expects to continue to pay a steady dividend in the future as well.<br />
 <br />
Nike leverages a massive and well-established network of more than 23,000 retail accounts in the U.S and over 28,000 internationally to reach a wide array of customers. The company&#8217;s retail accounts consist of a mix of footwear stores, sporting goods stores, athletic specialty stores, department stores, skate as well as tennis and golf shops.<br />
 <br />
Nike remains upbeat about its performance in the coming quarters. The company stressed that it was gradually gaining market share and was in a strong position to benefit when the global economy improves. In an effort to achieve its long-term sales target of $23 billion by fiscal 2011, Nike recently executed a restructuring plan, which reorganized its geographic segments, slashed management layers, and enhanced customer focus. Moreover, in order to reduce its operating costs, the company has retrenched about 5% of its 35,000-strong global workforce.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=NKE">Read the full analyst report on "NKE"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/nike-increases-quarterly-dividend-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Good News for Bristol-Myers &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/good-news-for-bristol-myers-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/good-news-for-bristol-myers-analyst-blog/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 15:40:00 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Abilify]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Astrazeneca Plc]]></category>
		<category><![CDATA[atherosclerosis]]></category>
		<category><![CDATA[autistic disorder]]></category>
		<category><![CDATA[bipolar disorder]]></category>
		<category><![CDATA[Bristol]]></category>
		<category><![CDATA[Bristol Myers Squibb Co]]></category>
		<category><![CDATA[Cefzil]]></category>
		<category><![CDATA[Depression]]></category>
		<category><![CDATA[Eli Lilly & Co]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[fatigue]]></category>
		<category><![CDATA[Heart Attack]]></category>
		<category><![CDATA[irritation]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Medarex;]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[Otsuka Pharmaceutical Co.;]]></category>
		<category><![CDATA[Pfizer Inc]]></category>
		<category><![CDATA[schizophrenia]]></category>
		<category><![CDATA[treatment of irritability associated with autistic disorder]]></category>
		<category><![CDATA[U.S. Food and Drug  Administration]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[vomiting]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27527/Good+News+for+Bristol-Myers+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Recently, <strong>Bristol-Myers Squibb Co</strong>. (<a href="http://www.zacks.com/stock/quote/BMY">BMY</a>) received approval from the U.S. Food and Drug Administration (FDA) to market Abilify (aripiprazole) for the treatment of irritability in pediatric patients having autistic disorder. Abilify can be used to treat children aged 6 to 17 years for symptoms of aggression toward others, deliberate self injury, temper tantrums and quick mood swings. <br />
<br />
Bristol-Myers and Otsuka Pharmaceutical Co. jointly develop and distribute the drug in the U.S. and Europe. The FDA approval of Abilify for treating irritation in pediatric patients with autistic disorder is based on data from two eight-week late-stage studies in which Abilify significantly improved scores on the irritability subscale of the caregiver-rated Aberrant Behavior Checklist (ABC-I), compared to placebo. <br />
<br />
The most common adverse affects were sedation, fatigue, vomiting, somnolence, tremor and pyrexia. However, the efficacy of Abilify for the maintenance treatment of irritability associated with autistic disorder was not evaluated. Abilify, which is approved to treat depression, bipolar disorder, and schizophrenia, generated sales of $2,153 million in 2008, up 30% from 2007. Furthermore, sales in the third quarter of 2009 grew 16% to $653 million. <br />
<br />
Abilify has been growing at about five times the overall antipsychotic market. The company&#8217;s beefed-up sales force and new Direct to Consumer (DTC) campaigns are aiding sales growth. Abilify faces competition from other drugs in the market such as <strong>Merck&#8217;s</strong> (<a href="http://www.zacks.com/stock/quote/MRK">MRK</a>) Saphris, <strong>Pfizer Inc.'s</strong> (<a href="http://www.zacks.com/stock/quote/PFE">PFE</a>) Geodon, <strong>Johnson &#38; Johnson's</strong> (<a href="http://www.zacks.com/stock/quote/JNJ">JNJ</a>) Risperdal, <strong>AstraZeneca PLC's</strong> (<a href="http://www.zacks.com/stock/quote/AZN">AZN</a>) Seroquel and <strong>Eli Lilly &#38; Co.'s</strong> (<a href="http://www.zacks.com/stock/quote/LLY">LLY</a>) Zyprexa. <br />
<br />
Plavix, the antiplatelet blood thinner indicated to reduce the risk of heart attack in patients with atherosclerosis, is the top growth driver for Bristol. However, patent expirations loom large on the company starting 2011 when the Plavix patent expires. The company has lost patent protection on products worth about $4 billion in sales over the past four years. <br />
<br />
Drugs such as Cefzil, Paraplatin, Glucophage, Monopril and Taxol are also experiencing declining sales due to generic competition. However, the $1 billion addition in cost cuts in 2012-2013, the extension of the Abilify agreement with Otsuka, and the acquisition of Medarex indicate that management is taking meaningful steps to prepare for the loss of exclusivity of Plavix. Currently, we are Neutral on Bristol-Myers.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BMY">Read the full analyst report on "BMY"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=LLY">Read the full analyst report on "LLY"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AZN">Read the full analyst report on "AZN"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=MRK">Read the full analyst report on "MRK"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PFE">Read the full analyst report on "PFE"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/good-news-for-bristol-myers-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Solar Energy Initiatives, Inc. (SNRY.OB): Grass Roots Solar</title>
		<link>http://www.straightstocks.com/investing-lessons/solar-energy-initiatives-inc-snry-ob-grass-roots-solar/</link>
		<comments>http://www.straightstocks.com/investing-lessons/solar-energy-initiatives-inc-snry-ob-grass-roots-solar/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 15:13:27 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Akeena Solar Inc]]></category>
		<category><![CDATA[Ascent Solar;]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[collector]]></category>
		<category><![CDATA[DayStar Technologies Inc.]]></category>
		<category><![CDATA[dealer networks]]></category>
		<category><![CDATA[Electricity]]></category>
		<category><![CDATA[Electricity generation]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Energy Conversion Devices Inc.]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Evergreen Solar Inc.]]></category>
		<category><![CDATA[fossil fuel systems]]></category>
		<category><![CDATA[gas-powered generators]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[home size power generation systems]]></category>
		<category><![CDATA[Hot water systems]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[photovoltaic systems]]></category>
		<category><![CDATA[Solar Energy Initiatives Inc.;]]></category>
		<category><![CDATA[Solar EnerTech Corp.]]></category>
		<category><![CDATA[solar heat collector]]></category>
		<category><![CDATA[Solar Inc.;]]></category>
		<category><![CDATA[Surplus Electricity]]></category>
		<category><![CDATA[thermal systems]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[XsunX;]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19472</guid>
		<description><![CDATA[
These days, solar is one of the most popular words in the green lexicon. You hear it everywhere, with most of the talk focusing on the increasingly large solar power plants that are now being built. New designs have dropped the price of large scale solar electricity generation by over 80% in the last 25 [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/solar-energy-initiatives-inc-snry-ob-grass-roots-solar/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Best Energy Investments in the World</title>
		<link>http://www.straightstocks.com/investing-lessons/the-best-energy-investments-in-the-world/</link>
		<comments>http://www.straightstocks.com/investing-lessons/the-best-energy-investments-in-the-world/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 15:00:37 +0000</pubDate>
		<dc:creator>Contrarian Profits</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Africa]]></category>
		<category><![CDATA[Alberta]]></category>
		<category><![CDATA[Bolivia]]></category>
		<category><![CDATA[Brazil]]></category>
		<category><![CDATA[Brian Hunt;]]></category>
		<category><![CDATA[CAD]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Casey Energy]]></category>
		<category><![CDATA[Casey Energy Report]]></category>
		<category><![CDATA[Casey Research]]></category>
		<category><![CDATA[chance oil]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Colombia]]></category>
		<category><![CDATA[contrarian profits]]></category>
		<category><![CDATA[conventional oil production]]></category>
		<category><![CDATA[crude oil]]></category>
		<category><![CDATA[Crux]]></category>
		<category><![CDATA[easy oil]]></category>
		<category><![CDATA[editor-in-chief]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[exxonmobil]]></category>
		<category><![CDATA[favorite energy]]></category>
		<category><![CDATA[foreign oil companies ownership]]></category>
		<category><![CDATA[Frank Giustra]]></category>
		<category><![CDATA[free online investment digest]]></category>
		<category><![CDATA[friendly oil source]]></category>
		<category><![CDATA[gulf of mexico]]></category>
		<category><![CDATA[huge oil-sands deposits]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Iraq]]></category>
		<category><![CDATA[Islamic Republic of Iran]]></category>
		<category><![CDATA[Kuwait]]></category>
		<category><![CDATA[Libya]]></category>
		<category><![CDATA[Lukas Lundin]]></category>
		<category><![CDATA[Marin Katusa;]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[Natural Gas]]></category>
		<category><![CDATA[Natural Gas Price]]></category>
		<category><![CDATA[natural gas sector]]></category>
		<category><![CDATA[Nexen]]></category>
		<category><![CDATA[Oecd]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[Oil Consumption]]></category>
		<category><![CDATA[oil deposits;]]></category>
		<category><![CDATA[Oil plays;]]></category>
		<category><![CDATA[Oil Prices]]></category>
		<category><![CDATA[oil sands]]></category>
		<category><![CDATA[oil-hungry nations]]></category>
		<category><![CDATA[Sam Magid]]></category>
		<category><![CDATA[Saudi Arabia]]></category>
		<category><![CDATA[senior energy analyst]]></category>
		<category><![CDATA[Stansberry]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[VANCOUVER]]></category>
		<category><![CDATA[Venezuela]]></category>

		<guid isPermaLink="false">http://www.contrarianprofits.com/?p=21125</guid>
		<description><![CDATA[Brian Hunt, editor in chief of Stansberry’s free online investment digest, a href="http://www.thedailycrux.com/"The Daily Crux/a,  interviewed Marin [Katusa, Casey Research]to get his take on where oil prices are headed for the long-term... the regions where investors and traders should focus their dollars... and some of his favorite energy companies with massive upside.]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/the-best-energy-investments-in-the-world/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HZHI, Horizon Health International Corp. Enters Into an Exclusive Agreement With Exmovere Holdings Inc., for Mobility Aid and BioSensor Products, Opening the Door to a Multi Million Dollar Industry</title>
		<link>http://www.straightstocks.com/stock-watch/hzhi-horizon-health-international-corp-enters-into-an-exclusive-agreement-with-exmovere-holdings-inc-for-mobility-aid-and-biosensor-products-opening-the-door-to-a-multi-million-dollar-industry/</link>
		<comments>http://www.straightstocks.com/stock-watch/hzhi-horizon-health-international-corp-enters-into-an-exclusive-agreement-with-exmovere-holdings-inc-for-mobility-aid-and-biosensor-products-opening-the-door-to-a-multi-million-dollar-industry/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 14:36:33 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[3-D]]></category>
		<category><![CDATA[604-998-3385]]></category>
		<category><![CDATA[advertisment services]]></category>
		<category><![CDATA[assistive technology]]></category>
		<category><![CDATA[British Columbia]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[cellular telephone]]></category>
		<category><![CDATA[Company Director]]></category>
		<category><![CDATA[consumer applications]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[Delbert G. Blewett]]></category>
		<category><![CDATA[disability products;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[e - commerce]]></category>
		<category><![CDATA[e-commerce system]]></category>
		<category><![CDATA[emergency services;]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[ergonomic solutions]]></category>
		<category><![CDATA[Exmovere Holdings Inc.]]></category>
		<category><![CDATA[forward to a long beneficial relationship]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[Horizon Health International Corp.]]></category>
		<category><![CDATA[Jeff Hoogveld]]></category>
		<category><![CDATA[mobility device]]></category>
		<category><![CDATA[mobility devices]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[North Vancouver;]]></category>
		<category><![CDATA[online data centers]]></category>
		<category><![CDATA[personal mobility device]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[Retail Stores]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[wearable device]]></category>
		<category><![CDATA[Workplace Medical Equipment Specialist]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.exmovere.com]]></category>
		<category><![CDATA[www.horizonhealthandsafety.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[Xplosivestocks.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4915</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

Monday Nov 23, 2009
DrStockPick.com Stock Report!
**************************************************************
 HZHI, Horizon Health International Corp., HZHI.PK
Horizon Health International Corp. Enters Into an Exclusive Agreement With Exmovere Holdings Inc., for Mobility Aid and BioSensor Products, Opening the Door to a Multi Million Dollar Industry
NORTH VANCOUVER, BRITISH COLUMBIA&#8211;(CRWENEWSWIRE - Nov [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/hzhi-horizon-health-international-corp-enters-into-an-exclusive-agreement-with-exmovere-holdings-inc-for-mobility-aid-and-biosensor-products-opening-the-door-to-a-multi-million-dollar-industry/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MWW Automotive Group (MWWC.OB) Subsidiary Signs Major Distribution Agreement</title>
		<link>http://www.straightstocks.com/investing-lessons/mww-automotive-group-mwwc-ob-subsidiary-signs-major-distribution-agreement/</link>
		<comments>http://www.straightstocks.com/investing-lessons/mww-automotive-group-mwwc-ob-subsidiary-signs-major-distribution-agreement/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 14:31:36 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Cobra]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Gerald Haas]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[Isomotive BV]]></category>
		<category><![CDATA[Michigan]]></category>
		<category><![CDATA[MWW Automotive Group]]></category>
		<category><![CDATA[owned subsidiary]]></category>
		<category><![CDATA[protective car accessories]]></category>
		<category><![CDATA[reduced auto insurance rates]]></category>
		<category><![CDATA[The Netherlands]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19470</guid>
		<description><![CDATA[MWW Automotive Group is a young corporation that has gained notoriety across the globe for producing and delivering their products, design and Class A painting services to automobile manufacturers and assembly lines across the world.  Today, MWW announced that Modelworxx, its wholly owned subsidiary located in Germany, signed an executive agreement with Isomotive BV, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/mww-automotive-group-mwwc-ob-subsidiary-signs-major-distribution-agreement/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Company News for November 23, 2009 &#8211; Corporate Summary</title>
		<link>http://www.straightstocks.com/stock-watch/company-news-for-november-23-2009-corporate-summary/</link>
		<comments>http://www.straightstocks.com/stock-watch/company-news-for-november-23-2009-corporate-summary/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 14:11:02 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Citigroup]]></category>
		<category><![CDATA[Coca Cola]]></category>
		<category><![CDATA[Ebay]]></category>
		<category><![CDATA[Goldman Sachs]]></category>
		<category><![CDATA[google]]></category>
		<category><![CDATA[Hershey]]></category>
		<category><![CDATA[Hsbc]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Kraft's]]></category>
		<category><![CDATA[microsoft]]></category>
		<category><![CDATA[News Corp]]></category>
		<category><![CDATA[Reliance Industries]]></category>
		<category><![CDATA[Tyson Foods]]></category>
		<category><![CDATA[UBS]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[weekend web outage]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27529/Company+News+for+November+23%2C+2009+-+Corporate+Summary</guid>
		<description><![CDATA[<p align="justify">&#8226; A large run of holiday sales offerings crashed the Ebay (NASDAQ:EBAY) website, causing a major weekend web outage</p>
<p align="justify">&#8226; Tyson Foods (NYSE:TSN) reported better-than-expected earnings of 28 cents a share, beating Zacks estimates by 2 cents, on revenues of $7.2 billion, which exceeded Zacks estimates of $6.85 billion</p>
<p align="justify">&#8226; India&#8217;s Reliance Industries bid $12 billion in cash for Lyondell Bassell when it exits bankruptcy</p>
<p align="justify">&#8226; Microsoft (NASDAQ:MSFT) is reportedly in discussions with News Corp. (NASDAQ:NWSA) to "de-index" the firm's news websites from Google (NASDAQ:GOOG)</p>
<p align="justify">&#8226; Coca-Cola (NYSE:KO) announced plans to more than double the number of its bottling plants in China over the next ten years as part of its goal to triple sales to the country</p>
<p align="justify">&#8226; Hershey (NYSE:HSY) trust encouraged the firm to counter Kraft's (NYSE:KFT) hostile, $16.2 billion bid with its own, $17 billion offer</p>
<p align="justify">&#8226; According to S&#38;P most US banks are failing to meet adequacy standards comfortably enough to avoid ratings downgrades. Both HSBC (NYSE:HBC) and Goldman Sachs (NYSE:GS) showed stronger-than-average balance sheets, with UBS (NYSE:UBS) and Citigroup (NYSE:C) well below average</p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/company-news-for-november-23-2009-corporate-summary/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>U.S. Bank Failures Hit 124 &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/u-s-bank-failures-hit-124-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/u-s-bank-failures-hit-124-analyst-blog/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 14:00:00 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Bank]]></category>
		<category><![CDATA[bank fails]]></category>
		<category><![CDATA[Bank Failures]]></category>
		<category><![CDATA[BB&T Corporation]]></category>
		<category><![CDATA[Central Bank of Stillwater]]></category>
		<category><![CDATA[Commerce Bank of Southwest Florida]]></category>
		<category><![CDATA[Department of the Treasury]]></category>
		<category><![CDATA[Deposit Insurance Fund]]></category>
		<category><![CDATA[Federal Deposit Insurance]]></category>
		<category><![CDATA[Federal Deposit Insurance Corporation]]></category>
		<category><![CDATA[Fifth Third Bancorp]]></category>
		<category><![CDATA[insurance fund]]></category>
		<category><![CDATA[JP Morgan Chase]]></category>
		<category><![CDATA[Minnesota]]></category>
		<category><![CDATA[Real Estate]]></category>
		<category><![CDATA[real estate loans]]></category>
		<category><![CDATA[regions financial]]></category>
		<category><![CDATA[Suntrust Banks]]></category>
		<category><![CDATA[U S Bank]]></category>
		<category><![CDATA[U.S. Bancorp]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Washington Mutual]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>
		<category><![CDATA[Zions Bancorp]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27518/U.S.+Bank+Failures+Hit+124+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
U.S. regulators on Friday closed down Commerce Bank of Southwest Florida. Though there are some early signs of economic recovery, bank failures go on growing with rising loan defaults. This takes the total number of bank failures to 124, compared to 25 in 2008 and 3 in 2007. The weak economy continues to weigh heavily on banks with a stream of loan defaults. <br />
<br />
As the industry has to tolerate bad loans that were made during the credit explosion, the trouble in the banking system goes even deeper, increasing the possibility of more bank failures. However, the regulators are trying to avoid panic by seizing banks slowly. Also, the slow seizing could be a strategy as it is hard to get buyers for so many failed banks. <br />
<br />
Commerce Bank had total assets of $79.7 million and total deposits of about $76.7 million. The failure of Commerce Bank represents another impact on the Federal Deposit Insurance Corporation&#8217;s (FDIC) fund for protecting customer accounts, as it has been appointed receiver for the bank. The latest failure is expected to cost the FDIC's insurance fund about $23.6 million. <br />
<br />
Bank failures have cost the federal deposit insurance fund more than $28 billion so far this year. The FDIC insures deposits at 8,195 institutions with roughly $13.5 trillion in assets. When a bank fails, it reimburses customers for deposits of up to $250,000 per account. The outbreak of bank failures has significantly stretched the regulator&#8217;s deposit insurance fund. <br />
<br />
The fund corpus now stands below $10 billion, down from $45 billion a year ago. Central Bank of Stillwater, Minnesota, will assume all of Commerce Bank&#8217;s deposits. The acquirer also entered into a loss-share agreement with the FDIC on $61 million of Commerce Bank's $79.7 million in assets. In the second quarter of 2009, the number of banks on the FDIC's list of problem institutions grew to 416 from 305 in the first quarter. This is the highest since the savings and loan crisis in 1994. <br />
<br />
Increasing loan losses on commercial real estate are expected to cause hundreds more bank failures in the next few years. The FDIC anticipates the bank failures to cost about $100 billion over the next four years. In order to replenish the declining fund, the FDIC board recently mandated the U.S. banks to pay fees for three years in advance. <br />
<br />
Also, the regulators are considering requesting the healthy banks to bail out the government soon as it is necessary to replenish the deposit insurance fund, which has slipped to 0.22% of insured deposits, below the mandated minimum of 1.15%. The FDIC also has access to the Treasury Department credit line of up to $500 billion. <br />
<br />
The failure of Washington Mutual last year was the largest in U.S. banking history. It was acquired by <strong>JP Morgan Chase</strong> (<a href="http://www.zacks.com/stock/quote/JPM">JPM</a>). The other major acquirers of failed institutions since 2008 include <strong>Fifth Third Bancorp</strong> (<a href="http://www.zacks.com/stock/quote/FITB">FITB</a>), <strong>U.S. Bancorp</strong>, <strong>Zions Bancorp</strong> (<a href="http://www.zacks.com/stock/quote/ZION">ZION</a>), <strong>SunTrust Banks</strong> (<a href="http://www.zacks.com/stock/quote/STI">STI</a>), <strong>PNC Financial</strong> (<a href="http://www.zacks.com/stock/quote/PNC">PNC</a>), <strong>BB&#38;T Corporation</strong> (<a href="http://www.zacks.com/stock/quote/BBT">BBT</a>) and <strong>Regions Financial</strong> (<a href="http://www.zacks.com/stock/quote/RF">RF</a>). The failed banks are victims of recession and rising loan losses. <br />
<br />
As a result of the ongoing market turmoil, these institutions experienced massive capital erosion stemming from losses due to a significant exposure to collateralized mortgage obligations, commercial real estate loans and other commercial and industrial loans. All these factors were responsible for a drag on profitability and write-downs. <br />
<br />
According to the FDIC, the bank failures have cost the federal deposit insurance fund more than $28 billion so far this year. Though current signals indicate that the economy may stabilize, we expect loan losses on commercial real estate portfolio to remain high for banks that hold large amounts of high-risk loans.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=JPM">Read the full analyst report on "JPM"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=FITB">Read the full analyst report on "FITB"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ZION">Read the full analyst report on "ZION"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=STI">Read the full analyst report on "STI"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PNC">Read the full analyst report on "PNC"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BBT">Read the full analyst report on "BBT"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=RF">Read the full analyst report on "RF"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/u-s-bank-failures-hit-124-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Technical Breakout Alert Issued for CytRx (NASDAQ:CYTR)</title>
		<link>http://www.straightstocks.com/stock-watch/technical-breakout-alert-issued-for-cytrx-nasdaqcytr/</link>
		<comments>http://www.straightstocks.com/stock-watch/technical-breakout-alert-issued-for-cytrx-nasdaqcytr/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 13:35:02 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[2 protocol]]></category>
		<category><![CDATA[Acute Myeloid Leukemia]]></category>
		<category><![CDATA[Alexion Pharmaceuticals Inc;]]></category>
		<category><![CDATA[Am-80]]></category>
		<category><![CDATA[Amgen Inc.]]></category>
		<category><![CDATA[APL]]></category>
		<category><![CDATA[bone marrow transplant]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[breast cancers]]></category>
		<category><![CDATA[Celsion Corporation]]></category>
		<category><![CDATA[Chairman]]></category>
		<category><![CDATA[chairman and CEO]]></category>
		<category><![CDATA[Chief Medical Officer]]></category>
		<category><![CDATA[chief scientific officer]]></category>
		<category><![CDATA[chronic myeloid leukemia]]></category>
		<category><![CDATA[CytRx Corporation]]></category>
		<category><![CDATA[Daniel Levitt]]></category>
		<category><![CDATA[director]]></category>
		<category><![CDATA[director of clinical oncology]]></category>
		<category><![CDATA[Discovery Laboratories Inc;]]></category>
		<category><![CDATA[drug development]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[European Medicines Agency]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[head]]></category>
		<category><![CDATA[Head of Oncology]]></category>
		<category><![CDATA[Hepatocellular carcinoma;]]></category>
		<category><![CDATA[INNO-406]]></category>
		<category><![CDATA[Jack R. Barber]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Joseph Rubinfeld]]></category>
		<category><![CDATA[leukemia]]></category>
		<category><![CDATA[leukemias]]></category>
		<category><![CDATA[lung cancers]]></category>
		<category><![CDATA[Max Link]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[MiV Investments Inc.]]></category>
		<category><![CDATA[multiple myeloma]]></category>
		<category><![CDATA[myelodysplastic syndrome;]]></category>
		<category><![CDATA[myelodysplastic syndromes]]></category>
		<category><![CDATA[one of the four initial founders]]></category>
		<category><![CDATA[ovarian cancer]]></category>
		<category><![CDATA[Pancreatic Cancer]]></category>
		<category><![CDATA[Philadelphia]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Protein Design Labs]]></category>
		<category><![CDATA[Sandoz Pharma]]></category>
		<category><![CDATA[Sandoz Pharmaceuticals]]></category>
		<category><![CDATA[sarcoma]]></category>
		<category><![CDATA[STAR-1]]></category>
		<category><![CDATA[The star]]></category>
		<category><![CDATA[treatment for patients with Chronic Myeloid Leukemia]]></category>
		<category><![CDATA[tumor]]></category>
		<category><![CDATA[tumors]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[who served as president]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=827</guid>
		<description><![CDATA[Miv Investments Inc. has initiated an independent bullish technical trading alert for 11/23/09 on CytRx Corporation (NASDAQ:CYTR). Shares of the company finished trading during 11/20/09 at $1.14 per share, up 20.18% from the opening bell on heavy buying pressure. As of 11/18/09, the biopharmaceutical company announced plans to initiate an open-label, multinational Phase 2 clinical [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/technical-breakout-alert-issued-for-cytrx-nasdaqcytr/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zacks Bull and Bear of the Day Highlights: Caterpillar, Cost Plus, Inc., Gap Inc., J.M. Smucker Company and Stone Energy Corporation &#8211; Press Releases</title>
		<link>http://www.straightstocks.com/stock-watch/zacks-bull-and-bear-of-the-day-highlights-caterpillar-cost-plus-inc-gap-inc-j-m-smucker-company-and-stone-energy-corporation-press-releases/</link>
		<comments>http://www.straightstocks.com/stock-watch/zacks-bull-and-bear-of-the-day-highlights-caterpillar-cost-plus-inc-gap-inc-j-m-smucker-company-and-stone-energy-corporation-press-releases/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 13:32:24 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Caterpillar]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[Cobra (GPSM2500) Car GPS Receiver;]]></category>
		<category><![CDATA[Cost Plus Inc.]]></category>
		<category><![CDATA[dealer network]]></category>
		<category><![CDATA[Gap Inc]]></category>
		<category><![CDATA[gas equivalent]]></category>
		<category><![CDATA[industrial gas turbines;]]></category>
		<category><![CDATA[J.M. Smucker Company]]></category>
		<category><![CDATA[Leonard Zacks;]]></category>
		<category><![CDATA[machinery prices]]></category>
		<category><![CDATA[Market Leader]]></category>
		<category><![CDATA[natural gas engines]]></category>
		<category><![CDATA[Old Navy]]></category>
		<category><![CDATA[Pillsbury;]]></category>
		<category><![CDATA[retail coffee market segment]]></category>
		<category><![CDATA[Stone Energy Corporation]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Equity Research]]></category>
		<category><![CDATA[Zacks Investment Research Inc.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27522/Zacks+Bull+and+Bear+of+the+Day+Highlights%3A+Caterpillar%2C+Cost+Plus%2C+Inc.%2C+Gap+Inc.%2C+J.M.+Smucker+Company+and+Stone+Energy+Corporation+-+Press+Releases</guid>
		<description><![CDATA[<p align="left"><strong>For Immediate Release</strong></p>
<p align="left">Chicago, IL &#8211; November 23, 2009 &#8211; Zacks Equity Research highlights <strong>Caterpillar </strong>(<a href="http://www.zacks.com/stock/quote/CAT">CAT</a>) as the Bull of the Day and <strong>Cost Plus, Inc.</strong> (<a href="http://www.zacks.com/stock/quote/CPWM">CPWM</a>) the Bear of the Day. In addition, Zacks Equity Research provides analysis on <strong>Gap Inc.</strong>(<a href="http://www.zacks.com/stock/quote/GPS">GPS</a>), <strong>J.M. Smucker Company </strong>(<a href="http://www.zacks.com/stock/quote/SJM">SJM</a>) and <strong>Stone Energy Corporation </strong>(<a href="http://www.zacks.com/stock/quote/SGY">SGY</a>).</p>
<p align="left">Full analysis of all these stocks is available at <a href="http://at.zacks.com/?id=5506">http://at.zacks.com/?id=5506</a></p>
<p align="left">Here is a synopsis of all five stocks:</p>
<p align="left"><a href="http://www.zacks.com/newsroom/commentary/index.php?type_id=6">Bull of the Day</a>:</p>
<p align="left"><strong>Caterpillar </strong>(<a href="http://www.zacks.com/stock/quote/CAT">CAT</a>) is a market leader in construction and mining equipment, diesel and natural gas engines, and industrial gas turbines. With its strong brand name, pricing power and global dealer network, we believe Caterpillar is well positioned to take advantage of the growing need for infrastructure development globally.</p>
<p align="left">Though the company expects 2009 sales to decline more than 35% year-over-year, it anticipates an improvement in its top-line in 2010. The company forecasts a 10% to 25% increase in sales for 2010, compared to the midpoint of the 2009 outlook range.</p>
<p align="left">Asserting its optimistic outlook, the company recently announced plans to increase its machinery prices by 2% effective January 2010. We are upgrading the stock to Outperform.</p>
<p><a href="http://www.zacks.com/newsroom/commentary/index.php?type_id=7">Bear of the Day</a>:</p>
<p align="left">Specialty retailer <strong>Cost Plus, Inc.</strong> (<a href="http://www.zacks.com/stock/quote/CPWM">CPWM</a>) is closing stores, cutting costs, and trying to preserve cash, but those moves will do little to reverse its weak sales trends and merchandise margins.</p>
<p align="left">In addition, management's guidance for the third quarter cautioned investors to prepare for more weakness. Cost Plus expects same-store sales to decrease 6%-11% and a pre-tax loss from continuing operations of $19-$24 million.</p>
<p align="left">Cost Plus is scheduled to report third quarter results on December 3. We have an Underperform rating on CPWM shares. Our six-month target price is $0.50.</p>
<p>Latest Posts on the Zacks <a href="http://www.zacks.com/stock/news/AnalystBlog">Analyst Blog</a>:</p>
<p align="left"><em>Gap&#8217;s Earnings Improve</em></p>
<p align="left"><strong>Gap Inc.</strong>(<a href="http://www.zacks.com/stock/quote/GPS">GPS</a>), a premier international specialty retailer, has reported healthy third quarter results despite challenging market conditions. The company reported net income of $307 million or 44 cents per share during the quarter compared to $246 million or 35 cents per share in the year-earlier quarter.</p>
<p align="left">The robust earnings were primarily driven by strong sales at its low-price Old Navy segment and the highest third quarter operating margins in a decade. Net sales during the quarter were $3.59 billion compared to $3.56 billion in the year-ago quarter, largely due to a 10% increase in comparable sales across 1,060 Old Navy stores that account for about 40% of the total sales.</p>
<p align="left">The Old Navy chain has benefited from the increasing preference among U.S. shoppers for lower-price and discount stores due to the continued challenging macroeconomic environment. Gross margins increased 380 basis points year-over-year to 42.5%. Operating margins during the quarter increased to 13.9% from 11.1% in the year-ago quarter due to effective cost-control measures and prudent inventory management policies.</p>
<p align="left"><em>Smucker&#8217;s Beats, Raises Guidance</em></p>
<p align="left"><strong>J.M. Smucker Company </strong>(<a href="http://www.zacks.com/stock/quote/SJM">SJM</a>) reported second quarter results with earnings of $1.22 per share, which was well above the Zacks Consensus Estimate of 99 cents. Quarterly earnings were up 21% compared to $1.01 reported in the prior-year quarter.</p>
<p align="left">Net sales for the quarter grew 51.7% year-over-year, primarily due to the addition of the Folgers coffee business. Excluding Folgers, volumes increased 1%, driven by Pillsbury, Crisco oils, Jif peanut butter and Hungry Jack brands. These were partially offset by declines in canned milk, fruit spreads, foodservices and natural foods.</p>
<p align="left">On a segment basis -- the U.S. retail coffee market segment posted $445.1 million in sales during the quarter. Volume also increased by approximately 5%. The continued expansion of the Dunkin' Donuts brand in the gourmet category and strong growth in traditional roast and ground coffee led to the improvement.</p>
<p align="left"><em>Stone Energy Outdoes Estimates</em></p>
<p align="left"><strong>Stone Energy Corporation </strong>(<a href="http://www.zacks.com/stock/quote/SGY">SGY</a>) reported third-quarter 2009 earnings of $1.06 per share, beating the Zacks Consensus Estimate of 66 cents and the year-earlier earnings of $1.04. The robust results were driven by increased production volumes and reduced costs.</p>
<p align="left">Production during the quarter averaged 239 million cubic feet of gas equivalent per day (MMcfe/d), compared to average daily production of 209 MMcfe/d in the prior quarter and 129 MMcfe/d in the year-ago quarter. This increase was primarily due to the company&#8217;s successful execution of its hydraulic rig work over program, reduced cycle time and optimization of individual well rates.</p>
<p align="left">Stone expects net daily production to average 225-235 MMcfe in the fourth quarter and 210-220 MMcfe in 2009.</p>
<p align="left">Get the full analysis of all these stocks by going to <a href="http://at.zacks.com/?id=5507">http://at.zacks.com/?id=5507</a>.</p>
<p align="left"><strong>About the Bull and Bear of the Day</strong></p>
<p align="left">Every day, the analysts at Zacks Equity Research select two stocks that are likely to outperform (Bull) or underperform (Bear) the markets over the next 3-6 months.</p>
<p align="left"><strong>About the Analyst Blog</strong></p>
<p align="left">Updated throughout every trading day, the <a href="http://www.zacks.com/stock/news/AnalystBlog">Analyst Blog</a> provides analysis from Zacks Equity Research about the latest news and events impacting stocks and the financial markets.</p>
<p align="left"><strong>About Zacks Equity Research</strong></p>
<p align="left">Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.</p>
<p align="left">Continuous analyst coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.</p>
<p align="left">Zacks <a href="http://at.zacks.com/?id=5508">"Profit from the Pros"</a> e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today by visiting <a href="http://at.zacks.com/?id=5508">http://at.zacks.com/?id=5508</a>.</p>
<p align="left"><strong>About Zacks </strong></p>
<p align="left">Zacks.com is a property of <a href="http://www.zacks.com/">Zacks Investment Research</a>, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the <a href="http://www.zacks.com/rank/index.php">Zacks Rank</a>, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at <a href="http://at.zacks.com/?id=5509">http://at.zacks.com/?id=5509</a>.</p>
<p align="left">Visit <a href="http://www.zacks.com/performance">http://www.zacks.com/performance</a> for information about the performance numbers displayed in this press release.</p>
<p align="left">Follow us on Twitter: <a href="http://twitter.com/zacksresearch">http://twitter.com/zacksresearch</a></p>
<p align="left">Join us on Facebook: <a href="http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts">http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts</a></p>
<p align="left">Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.</p>
<p align="left">Contact:<br />
Mark Vickery<br />
Web Content Editor<br />
312-265-9380<br />
Visit: <a href="www.zacks.com">www.zacks.com </a></p>
<p align="left"> </p>
<p align="left"> </p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/zacks-bull-and-bear-of-the-day-highlights-caterpillar-cost-plus-inc-gap-inc-j-m-smucker-company-and-stone-energy-corporation-press-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>U.S. Rig Count Hits 8-Month High &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/u-s-rig-count-hits-8-month-high-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/u-s-rig-count-hits-8-month-high-analyst-blog/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 13:20:43 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[active natural gas rigs]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[back oil]]></category>
		<category><![CDATA[Baker Hughes Inc]]></category>
		<category><![CDATA[Cameron International]]></category>
		<category><![CDATA[Energy Demand]]></category>
		<category><![CDATA[energy service firms]]></category>
		<category><![CDATA[firm going forward]]></category>
		<category><![CDATA[halliburton company]]></category>
		<category><![CDATA[Helmerich & Payne Inc]]></category>
		<category><![CDATA[Nabors Industries]]></category>
		<category><![CDATA[National-Oilwell]]></category>
		<category><![CDATA[Natural Gas]]></category>
		<category><![CDATA[natural gas woes]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Oil And Gas]]></category>
		<category><![CDATA[oil and gas rig count]]></category>
		<category><![CDATA[oil rig count]]></category>
		<category><![CDATA[oil rigs;]]></category>
		<category><![CDATA[Patterson UTI Energy;]]></category>
		<category><![CDATA[Schlumberger Limited]]></category>
		<category><![CDATA[Smith International Inc]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Weatherford International Ltd.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27520/U.S.+Rig+Count+Hits+8-Month+High+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
According to data from <strong>Baker Hughes Inc.</strong> (<a href="http://www.zacks.com/stock/quote/bhi">BHI</a>), the number of rigs searching for oil and gas in the U.S. rose for the week ended Nov. 20, reflecting ramped-up drilling activity by the producers amid recent optimism about economic recovery.<br />
<br />
As shown in the first chart below from Baker Hughes, rigs exploring and producing in the U.S. totaled 1,113 during the week. This is up by 12 from the previous week&#8217;s tally and represents the fifth successive weekly gain. The current nationwide rig count is 27% higher from the 2009 low of 876 (set in the week ended June 12).<br />
<br />
The combined oil and gas rig count is down by 828 from the year-ago period. It rose to a 22-year high in 2008, peaking at 2,031 in the weeks ended Aug. 29 and Sept. 12.<br />
<br />
<img src="http://www.zacks.com/images/upload_dir/1258981844.gif" alt="" /><br />
<br />
The number of natural gas rigs drilling in the U.S. decreased by 2 to 726 -- the second loss in as many weeks. The rig count remains 55% lower than its peak of 1,606 in late summer 2008. In the year-ago period, there were 1,511 active natural gas rigs. This is shown in the following chart, also from Baker Hughes.<br />
<br />
<img src="http://www.zacks.com/images/upload_dir/1258981862.gif" alt="" /><br />
<br />
The oil rig count was up by 14 to 375, maintaining the positive momentum from the past nine weeks. But the tally is down approximately 11% from the previous year&#8217;s count of 419, as shown in the following chart from Baker Hughes. Oil rigs peaked at 442 in early November last year.<br />
<br />
<img src="http://www.zacks.com/images/upload_dir/1258981879.gif" alt="" /><br />
<br />
The number of miscellaneous rigs, at 12, remains unchanged from the previous week.<br />
<br />
Producers had scaled back oil and gas drilling operations over the past several months in the midst of falling commodity prices and tighter access to credit. However, during recent weeks, there have been signs that the companies were beginning to bring rigs back on line (especially oil rigs) amid signs of economic stabilization that could drive up energy demand. This pushed the nationwide rig count above 1,100 working units for the week ended Nov. 13, the first time since March.<br />
<br />
The overall picture, though, remains weak, particularly for natural gas, whose inventories have recently hit a new record high of 3.83 trillion cubic feet (Tcf) and is threatening to test the maximum capacity of 3.89 Tcf. The supply picture is expected to reverse in the coming months as producers bet on colder weather and the lagging effect of the sharp drop in domestic drilling activity takes hold.<br />
<br />
Until then, we believe that natural gas woes (especially in North America) will continue to haunt energy service firms like<strong> Halliburton Company </strong>(<a href="http://www.zacks.com/stock/quote/hal">HAL</a>), <strong>Schlumberger Limited </strong>(<a href="http://www.zacks.com/stock/quote/slb">SLB</a>), Baker Hughes, <strong>Smith International Inc.</strong> (<a href="http://www.zacks.com/stock/quote/sii">SII</a>), <strong>National-Oilwell Varco </strong>(<a href="http://www.zacks.com/stock/quote/nov">NOV</a>) and<strong> Weatherford International Ltd. </strong>(<a href="http://www.zacks.com/stock/quote/wft">WFT</a>). These oilfield service names have seen their revenues and earnings plunge in the last few quarters on the back of lower volumes and a very competitive pricing environment. We have Neutral recommendations on all the above-mentioned companies.<br />
<br />
We also maintain our Neutral recommendations for contract drillers such as <strong>Nabors Industries </strong>(<a href="http://www.zacks.com/stock/quote/nbr">NBR</a>),<strong> Patterson-UTI Energy</strong> (<a href="http://www.zacks.com/stock/quote/pten">PTEN</a>) and <strong>Helmerich &#38; Payne, Inc. </strong>(<a href="http://www.zacks.com/stock/quote/hp">HP</a>), given the extent of excess capacity in the sector that is expected to weigh on dayrates and margins well into next year.<br />
<br />
We are positive on oilfield companies like<strong> Cameron International</strong> (<a href="http://www.zacks.com/stock/quote/cam">CAM</a>) that derives about two-thirds of its revenue from outside North America. Cameron&#8217;s international operations are expected to be a key growth driver for the firm going forward and will play an offsetting role to the relatively soft U.S. drilling scene.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BHI">Read the full analyst report on "BHI"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=HAL">Read the full analyst report on "HAL"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=SLB">Read the full analyst report on "SLB"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=SII">Read the full analyst report on "SII"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=NOV">Read the full analyst report on "NOV"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=WFT">Read the full analyst report on "WFT"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=NBR">Read the full analyst report on "NBR"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PTEN">Read the full analyst report on "PTEN"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=HP">Read the full analyst report on "HP"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=CAM">Read the full analyst report on "CAM"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/u-s-rig-count-hits-8-month-high-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zacks Analyst Blog Highlights: Pozen, Sanofi-Aventis, Bristol-Myers, AstraZeneca and ADC Telecommunications Inc. &#8211; Press Releases</title>
		<link>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-pozen-sanofi-aventis-bristol-myers-astrazeneca-and-adc-telecommunications-inc-press-releases/</link>
		<comments>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-pozen-sanofi-aventis-bristol-myers-astrazeneca-and-adc-telecommunications-inc-press-releases/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 13:20:07 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[ADC Telecommunications Inc.;]]></category>
		<category><![CDATA[American Heart Association;]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Astrazeneca]]></category>
		<category><![CDATA[Aventis]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Bristol]]></category>
		<category><![CDATA[cardiovascular disease]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[gastric ulcers]]></category>
		<category><![CDATA[heart attacks;]]></category>
		<category><![CDATA[Leonard Zacks;]]></category>
		<category><![CDATA[strokes]]></category>
		<category><![CDATA[the American College;]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Investment Research Inc.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27519/Zacks+Analyst+Blog+Highlights%3A+Pozen%2C+Sanofi-Aventis%2C+Bristol-Myers%2C+AstraZeneca+and+ADC+Telecommunications+Inc.+-+Press+Releases</guid>
		<description><![CDATA[<p align="left"><strong>For Immediate Release</strong></p>
<p align="left">Chicago, IL &#8211; November 23, 2009 &#8211; Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: <strong>Pozen </strong>(<a href="void(0)">POZN</a>), <strong>Sanofi-Aventis </strong>(<a href="void(0)">SNY</a>), <strong>Bristol-Myers </strong>(<a href="void(0)">BMY</a>), <strong>AstraZeneca </strong>(<a href="void(0)">AZN</a>) and <strong>ADC Telecommunications Inc.</strong> (<a href="void(0)">ADCT</a>).</p>
<p align="left">Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5513">http://at.zacks.com/?id=5513</a></p>
<p align="left"><strong>Here are highlights from Friday&#8217;s Analyst Blog: </strong></p>
<p align="left"><strong>Pozen Initiates New Phase III </strong></p>
<p align="left">This morning, <strong>Pozen </strong>(<a href="void(0)">POZN</a>) initiated phase III studies on PA-325/40, a fixed-dose combination of 325mg enteric coated aspirin and 40mg of immediate release omeprazole. The phase III program will consist of two pivotal trials conducted under a Special Protocol Assessment (SPA) agreed upon with the U.S. FDA, and one long-term safety study.</p>
<p align="left">The two pivotal programs will enroll approximately 500 patients per study at over 100 sites around the U.S. The primary endpoint of the pivotal studies is the cumulative incidence of gastric ulcers over the six-month treatment period for PA32540 versus 325 mg of enteric-coated aspirin. The long-term study will enroll approximately 400 patients and assess safety over a period of one year.</p>
<p align="left">Pozen is developing PA-325/40 for use in the secondary prevention of heart attacks and strokes in patients at risk for associated gastric ulcers. Aspirin is the No. 1 recommended agent for at-risk patients, with some 50 million Americans take daily aspirin therapy for secondary prevention of heart attacks and strokes.</p>
<p align="left">However, according to data presented at the American College of Gastroenterology and at the American Heart Association meeting, the use of low-dose aspirin for cardiovascular disease prophylaxis is associated with a 2- to 4-fold increase in gastro-intestinal (GI) complications, including gastric ulcers. Enteric coating is not a sufficient to reduce the risk of GI bleeding, and thus the majority of patients that should be taking 325mg aspirin are non-compliant or taking suboptimal low-dose (81mg) "baby" aspirin instead.</p>
<p align="left">Pozen&#8217;s PA-325/40 is designed to provide immediate-release omeprazole as a GI-protectant for patients taking full-dose 325mg daily aspirin therapy. If the phase III trials meet the primary endpoint of reduction in cumulative incidence of gastric ulcers, we expect PA-325/40 to be approved by the U.S. FDA with the full cardiovascular label claims of regular enteric-coated aspirin. This is a significant market opportunity in our view, considering less than 15% of the 50 million Americans on daily aspirin therapy are taking a GI-protectant such as omeprazole.</p>
<p align="left">Recently, data from a retrospective analysis of patients that use <strong>Sanofi-Aventis </strong>(<a href="void(0)">SNY</a>) / <strong>Bristol-Myers&#8217; </strong>(<a href="void(0)">BMY</a>) Plavix (clopidogrel) showed an increased risk of major adverse cardiovascular events (MACE) by as much as 50% while taking a proton pump inhibitor (PPI) such as <strong>AstraZeneca&#8217;s </strong>(<a href="void(0)">AZN</a>) omeprazole (Prilosec) or esomeprazole (Nexium). The data included analysis of outcomes from 16,700 patients who underwent percutaneous coronary intervention and continued Plavix for 12 months after the procedure.</p>
<p align="left"><strong>ADC Dips on Weak Outlook </strong></p>
<p align="left">Yesterday, after market close, <strong>ADC Telecommunications Inc.</strong> (<a href="void(0)">ADCT</a>) declared financial results for the fourth quarter of fiscal 2009. Earlier, the Board of Directors of ADC had taken a decision to change its fiscal year from Oct 31 to Sep 30. As a result, fiscal year 2009 ended on Sep 30, 2009, which means the company got only two months as its fourth quarter. The fourth quarter of fiscal 2009 would, therefore, not be comparable to either the prior-year quarter or the previous quarter. For this reason, management has presented pro forma results for the three month period ending Sep 30 and its comparable quarter.</p>
<p align="left">Actual revenue of fourth quarter 2009 was $183.9 million, below the Zacks Consensus Estimate of $189 million. Quarterly pro forma revenue was $293.6 million, down 17.5% year-over-year. This significant decline in revenue is the result of the global economic recession across all the three business segments.</p>
<p align="left">On a GAAP basis, net loss in the quarter was $19.8 million or a loss of 20 cents per share compared to a net loss of $5.6 million or a loss of 5 cents per share in the prior-year quarter. However, adjusted net income (excluding $25.5 million special charges and $0.6 million loss from discontinued operations, net of taxes) in the reported quarter was $6.3 million or an income of 6 cents per share, higher than the Zacks Consensus Estimate of an income of 4 cents per share.</p>
<p align="left">Pro forma gross margin for the quarter was 34.6% compared to 33% in the year-ago quarter. This reflects the aggressive cost cutting measures taken by management during the past one year. Pro forma quarterly operating expenses were $113 million compared to $106.2 million in the prior-year quarter.</p>
<p align="left">Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5515">http://at.zacks.com/?id=5515</a>.</p>
<p align="left"><strong>About Zacks Equity Research</strong></p>
<p align="left">Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.</p>
<p align="left">Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.</p>
<p align="left">Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: <a href="http://at.zacks.com/?id=5517">http://at.zacks.com/?id=5517</a></p>
<p align="left"><strong>About Zacks </strong></p>
<p align="left">Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at <a href="http://at.zacks.com/?id=5518">http://at.zacks.com/?id=5518</a>.</p>
<p align="left">Visit <a href="http://www.zacks.com/performance">http://www.zacks.com/performance</a> for information about the performance numbers displayed in this press release.</p>
<p align="left">Follow us on Twitter: <a href="http://twitter.com/zacksresearch">http://twitter.com/zacksresearch</a></p>
<p align="left">Join us on Facebook: <a href="http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts">http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts</a></p>
<p align="left">Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.</p>
<p align="left">Contact:<br />
Mark Vickery<br />
Web Content Editor<br />
312-265-9380<br />
Visit: <a href="www.zacks.com">www.zacks.com </a></p>
<p align="left"> </p>
<p align="left"> </p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-pozen-sanofi-aventis-bristol-myers-astrazeneca-and-adc-telecommunications-inc-press-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zacks Analyst Blog Highlights: Dell Inc., Berkshire Hathaway, Burlington Northern Santa Fe Corporation, JPMorgan Chase and Wells Fargo &#8211; Press Releases</title>
		<link>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-dell-inc-berkshire-hathaway-burlington-northern-santa-fe-corporation-jpmorgan-chase-and-wells-fargo-press-releases/</link>
		<comments>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-dell-inc-berkshire-hathaway-burlington-northern-santa-fe-corporation-jpmorgan-chase-and-wells-fargo-press-releases/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 12:49:16 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Americas]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Asia Pacific]]></category>
		<category><![CDATA[Berkshire Hathaway]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Brazil]]></category>
		<category><![CDATA[Brocade;]]></category>
		<category><![CDATA[Burlington Northern Santa Fe Corporation]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[CEO and Chairman]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Dell Inc]]></category>
		<category><![CDATA[Gas Utilities]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Jpmorgan Chase]]></category>
		<category><![CDATA[Juniper]]></category>
		<category><![CDATA[Leonard Zacks;]]></category>
		<category><![CDATA[owned subsidiary]]></category>
		<category><![CDATA[retail]]></category>
		<category><![CDATA[Russia]]></category>
		<category><![CDATA[Storage Systems]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Warren Buffett]]></category>
		<category><![CDATA[wells fargo]]></category>
		<category><![CDATA[Windows 7;]]></category>
		<category><![CDATA[Zacks Investment Research Inc.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27516/Zacks+Analyst+Blog+Highlights%3A+Dell+Inc.%2C+Berkshire+Hathaway%2C+Burlington+Northern+Santa+Fe+Corporation%2C+JPMorgan+Chase+and+Wells+Fargo+-+Press+Releases</guid>
		<description><![CDATA[<p align="left"><strong>For Immediate Release</strong></p>
<p align="left">Chicago, IL &#8211; November 23, 2009 &#8211; Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: <strong>Dell Inc.</strong> (<a href="void(0)">DELL</a>), <strong>Berkshire Hathaway </strong>(<a href="void(0)">BRK.A</a>), <strong>Burlington Northern Santa Fe Corporation </strong>(<a href="void(0)">BNI</a>), <strong>JPMorgan Chase </strong>(<a href="void(0)">JPM</a>) and <strong>Wells Fargo </strong>(<a href="void(0)">WFC</a>).</p>
<p align="left">Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5513">http://at.zacks.com/?id=5513</a></p>
<p align="left"><strong>Here are highlights from Friday&#8217;s Analyst Blog: </strong></p>
<p align="left"><strong>Dell Falls Short of Expectations </strong></p>
<p align="left"><strong>Dell Inc.</strong> (<a href="void(0)">DELL</a>) reported third quarter 2010 EPS of 23 cents, below the Zacks Consensus Estimate of 27 cents.</p>
<p align="left">Revenue for the quarter was $10.75 billion, down 17.0% from $12.97 billion reported in the year-ago quarter and up 1.0% from $10.62 billion reported in the previous quarter. The company&#8217;s third quarter reported revenue was adversely affected by the timing of the Windows 7 launch and due to backlog buildup in the company&#8217;s SMB and consumer businesses.</p>
<p align="left">Large Enterprise posted revenue of $3.4 billion, an increase of 4.0% sequentially and decline of 23.0% year-over-year. In the last quarter, the company expended its networking partnership with Brocade and Juniper, and introduced products like PowerEdge 11g servers and expanded PowerVault storage systems.</p>
<p align="left">Public revenue for the quarter was $3.7 billion, down 3.0% on sequentially and 7.0% from the year-ago quarter. Shipments were down 12.0% on a sequential basis, due to seasonality in the U.S. public sector business.</p>
<p align="left">Small and Medium Business revenue for the quarter was $3.0 billion, up 5.0% sequentially and down 19.0% from the year-ago quarter. Shipments increased 9% sequentially. The segment benefited from steadily improving demand in both the Americas and the Asia-Pacific region, as well as better performance in EMEA during the second half.</p>
<p align="left">Revenues for Consumer Business were down 10.0% year-over-year, but flat sequentially to $2.8 billion with shipments growing 4% sequentially.</p>
<p align="left">Dell&#8217;s total sales in China, India, Brazil and Russia increased 18.0% sequentially and 5.0% over last year. China, the second-largest revenue generating country for Dell, reported revenue increase of 20.0% sequentially and 8.0% from the year-ago quarter.</p>
<p align="left"><strong>Buffett Borrows for Rail Acquisition</strong></p>
<p align="left">Warren Buffett, the CEO and Chairman of <strong>Berkshire Hathaway </strong>(<a href="void(0)">BRK.A</a>) announced on Thursday to borrow $8 billion of loan for the acquisition of <strong>Burlington Northern Santa Fe Corporation </strong>(<a href="void(0)">BNI</a>). Berkshire Hathaway, which already owns a 22% stake in Burlington Northern, announced earlier this month it would acquire the rest for a total value of $34 billion. Buffet agreed to pay $100 a share in cash and stock to buy the rest of the company.</p>
<p align="left">The $8 billion loan that will be provided by <strong>JPMorgan Chase </strong>(<a href="void(0)">JPM</a>) and <strong>Wells Fargo </strong>(<a href="void(0)">WFC</a>) is intended to be paid back in three years&#8217; time.</p>
<p align="left">For Berkshire, the acquisition of Burlington Northern, or BNSF, the second largest railroad, will be its biggest to date. With it, Berkshire is adding a railroad transportation business with its already diverse range of businesses including retail, manufacturing and insurance, as well as several regional electric and gas utilities.</p>
<p align="left">The acquisition is expected to close in early 2010 and is subject to Burlington Northern&#8217;s shareholder approval. Post acquisition, Burlington Northern will operate from its headquarters as a wholly owned subsidiary of Berkshire Hathaway.</p>
<p align="left">Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5515">http://at.zacks.com/?id=5515</a>.</p>
<p align="left"><strong>About Zacks Equity Research</strong></p>
<p align="left">Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.</p>
<p align="left">Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.</p>
<p align="left">Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: <a href="http://at.zacks.com/?id=5517">http://at.zacks.com/?id=5517</a></p>
<p align="left"><strong>About Zacks </strong></p>
<p align="left">Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at <a href="http://at.zacks.com/?id=5518">http://at.zacks.com/?id=5518</a>.</p>
<p align="left">Visit <a href="http://www.zacks.com/performance">http://www.zacks.com/performance</a> for information about the performance numbers displayed in this press release.</p>
<p align="left">Follow us on Twitter: <a href="http://twitter.com/zacksresearch">http://twitter.com/zacksresearch</a></p>
<p align="left">Join us on Facebook: <a href="http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts">http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts</a></p>
<p align="left">Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.</p>
<p align="left">Contact:<br />
Mark Vickery<br />
Web Content Editor<br />
312-265-9380<br />
Visit: <a href="www.zacks.com">www.zacks.com </a></p>
<p align="left"> </p>
<p align="left"> </p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-dell-inc-berkshire-hathaway-burlington-northern-santa-fe-corporation-jpmorgan-chase-and-wells-fargo-press-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>When will the depression be over? When the work is done.</title>
		<link>http://www.straightstocks.com/investing-lessons/when-will-the-depression-be-over-when-the-work-is-done/</link>
		<comments>http://www.straightstocks.com/investing-lessons/when-will-the-depression-be-over-when-the-work-is-done/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 12:32:40 +0000</pubDate>
		<dc:creator>Bill Bonner</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Bill Bonner]]></category>
		<category><![CDATA[contrarian profits]]></category>
		<category><![CDATA[Dow 30]]></category>
		<category><![CDATA[National Bureau of Economic Research]]></category>
		<category><![CDATA[Robert Shiller]]></category>
		<category><![CDATA[The Daily Reckoning]]></category>
		<category><![CDATA[the New York Times]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[wall street]]></category>
		<category><![CDATA[wealth insurance]]></category>

		<guid isPermaLink="false">http://www.contrarianprofits.com/?p=21119</guid>
		<description><![CDATA[Bill Bonner, venerable voice of reason (with a touch of doom), at a href="http://www.dailyreckoning.co.uk"The Daily Recokoning/a, looks long term at gold, the markets, and the end of the depression.]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/when-will-the-depression-be-over-when-the-work-is-done/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Transportation Sector: powered by recovery</title>
		<link>http://www.straightstocks.com/investing-lessons/transportation-sector-powered-by-recovery/</link>
		<comments>http://www.straightstocks.com/investing-lessons/transportation-sector-powered-by-recovery/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 10:18:51 +0000</pubDate>
		<dc:creator>Contrarian Profits</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[bewilderment]]></category>
		<category><![CDATA[contrarian profits]]></category>
		<category><![CDATA[David Fessler]]></category>
		<category><![CDATA[head]]></category>
		<category><![CDATA[Louis Basenese]]></category>
		<category><![CDATA[oil  and gas pipelines]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://www.contrarianprofits.com/?p=21116</guid>
		<description><![CDATA[The Transportation Sector: The Market’s Most Important Domain 

Airlines, railways, package carriers, even oil and gas pipelines are all industries that make up the transportation sector.

But why should you care about it?

Because transportation is actually the most important sector – and for good reason: growth or contraction here serves as a proxy for both U.S. and global economic growth.]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/transportation-sector-powered-by-recovery/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prieur’s readings (November 23, 2009)</title>
		<link>http://www.straightstocks.com/investing-lessons/prieur%e2%80%99s-readings-november-23-2009/</link>
		<comments>http://www.straightstocks.com/investing-lessons/prieur%e2%80%99s-readings-november-23-2009/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 08:38:15 +0000</pubDate>
		<dc:creator>Prieur du Plessis</dc:creator>
				<category><![CDATA[Bonds]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Aline van Duyn]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[American Chamber of Commerce]]></category>
		<category><![CDATA[Barack Obama]]></category>
		<category><![CDATA[CBS]]></category>
		<category><![CDATA[Chairman]]></category>
		<category><![CDATA[Commission of European Communities;]]></category>
		<category><![CDATA[Daria Taglioni (Vox)]]></category>
		<category><![CDATA[Dean Baker]]></category>
		<category><![CDATA[Economist]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Executive]]></category>
		<category><![CDATA[Financial Times]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[Hussman Funds]]></category>
		<category><![CDATA[investment postcards]]></category>
		<category><![CDATA[James Kwak;]]></category>
		<category><![CDATA[John Hussman]]></category>
		<category><![CDATA[Mark Thoma]]></category>
		<category><![CDATA[Michael Panzner]]></category>
		<category><![CDATA[MoneyWatch]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[Morgan Stanley Asia]]></category>
		<category><![CDATA[Paul Krugman]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Richard Baldwin]]></category>
		<category><![CDATA[Robert Shiller]]></category>
		<category><![CDATA[Robert Skidelsky]]></category>
		<category><![CDATA[Singapore]]></category>
		<category><![CDATA[Stephen Roach]]></category>
		<category><![CDATA[the New York Times]]></category>
		<category><![CDATA[times Online]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[William Rees-Mogg;]]></category>

		<guid isPermaLink="false">http://www.investmentpostcards.com/?p=14120</guid>
		<description><![CDATA[This post provides links to a number of interesting articles I have read over the past few days that you may also enjoy. Please also add the links to any other worthwhile articles you would like to share to the comments section. ]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/prieur%e2%80%99s-readings-november-23-2009/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>On the Ground in Brazil</title>
		<link>http://www.straightstocks.com/investing-lessons/on-the-ground-in-brazil/</link>
		<comments>http://www.straightstocks.com/investing-lessons/on-the-ground-in-brazil/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 06:00:00 +0000</pubDate>
		<dc:creator>Frank Holmes</dc:creator>
				<category><![CDATA[Emerging Markets]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[1-800-873-8637]]></category>
		<category><![CDATA[1-800-US-FUNDS]]></category>
		<category><![CDATA[Brazil]]></category>
		<category><![CDATA[Brian  Hicks;]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[countryrsquo;s inadequate infrastructure]]></category>
		<category><![CDATA[Electricity]]></category>
		<category><![CDATA[Frank Holmes;]]></category>
		<category><![CDATA[Frank Talk]]></category>
		<category><![CDATA[Global Resources Fund]]></category>
		<category><![CDATA[global strategist]]></category>
		<category><![CDATA[Guarulhos International Airport]]></category>
		<category><![CDATA[Jack Dzierwa]]></category>
		<category><![CDATA[leading producer]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[oil reserves]]></category>
		<category><![CDATA[Rio De Janeiro]]></category>
		<category><![CDATA[Satilde;o Paulorsquo;s Guarulhos International Airport]]></category>
		<category><![CDATA[U.S. Energy Information Administration]]></category>
		<category><![CDATA[U.S. Global Brokerage Inc.]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[www.usfunds.com]]></category>

		<guid isPermaLink="false">tag:www.usfunds.com://ef43e2180f70a384e6055d546bfc2234</guid>
		<description><![CDATA[If seeing is believing, natural resources and infrastructure opportunities abound in Brazil.
The above photo was snapped by our global strategist Jack Dzierwa at Satilde;o Paulorsquo;s Guarulhos International Airport as he spent hours trying to board a domestic flight to Rio de Janeiro. Not surprisingly, he didnrsquo;t make the flight.
Jack has traveled extensively around the world, and he says hersquo;s never seen anything like the hectic scene at Guarulhos, which just canrsquo;t service the rapidly growing number of Brazilians who can now afford to travel by air.
Scenes like this are important for investment managers to experience in order to grasp the significance of whatrsquo;s taking place in emerging countries like Brazil. You just canrsquo;t get the full flavor of the chaos at Guarulhos from an economic data spreadsheet or a research report.
Jack traveled to Brazil to collect some insight on the countryrsquo;s infrastructure development and the best prospects for investment. His experience at the airport gives him tacit knowledge and a clear understanding that Brazil will have to expand on its domestic infrastructure.
Brian Hicks, who co-manages our Global Resources Fund (PSPFX), has also spent the week in Brazil ndash; he has been doing research and meeting with natural resources companies.
Brazil is a key driver for natural resources and infrastructure markets. It is home to 190 million people, many of them moving into the middle class, and itrsquo;s also one of the worldrsquo;s fastest-growing economies.
Similar to China, this rise of the middle class will increase demand for oil and other commodities, and its expansion will put growing pressure on the countryrsquo;s inadequate infrastructure.
Just a couple of weeks ago, a blackout left nearly 60 million people without electricity and another 7 million without water. Traffic in downtown Satilde;o Paulo is so bad that many businessmen use helicopters as taxis to get around the city. Brazil only has three main international airports, despite that it has 14 cities with at least 1 million residents.
The U.S. Energy Information Administration estimates that Brazil has more than 12 billion barrels of proven oil reserves. That number is certain to grow as we learn more about the large discoveries recently made off its southeastern coast. In addition to vast reserves of oil, it is also a leading producer of iron ore, aluminum, platinum and other industrial metals.
This natural wealth puts Brazil in an enviable position compared to some other large emerging economies. As the domestic demand for resources increases with infrastructure expansion, much of that demand can be met from internal sources. This benefits the economy on both ends and sets the stage for further economic growth.
Please consider carefully a fundrsquo;s investment objectives, risks, charges and expenses. For this and other important information, obtain a fund prospectus by visiting www.usfunds.com or by calling 1-800-US-FUNDS (1-800-873-8637). Read it carefully before investing. Distributed by U.S. Global Brokerage, Inc.
All opinions expressed and data provided are subject to change without notice. Some of these opinions may not be appropriate to every investor. Foreign and emerging market investing involves special risks such as currency fluctuation and less public disclosure, as well as economic and political risk. Because the Global Resources Fund concentrates its investments in a specific industry, the fund may be subject to greater risks and fluctuations than a portfolio representing a broader range of industries. #09-818]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/on-the-ground-in-brazil/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>SEED, CVAT, HZHI, DrStockPick.com Watch List! for Monday Nov 23, 2009, Origin Agritech Limited, Cavitation Technologies Inc. and Horizon Health International Corp.</title>
		<link>http://www.straightstocks.com/stock-watch/seed-cvat-hzhi-drstockpick-com-watch-list-for-monday-nov-23-2009-origin-agritech-limited-cavitation-technologies-inc-and-horizon-health-international-corp/</link>
		<comments>http://www.straightstocks.com/stock-watch/seed-cvat-hzhi-drstockpick-com-watch-list-for-monday-nov-23-2009-origin-agritech-limited-cavitation-technologies-inc-and-horizon-health-international-corp/#comments</comments>
		<pubDate>Sun, 22 Nov 2009 23:30:46 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[advertisment services]]></category>
		<category><![CDATA[Agricultural Biotechnology]]></category>
		<category><![CDATA[assistive technology]]></category>
		<category><![CDATA[beverage]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[Calgary]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Cavitation Technologies Inc.]]></category>
		<category><![CDATA[chemical industries]]></category>
		<category><![CDATA[corn product]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[crude oil]]></category>
		<category><![CDATA[disability products;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[e - commerce]]></category>
		<category><![CDATA[eBay US]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[ergonomic solutions]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[Horizon Health International Corp.]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[king]]></category>
		<category><![CDATA[leader in the development]]></category>
		<category><![CDATA[Ministry of Agriculture]]></category>
		<category><![CDATA[Nano Cavitation Technologies]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[On-line sales]]></category>
		<category><![CDATA[online shopping network]]></category>
		<category><![CDATA[Origin Agritech Limited]]></category>
		<category><![CDATA[owned subsidiary]]></category>
		<category><![CDATA[physical and chemical refining]]></category>
		<category><![CDATA[player]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[Retail Stores]]></category>
		<category><![CDATA[Samson Industries]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[seed products]]></category>
		<category><![CDATA[south korea]]></category>
		<category><![CDATA[Southeast Asia]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[US Subsidiary SunCity Ventures]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[vegetable oil refining]]></category>
		<category><![CDATA[Workplace Medical Equipment Specialist]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.horizonhealthandsafety-canada]]></category>
		<category><![CDATA[www.horizonhealthandsafety-us]]></category>
		<category><![CDATA[www.medichair-calgary.com]]></category>
		<category><![CDATA[www.originagritech.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[Xplosivestocks.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4910</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

DrStockPick.com Watch List!
My Picks for Monday Nov 23, 2009 are:
**************************************************************
 SEED, Origin Agritech Limited
SEED, a leading agricultural biotechnology company and a top player in seed industry, specializes in research and development, production, sale and distribution of agricultural crop seeds. The Company&#8217;s major seed products [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/seed-cvat-hzhi-drstockpick-com-watch-list-for-monday-nov-23-2009-origin-agritech-limited-cavitation-technologies-inc-and-horizon-health-international-corp/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CVAT, PWRM, HZHI, HCEI, PSFT, TAXS, CSRH, AQNM, Stocks at a Glance. DrStockPick.com Report!</title>
		<link>http://www.straightstocks.com/stock-watch/cvat-pwrm-hzhi-hcei-psft-taxs-csrh-aqnm-stocks-at-a-glance-drstockpick-com-report/</link>
		<comments>http://www.straightstocks.com/stock-watch/cvat-pwrm-hzhi-hcei-psft-taxs-csrh-aqnm-stocks-at-a-glance-drstockpick-com-report/#comments</comments>
		<pubDate>Sun, 22 Nov 2009 19:16:21 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[(718) 951-8021]]></category>
		<category><![CDATA[(818) 718-0905]]></category>
		<category><![CDATA[(951) 657-8832]]></category>
		<category><![CDATA[+1 866 824 8854]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[advertisment services]]></category>
		<category><![CDATA[Agri Process Innovations Inc.]]></category>
		<category><![CDATA[ALS]]></category>
		<category><![CDATA[Amplification Technologies Inc.]]></category>
		<category><![CDATA[Aquentium Inc.;]]></category>
		<category><![CDATA[assistive technology]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[beverage]]></category>
		<category><![CDATA[BioMedReports.com]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cavitation Technologies Inc.]]></category>
		<category><![CDATA[chemical industries]]></category>
		<category><![CDATA[chemical sensors]]></category>
		<category><![CDATA[Consorteum Holdings Inc.;]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[crude oil refining;]]></category>
		<category><![CDATA[CSRH]]></category>
		<category><![CDATA[CVAT]]></category>
		<category><![CDATA[diagnostic tests]]></category>
		<category><![CDATA[disability products;]]></category>
		<category><![CDATA[Distribution Inc]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[drug development]]></category>
		<category><![CDATA[e - commerce]]></category>
		<category><![CDATA[end-product]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Energy Drinks]]></category>
		<category><![CDATA[environmental friendly technology]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[ergonomic solutions]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[Food Safety]]></category>
		<category><![CDATA[General Counsel for TAXS]]></category>
		<category><![CDATA[green technologies;]]></category>
		<category><![CDATA[Healthy Coffee International Inc.]]></category>
		<category><![CDATA[Healthy Coffee USA Inc.]]></category>
		<category><![CDATA[high-energy physics]]></category>
		<category><![CDATA[Homeland Security]]></category>
		<category><![CDATA[Horizon Health International Corp.]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[Indiana]]></category>
		<category><![CDATA[InGaAs/InP technologies]]></category>
		<category><![CDATA[Internet-driven international business model]]></category>
		<category><![CDATA[Jack Mayer]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Krishna Linga]]></category>
		<category><![CDATA[leader in the development]]></category>
		<category><![CDATA[light level imaging]]></category>
		<category><![CDATA[Mark Taggatz;]]></category>
		<category><![CDATA[medical diagnostics]]></category>
		<category><![CDATA[medical imaging]]></category>
		<category><![CDATA[Michael Sharp]]></category>
		<category><![CDATA[Michael Wallace]]></category>
		<category><![CDATA[mining]]></category>
		<category><![CDATA[motivational speaker]]></category>
		<category><![CDATA[neurodegenerative disease;]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[New Zealand]]></category>
		<category><![CDATA[news portal;]]></category>
		<category><![CDATA[non-chemical sanitation equipment]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[online transactions]]></category>
		<category><![CDATA[Palm Springs]]></category>
		<category><![CDATA[Pilipinas]]></category>
		<category><![CDATA[PK Healthy Coffee INTL]]></category>
		<category><![CDATA[platform semiconductor]]></category>
		<category><![CDATA[platform semiconductor technology]]></category>
		<category><![CDATA[Power 3 Medical Products Inc.]]></category>
		<category><![CDATA[Power3 Medical Products Inc.;]]></category>
		<category><![CDATA[PowerSafe Technology Corp.]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[President & COO]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[PSFT]]></category>
		<category><![CDATA[Quent Rickerby;]]></category>
		<category><![CDATA[Retail Stores]]></category>
		<category><![CDATA[Savi Ranch Parkway business complex]]></category>
		<category><![CDATA[scientific instrumentation]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[semiconductor]]></category>
		<category><![CDATA[speaker]]></category>
		<category><![CDATA[spectroscopy]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[Sweden]]></category>
		<category><![CDATA[TaxMasters Inc.]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[vegetable oil refining]]></category>
		<category><![CDATA[Waste To Energy]]></category>
		<category><![CDATA[workflow management software application]]></category>
		<category><![CDATA[Workplace Medical Equipment Specialist]]></category>
		<category><![CDATA[www.amplificationtechnologies.com]]></category>
		<category><![CDATA[www.apinnovations.com]]></category>
		<category><![CDATA[www.aquentium.com]]></category>
		<category><![CDATA[www.consorteum.com]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.HCEI.biz]]></category>
		<category><![CDATA[www.HealthyCoffee.com]]></category>
		<category><![CDATA[www.horizonhealthandsafety-canada]]></category>
		<category><![CDATA[www.horizonhealthandsafety-us]]></category>
		<category><![CDATA[www.power3medical.com]]></category>
		<category><![CDATA[www.psftinc.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[www.txmstr.com]]></category>
		<category><![CDATA[Xplosivestocks.com]]></category>
		<category><![CDATA[Yorba Linda]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4909</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

Sunday November 22, 2009
DrStockPick.com Stock Report!
CVAT, PWRM, HZHI, HCEI, PSFT, TAXS, CSRH, AQNM
**************************************************************
 HCEI, Healthy Coffee International Inc., HCEI.PK
HCEI is well positioned in the market place at the intersection of three mega-billion dollar industries: coffee, wellness and energy drinks, and has quickly established offices [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/cvat-pwrm-hzhi-hcei-psft-taxs-csrh-aqnm-stocks-at-a-glance-drstockpick-com-report/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Factors in local house price declines</title>
		<link>http://www.straightstocks.com/investing-lessons/factors-in-local-house-price-declines/</link>
		<comments>http://www.straightstocks.com/investing-lessons/factors-in-local-house-price-declines/#comments</comments>
		<pubDate>Sun, 22 Nov 2009 14:46:32 +0000</pubDate>
		<dc:creator>James Hamilton</dc:creator>
				<category><![CDATA[Economics]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[advisor]]></category>
		<category><![CDATA[candidate]]></category>
		<category><![CDATA[Christopher Otrok]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[great teacher]]></category>
		<category><![CDATA[Marco Del Negro]]></category>
		<category><![CDATA[Michigan]]></category>
		<category><![CDATA[Professor]]></category>
		<category><![CDATA[Real Estate]]></category>
		<category><![CDATA[Richard Carson]]></category>
		<category><![CDATA[Sam Dastrup]]></category>
		<category><![CDATA[UCSD]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://www.econbrowser.com/archives/2009/11/factors_in_loca.html</guid>
		<description><![CDATA[<p>UCSD Ph.D. candidate <a href="http://dastrup.ucsd.edu/">Sam Dastrup</a> has completed a <a href="http://dastrup.ucsd.edu/SamuelDastrupPaper.pdf">very interesting study</a> with his advisor <a href="http://www.econ.ucsd.edu/~rcarson/">Professor Richard Carson</a> of what accounts for differences across U.S. communities in the magnitude of the decline in real estate prices that we've seen over the last several years.</p>

<p>Although many commentators write as if there were a national housing market, there have been huge differences in the experience across communities.  <a>Dastrup and Carson</a> examine the OFHEO matched-sale data for house prices as calculated separately for 358 U.S. standard metropolitan statistical areas.  As seen in the map below, the magnitude of the price decline has differed greatly across U.S. communities, with the biggest drops in the southwest, Florida, and Michigan.</p> 

<br />

<table>
<caption align="bottom"> <h5>
Magnitude of house price declines for 358 SMSAs.  Source:
<a href="http://dastrup.ucsd.edu/SamuelDastrupPaper.pdf">Carson and Dastrup (2009)</a>.
</h5></caption>
<tr><td><img alt="dastrup1.jpg" src="http://www.econbrowser.com/archives/2009/11/dastrup1.jpg"/></td></tr></table>

<br />

<p><a href="http://dastrup.ucsd.edu/SamuelDastrupPaper.pdf">Dastrup and Carson</a> look at how the magnitudes of the price declines correlate with a number of other community characteristics such as overbuilding (as measured by growth in building permits relative to the local labor force), extent of subprime lending, owner-occupied units, and fundamentals such as median income.  Dastrup and Carson find that all of these measures were statistically significantly related to the magnitude of the housing price decline.  But by far the most important variable was the magnitude of the previous price run-up, which all by itself can account for more than half of the observed variance in the size of the price decline across different communities.</p>  

<br />

<table>
<caption align="bottom"> <h5>
Magnitude of house price increase prior to peak (horizontal axis) versus magnitude of house price decline (vertical axis).  Source:
<a href="http://dastrup.ucsd.edu/SamuelDastrupPaper.pdf">Carson and Dastrup (2009)</a>.
</h5></caption>
<tr><td><img alt="dastrup2.gif" src="http://www.econbrowser.com/archives/2009/11/dastrup2.gif"/></td></tr></table>

<br />

<p>I see this as consistent with earlier research by <a href="http://www.econbrowser.com/archives/2007/11/new_research_on_2.html">Marco Del Negro and Christopher Otrok</a> which documented a common national factor driving much of the U.S. housing price boom, which in the Del Negro-Ostrok specification was allowed to affect different communities with different coefficients.  My understanding of what happened is that low interest rates and in particular a deterioration of underwriting standards fueled an increase in housing demand everywhere in the earlier part of this decade.  The magnitude of the price increase that this produced differed across communities as a function of local conditions.  When these aggregate factors reversed, so did the prices.</p>

<p>The more prices were artificially bid up, the more spectacularly they declined.</p>

<p><em>Postscript to potential employers:</em> Sam's a great teacher, and looking for a job.</p>

]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/factors-in-local-house-price-declines/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prieur’s readings (November 21, 2009)</title>
		<link>http://www.straightstocks.com/investing-lessons/prieur%e2%80%99s-readings-november-21-2009/</link>
		<comments>http://www.straightstocks.com/investing-lessons/prieur%e2%80%99s-readings-november-21-2009/#comments</comments>
		<pubDate>Sat, 21 Nov 2009 08:24:30 +0000</pubDate>
		<dc:creator>Prieur du Plessis</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Alan Grayson;]]></category>
		<category><![CDATA[bank regulator;]]></category>
		<category><![CDATA[Carmen Reinhart;]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Christian Science Monitor]]></category>
		<category><![CDATA[David Streitfeld]]></category>
		<category><![CDATA[Economist]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[Gordon Chang (Forbes)]]></category>
		<category><![CDATA[harvard]]></category>
		<category><![CDATA[house finance committee]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[investment postcards]]></category>
		<category><![CDATA[itching]]></category>
		<category><![CDATA[jim jubak]]></category>
		<category><![CDATA[Kenneth Rogoff;]]></category>
		<category><![CDATA[Liu Mingkang;]]></category>
		<category><![CDATA[Mark Trumbull]]></category>
		<category><![CDATA[radical solutions]]></category>
		<category><![CDATA[Randall Forsyth;]]></category>
		<category><![CDATA[Real Estate]]></category>
		<category><![CDATA[Ron Paul]]></category>
		<category><![CDATA[the Christian Science Monitor;]]></category>
		<category><![CDATA[the New York Times]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://www.investmentpostcards.com/?p=13998</guid>
		<description><![CDATA[This post provides links to a number of interesting articles I have read over the past few days that you may also enjoy. Please also add the links to any other worthwhile articles you would like to share to the comments section. ]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/prieur%e2%80%99s-readings-november-21-2009/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Echo Therapeutics Bullish on Recent News (OTC:ECTE)</title>
		<link>http://www.straightstocks.com/stock-watch/echo-therapeutics-bullish-on-recent-news-otcecte/</link>
		<comments>http://www.straightstocks.com/stock-watch/echo-therapeutics-bullish-on-recent-news-otcecte/#comments</comments>
		<pubDate>Sat, 21 Nov 2009 01:32:00 +0000</pubDate>
		<dc:creator>Jay Garcilazo</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[AzoneTS™ Pipeline]]></category>
		<category><![CDATA[comfortable-to-wear continuous glucose monitoring device]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[diabetes care;]]></category>
		<category><![CDATA[drug delivery]]></category>
		<category><![CDATA[Echo Therapeutics Inc.]]></category>
		<category><![CDATA[FavStocks]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[MivInvestments Inc.]]></category>
		<category><![CDATA[Prelude SkinPrep System]]></category>
		<category><![CDATA[skin ablation control technology]]></category>
		<category><![CDATA[Symphony tCGM System]]></category>
		<category><![CDATA[Symphony™ tCGM System]]></category>
		<category><![CDATA[Symphony™ tCGM System Pipeline]]></category>
		<category><![CDATA[transdermal biosensor technologies]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[wireless transmission]]></category>

		<guid isPermaLink="false">http://www.favstocks.com/?p=2142</guid>
		<description><![CDATA[   MivInvestments Inc. has initiated an independent bullish technical trading alert for 11/20/09 on Echo Therapeutics, Inc. (OTC:ECTE.OB). Shares of the company finished the day at $1.35, up 8.15% from the opening bell ...]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/echo-therapeutics-bullish-on-recent-news-otcecte/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Exponential Growth, Finite World &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/exponential-growth-finite-world-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/exponential-growth-finite-world-analyst-blog/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 21:27:04 +0000</pubDate>
		<dc:creator>Dirk Van Dijk</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[actual oil discovery]]></category>
		<category><![CDATA[Africa]]></category>
		<category><![CDATA[Alaska]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[Bangladesh]]></category>
		<category><![CDATA[Burma]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[computer chips]]></category>
		<category><![CDATA[EnCana]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[energy consumption]]></category>
		<category><![CDATA[energy needs]]></category>
		<category><![CDATA[Energy Use]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[gas producers]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[I-shares  MSCI Emerging Market Fund]]></category>
		<category><![CDATA[international energy agency]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Latin America]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[natural annual global crude oil depletion rate]]></category>
		<category><![CDATA[Natural Gas]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[North Sea]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[Petrobras]]></category>
		<category><![CDATA[potato chips]]></category>
		<category><![CDATA[Russia]]></category>
		<category><![CDATA[south korea]]></category>
		<category><![CDATA[Thomas Malthus]]></category>
		<category><![CDATA[United Nations]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Wisdom Tree India]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27512/Exponential+Growth%2C+Finite+World+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
I want to talk about the challenge of exponential growth in a finite world. This is a concept that while on its surface seems easy to get, most people don&#8217;t fully grasp it.<br />
<br />
Any growth rate that is positive will lead to a doubling in size eventually -- the higher the growth rate, the quicker the doubling. A quick "back of the envelope" method of figuring it out is known as the rule of 70. If you divide a growth rate into 70, it will roughly give you the time for something to double. Thus if something is growing at 2% a year, then it will double in about 35 years, at 5% only 14 years, etc. If you want to be more precise, you can always use your Y^x button on your calculator, but the rule of 70 will do for this discussion.<br />
<br />
Clearly, exponential growth is what we are looking for when we invest -- better known as compound interest -- and it is vital to anyone&#8217;s financial health that they stay on the right side of it. People who get on the wrong side -- for example, by carrying a credit card balance -- are eventually headed towards financial oblivion. If that is you, then your best investment is probably not one of the stocks or ETFs that I recommend, it is paying down you damm Visa bill.<br />
<br />
It is also why I try to watch the downside when I make investment decisions. It is far more important to avoid 50% losses than it is to have a 50% gain. After all, if you had a 50% gain in one year, but in the next year you suffered a 50% loss, at the end of two years  that dollar would have turned into just $0.75 -- a 25% loss.<br />
<br />
However, far more important to the world is the dark side of exponential growth. Let's start with the obvious one: population growth. The table below comes from Wikipedia, but is based on UN data. Note that from 1750 to 1800, the world population grew from 791 million to 978 million -- an increase of 187 million, or 0.4% per year. From 1850 to 1900, it grew from 1.262 billion to 1.650 billion -- an increase of 388 million or at 0.53% per year.<br />
<br />
Thus, even very small growth rates can result in some very large increases extended long enough, and as the base grows, the absolute increase gets larger each year even if the rate of increase stays the same. Now look at what has happened more recently. From 1950 to 1999, world population increased by 3.457 billion, more than doubling from 2.521 billion, an increase of 1.78% per year. Lately we have seen a slowdown in the growth rate; from 1999 to 2008 it was just 1.29% per year, but that has meant an increase of 729 million in just nine years, or 92% of the entire world population in 1750.<br />
<br />
Looking forward, the U.N does see a further reduction in the rate of growth, to just 0.68% per year, or almost back down to the growth rate in the very earliest days of the Industrial Revolution. But the base is so much larger, the absolute increase is 2.2 billion, or almost the world population of 1950. The effect is that a long-term graph of world population looks like a picture of a rocket launch. And unless you believe in the Mayan calendar or the equally silly "end times" nonsense, this is going to cause some very big problems (not that the end of the world in 2012 wouldn't be a very big problem on its own).<br />
<br />
Now look at where the growth is coming from. The combined populations of North America (Mexico is included in the Latin American numbers, so basically the US and Canada) and Europe are actually expected to fall from the current 1.069 billion to 1.020 billion. All of the growth is coming from Asia, Africa and Latin America.<br />
<br />
The only thing that can keep up with exponential growth is something that itself grows exponentially. Fortunately, the one thing that grows exponentially at a very fast rate is computing power, which in turn allows for technological advances. So far, technology has managed to hold off the worst of the problems that one might expect. After all, this analysis is not exactly original. It was first made by Thomas Malthus back before world population hit the 1 billion mark.<br />
<br />
However, you can eat potato chips, not computer chips. One of the things that technology has done is level the playing field, so that people in Asia and eventually Africa will have the same shot at success as people in the U.S. and Europe. They can see how we live, and surprise, surprise -- they would prefer to live the way we do, and are increasingly able to do so. As they do, the economic growth opportunities will be huge.<br />
<br />
That is why I like the emerging markets story so much. However, given the challenges of trying to research foreign firms who might be best positioned to take advantage of these trends, it probably makes sense to use ETFs such as the I-shares <strong>MSCI Emerging Market Fund</strong> (<a href="http://www.zacks.com/stock/quote/eem">EEM</a>) or more country-specific variants like the <strong>Claymore China Small Cap ETF</strong> (<a href="http://www.zacks.com/stock/quote/hao">HAO</a>) or the <strong>Wisdom Tree India Earnings ETF </strong>(<a href="http://www.zacks.com/stock/quote/epi">EPI</a>).<br />
<br />
<img alt="" src="http://www.zacks.com/images/upload_dir/1258752669.jpg" /><br />
<img alt="" src="http://www.zacks.com/images/upload_dir/1258752681.jpg" /><br />
<br />
One of the things that has been absolutely key to our ability to have so much higher living standards today than back in, say, 1850 is that we use a lot more energy.<br />
<br />
So let&#8217;s take a look at energy consumption per capita (the data I&#8217;m using comes from <a href="http://earthtrends.wri.org/searchable_db/index.php?step=countries&#38;ccID%5B%5D=0&#38;ccID%5B%5D=1&#38;ccID%5B%5D=6&#38;ccID%5B%5D=2&#38;ccID%5B%5D=3&#38;ccID%5B%5D=5&#38;ccID%5B%5D=7&#38;allcountries=checkbox&#38;theme=6&#38;variable_ID=351&#38;action=select_years">here</a> if you want to investigate further). In 2005, people in North America used the equivalent of 8157.9 kilograms of oil per year (kgoe/y) per person, up from 7942.9 kgoe/y in 2000. Thus while our rate of increase in energy consumption was just 0.54% per year, it was on a high base so the absolute increase was 215 kgoe/y over that time.<br />
<br />
Now look at Asia (excluding the Middle East). In 2000, they were using 865.2 kgoe/y, and by 2005 it was up to 1051.5 per year. That is an increase of 3.98% per year, or to go back to the rule of 70, it means that if it keeps up Asia&#8217;s energy consumption per capita will double by 2022. Combine that with a population that is expected to grow at 0.6% per year, and Houston, we have a problem. <br />
<br />
However, note that the absolute increase in energy use per capita in Asia was just 186 kgoe/y, or just 86.5% of the increase in North America, despite the far higher growth rate. However, if the relative growth rates continue, that will not last. If we extrapolate out the growth rates of 2000 to 2005 then by 2015, Asia&#8217;s per capita consumption will grow to 1,553.0 kgoe/y, an increase of 501.5, while the absolute increase in North America will be "only" 451.4 kgoe/y.<br />
<br />
Put another way, right now we use 7.76x as much energy per person as in Asia (keep in mind these figures include relatively rich countries like Japan and South Korea, as well as basket-cases like Burma and Bangladesh), and by 2015 that ratio will fall all the way down to 5.54x as much.<br />
<br />
Now, the peak year for actual oil discovery in the world was in 1964, and as you pump oil out of the ground it is gone. Once you reach the point where you have pumped half the original oil in a field, it is basically impossible to increase the annual output from that field without causing serious damage that eventually results in that oil being trapped forever. Most of the currently producing fields are past their peak. As the International Energy Agency (IEA) found last year:<br />
<br />
<em>"Output from the world's oilfields is declining faster than previously thought, the IEA said in its annual report. Without extra investment to raise production, the natural annual global crude oil depletion rate is 9.1%. The findings suggest the world will struggle to produce enough oil to make up for steep declines in existing fields, such as in the North Sea, Russia and Alaska. The effort will become even more acute as prices fall and investment decisions are delayed. Even with investment, the annual rate of output decline is 6.4."</em> (See <a href="http://www.post1.net/lowem/entry/peak_oil_iea_reports_global_depletion_rate_could_go_up_to_9_1_struggle_to_produce_crude_oil">here</a> for full story.) <br />
<br />
Now the situation is better for natural gas (NG) than it is for oil, but eventually that will run out as well. However, we have much more time thanks to the new shale plays here in the U.S. We need to shift to more usage of NG as a bridge towards the eventual goal of producing most of our energy from renewable sources like wind and solar. But given the tiny fraction of the world&#8217;s energy they now represent, we will need many years of very fast growth in them to make a substantial dent in world energy needs.  <br />
<br />
Natural gas also has the benefit of being located here in North America, rather than in rather unstable and hostile areas of the world, the way oil is.<br />
<br />
The U.S. cannot continue to run massive trade deficits with the rest of the world. The trade deficit is the source of our external debt, not the fiscal deficit. Our external debt is now (<a href="http://www.ustreas.gov/tic/external-debt.shtml">as of 6/30/09</a>)  at $13.454 trillion -- up from just $7.744 trillion five years ago. That is a growth rate of 11.7% per year, and is clearly not sustainable (that might be overstating it since it is a gross number; we do hold some debts of other countries that offsets it in part). Still, even if the net growth rate is half that amount, it is clearly unsustainable, and is one of the reasons the dollar is going to be under long-term pressure.<br />
<br />
Putting this all together it seems clear to me that the price of energy must continue to rise over the long term. Companies that are going to be able to increase their production of oil, such as <strong>Petrobras </strong>(<a href="http://www.zacks.com/stock/quote/pbr">PBR</a>) are going to be exceptionally well positioned.<br />
<br />
While natural gas should see a big growth in demand, it is not a perfect substitute for oil. Still, big gas producers like<strong> EnCana </strong>(<a href="http://www.zacks.com/stock/quote/eca">ECA</a>) have a very bright long-term future. I would also note that what I am saying about oil also holds true for other commodities. Energy and commodities are going to be the real stores of value and of wealth over the next few decades.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=EEM">Read the full analyst report on "EEM"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=HAO">Read the full analyst report on "HAO"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=EPI">Read the full analyst report on "EPI"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PBR">Read the full analyst report on "PBR"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ECA">Read the full analyst report on "ECA"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/exponential-growth-finite-world-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Cowen’s Stone Maintains Suntech (NYSE:STP) at NEUTRAL on Q3 Earnings Report</title>
		<link>http://www.straightstocks.com/investing-lessons/cowen%e2%80%99s-stone-maintains-suntech-nysestp-at-neutral-on-q3-earnings-report/</link>
		<comments>http://www.straightstocks.com/investing-lessons/cowen%e2%80%99s-stone-maintains-suntech-nysestp-at-neutral-on-q3-earnings-report/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 21:06:00 +0000</pubDate>
		<dc:creator>Small Cap Pulse</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Cowen’s Stone Maintains Suntech]]></category>
		<category><![CDATA[Czech Republic]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[France]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[Italy]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Korea]]></category>
		<category><![CDATA[R]]></category>
		<category><![CDATA[Results Suntech]]></category>
		<category><![CDATA[Rob Stone]]></category>
		<category><![CDATA[small cap pulse]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.smallcappulse.com/index.php/site/cowens_stone_maintains_suntech_nysestp_at_neutral_on_q3_earnings_report/#When:13:06:00Z</guid>
		<description><![CDATA[November 20, 2009 ndash; Analyst Comments ndash; Cowenrsquo;s Rob Stone weighed in on Suntechrsquo;s (NYSE:STP) Q3 financial results this morning noting that given the delayed ramp of Pluto and thin-film production, and outstanding GSF A/R exposure, he thinks shares are fairly valued. He maintains a NEUTRAL rating on the stock. 


Q3 Results


Suntech (NYSE:STP) reported Q3 revenues of $473.1 million, compared with revenues of $594.4 million for the same period last year, and $320.9 million in Q209. Gross margins in Q3 were 17.7%, down from 18.5% in Q2, and 21.5% in Q308. Net income was $30,1, or $0.16 per diluted ADS, compared with $42.5 million for the same period last year and $9.6 million in Q208. Highlights for the quarter included hitting 16.53% conversion efficiency. Management increased its FY09 shipment target from 600MW to a range of 640MW to 660MW, and an increase in total cell and module production capacity to 1.4GW by mid-2010, of which 450MW will be Pluto-enabled. 


Stonersquo;s Key Takeaways


middot;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Shipments to Germany should continue to grow, but account for a smaller percentage, with stronger growth in the rest of Europe (Italy, France, Czech Republic) 


middot;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; U.S. distribution and utility scale projects, China and other Asian markets (Australia, Korea and Japan) should also drive growth


middot;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Raising 2009-12E shipments to 640MW, 1.1GW, 1.6GW and 2.2GW including system integration of 37MW, 100MW, 160MW and 230MW


middot;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Mix of systems reduces GM by about 60 basis points in 2009, 80-100 basis points in 2011/12 but GM in 2010 reflect better H1 module ASPs


middot;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Raised EPS to $0.35, $0.65, $0.99 and $1.35 on revenue of $1.6B, $2.1B, $2.7B and $3.5B]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/cowen%e2%80%99s-stone-maintains-suntech-nysestp-at-neutral-on-q3-earnings-report/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Buffett Borrows for Rail Acquisition &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/buffett-borrows-for-rail-acquisition-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/buffett-borrows-for-rail-acquisition-analyst-blog/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 20:11:51 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Berkshire Hathaway]]></category>
		<category><![CDATA[Burlington Northern Santa Fe Corporation]]></category>
		<category><![CDATA[CEO and Chairman]]></category>
		<category><![CDATA[Fort Worth]]></category>
		<category><![CDATA[Gas Utilities]]></category>
		<category><![CDATA[Jpmorgan Chase]]></category>
		<category><![CDATA[Major]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[owned subsidiary]]></category>
		<category><![CDATA[railroad networks]]></category>
		<category><![CDATA[retail]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Warren Buffett]]></category>
		<category><![CDATA[wells fargo]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27510/Buffett+Borrows+for+Rail+Acquisition+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Warren Buffett, the CEO and Chairman of <strong>Berkshire Hathaway</strong> (<a href="http://www.zacks.com/stock/quote/brk.a">BRK.A</a>)/(<a href="http://www.zacks.com/stock/quote/brk.b">BRK.B</a>), announced on Thursday to borrow $8 billion of loan for the acquisition of <strong>Burlington Northern Santa Fe Corporation </strong>(<a href="http://www.zacks.com/stock/quote/bni">BNI</a>). Berkshire Hathaway, which already owns a 22% stake in Burlington Northern, announced earlier this month it would acquire the rest for a total value of $34 billion. Buffet agreed to pay $100 a share in cash and stock to buy the rest of the company.<br />
<br />
The $8 billion loan that will be provided by <strong>JPMorgan Chase </strong>(<a href="http://www.zacks.com/stock/quote/jpm">JPM</a>) and<strong> Wells Fargo</strong> (<a href="http://www.zacks.com/stock/quote/wfc">WFC</a>) is intended to be paid back in three years&#8217; time.<br />
<br />
For Berkshire, the acquisition of Burlington Northern, or BNSF, the second largest railroad, will be its biggest to date. With it, Berkshire is adding a railroad transportation business with its already diverse range of businesses including retail, manufacturing and insurance, as well as several regional electric and gas utilities.<br />
<br />
The acquisition is expected to close in early 2010 and is subject to Burlington Northern&#8217;s shareholder approval. Post acquisition, Burlington Northern will operate from its headquarters as a wholly owned subsidiary of Berkshire Hathaway.<br />
<br />
Based in Fort Worth, Texas, Burlington Northern operates one of the largest railroad networks in North America through its subsidiary, with 33,500 route miles covering 28 U.S. states and two Canadian provinces. This network covers two-thirds of the western United States, stretching from major Pacific Northwest and Southern California. The company employs more than 40,000 people.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BNI">Read the full analyst report on "BNI"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BRK.A">Read the full analyst report on "BRK.A"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BRK.B">Read the full analyst report on "BRK.B"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=JPM">Read the full analyst report on "JPM"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=WFC">Read the full analyst report on "WFC"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/buffett-borrows-for-rail-acquisition-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>11-18-09 Audio Interview with One World Ventures, Inc. (OTCPK: OWVI)</title>
		<link>http://www.straightstocks.com/investing-lessons/11-18-09-audio-interview-with-one-world-ventures-inc-otcpk-owvi/</link>
		<comments>http://www.straightstocks.com/investing-lessons/11-18-09-audio-interview-with-one-world-ventures-inc-otcpk-owvi/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 20:00:23 +0000</pubDate>
		<dc:creator>Stuart T. Smith</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[finance]]></category>
		<category><![CDATA[One World Ventures Inc.]]></category>
		<category><![CDATA[smallcapvoice]]></category>
		<category><![CDATA[SmallCapVoice.com]]></category>
		<category><![CDATA[Stephen Prior]]></category>
		<category><![CDATA[Stuart T. Smith;]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://smallcapvoice.com/blog/?p=3138</guid>
		<description><![CDATA[
Stephen Prior, CEO of One World Ventures (OTCPK: OWVI), is featured in this audio interview conducted by Stuart T. Smith of SmallCapVoice.com. During the interview Mr. Prior provides a company overview, status and answers many questions that investors have poised.
One World Ventures, Inc. is a holding company with management resourced in Asia and the United [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/11-18-09-audio-interview-with-one-world-ventures-inc-otcpk-owvi/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
<enclosure url="http://smallcapvoice.com/blog/wp-content/uploads/owvi-11-18-09.mp3" length="17664083" type="audio/mpeg" />
		</item>
		<item>
		<title>HCEI, Healthy Coffee International is Looking to Achieve Its Short Term Goal of $1 Million a Month in Sales</title>
		<link>http://www.straightstocks.com/stock-watch/hcei-healthy-coffee-international-is-looking-to-achieve-its-short-term-goal-of-1-million-a-month-in-sales/</link>
		<comments>http://www.straightstocks.com/stock-watch/hcei-healthy-coffee-international-is-looking-to-achieve-its-short-term-goal-of-1-million-a-month-in-sales/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 19:36:53 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[(949) 209-8850]]></category>
		<category><![CDATA[advertisment services]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[corporate site]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[Energy Drinks]]></category>
		<category><![CDATA[Establishing Offices Worldwide]]></category>
		<category><![CDATA[Healthy Coffee International Inc.]]></category>
		<category><![CDATA[Healthy Coffee USA Inc.]]></category>
		<category><![CDATA[Internet-driven international business model]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[New Zealand]]></category>
		<category><![CDATA[Orleans Arena]]></category>
		<category><![CDATA[Pilipinas]]></category>
		<category><![CDATA[PK Healthy Coffee INTL]]></category>
		<category><![CDATA[Rick Aguiluz]]></category>
		<category><![CDATA[Savi Ranch Parkway business complex]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Sweden]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[www.HCEI.biz]]></category>
		<category><![CDATA[www.HealthyCoffee.com]]></category>
		<category><![CDATA[www.healthycoffee.us]]></category>
		<category><![CDATA[Xplosivestocks.com]]></category>
		<category><![CDATA[Yorba Linda]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4903</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Friday Nov 20, 2009
DrStockPick.com Stock Report!
**************************************************************
 HCEI, Healthy Coffee International Inc., HCEI.PK
HCEI’s proprietary formulas combine the health benefits of Ginseng, Reishi Mushroom, and other top quality ingredients with the world’s finest coffee beans to create a line of deliciously healthy instant gourmet coffee drinks.
Last [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/hcei-healthy-coffee-international-is-looking-to-achieve-its-short-term-goal-of-1-million-a-month-in-sales/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Smucker&#8217;s Beats, Raises Guidance &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/smuckers-beats-raises-guidance-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/smuckers-beats-raises-guidance-analyst-blog/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 18:48:53 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Folgers]]></category>
		<category><![CDATA[Pillsbury;]]></category>
		<category><![CDATA[retail coffee market segment]]></category>
		<category><![CDATA[retail consumer market segment]]></category>
		<category><![CDATA[retail oils]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27507/Smucker%27s+Beats%2C+Raises+Guidance+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>J.M. Smucker Company</strong> (<a href="http://www.zacks.com/stock/quote/sjm">SJM</a>) reported second quarter results with earnings of $1.22 per share, which was well above the Zacks Consensus Estimate of 99 cents. Quarterly earnings were up 21% compared to $1.01 reported in the prior-year quarter.<br />
<br />
Net sales for the quarter grew 51.7% year-over-year, primarily due to the addition of the Folgers coffee business. Excluding Folgers, volumes increased 1%, driven by Pillsbury, Crisco oils, Jif peanut butter and Hungry Jack brands. These were partially offset by declines in canned milk, fruit spreads, foodservices and natural foods.<br />
<br />
On segment basis -- the U.S. retail coffee market segment posted $445.1 million in sales during the quarter. Volume also increased by approximately 5%. The continued expansion of the Dunkin' Donuts brand in the gourmet category and strong growth in traditional roast and ground coffee led to the improvement.<br />
<br />
Net sales of the U.S. retail consumer market segment were down 4% compared to the prior year, primarily due to flat volumes. Gains in Jif peanut butter and Hungry Jack pancake mixes and syrups were fully offset by declines in potatoes, fruit spreads, Smucker's Uncrustables sandwiches and the specialty foods business.<br />
<br />
The U.S. retail oils and baking market segment sales declined 9% year-over-year. The decline reflected the impact of price declines in oils, flour and canned milk, and higher promotional spending on Crisco oils. However, volumes grew 3%, due to double-digit gains in Pillsbury and Crisco brands fully offsetting the declines in canned milk.<br />
<br />
Net sales in the special markets segment grew 15%, driven primarily by the acquisition of Folgers. Volumes were down 1% due to declines in foodservice and natural foods partially offset by gains in Canada.<br />
<br />
Gross margin for the quarter expanded 962 basis points (bps) to 38.5% versus 28.9% in the prior-year quarter. The acquisition of Folgers contributed almost 90% of this increase.<br />
<br />
Interest expense for the quarter increased by 54% or $6.2 million during the quarter due to an increase in the debt level related to the Folgers transaction. However, the company had repaid approximately $75 million of debt on June 1, 2009.<br />
<br />
Cash and cash equivalents at the end of the first half were $410 million, compared to $166 million in the prior-year quarter.<br />
<br />
Based on the performance of the company during the second quarter, the company raised its guidance for fiscal 2010. Annual earnings are now expected to be in the range of $3.95 and $4.05 per share. Previous guidance was $3.65 and $3.80.<br />
<br />
Net sales for the year are reiterated at approximately $4.5 billion.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=SJM">Read the full analyst report on "SJM"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/smuckers-beats-raises-guidance-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pozen Initiates New Phase III  &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/pozen-initiates-new-phase-iii-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/pozen-initiates-new-phase-iii-analyst-blog/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 17:33:31 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[adenomas;]]></category>
		<category><![CDATA[American Heart Association;]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Astrazeneca]]></category>
		<category><![CDATA[Aventis]]></category>
		<category><![CDATA[Bristol]]></category>
		<category><![CDATA[cardiovascular disease]]></category>
		<category><![CDATA[Colon Cancer]]></category>
		<category><![CDATA[colon cancer prevention]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[gastric ulcers]]></category>
		<category><![CDATA[heart attacks;]]></category>
		<category><![CDATA[Plavix]]></category>
		<category><![CDATA[strokes]]></category>
		<category><![CDATA[the American College;]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27505/Pozen+Initiates+New+Phase+III++-+Analyst+Blog</guid>
		<description><![CDATA[<br />
This morning, <strong>Pozen </strong>(<a href="http://www.zacks.com/stock/quote/pozn">POZN</a>) initiated phase III studies on PA-325/40, a fixed-dose combination of 325mg enteric coated aspirin and 40mg of immediate release omeprazole. The phase III program will consist of two pivotal trials conducted under a Special Protocol Assessment (SPA) agreed upon with the U.S. FDA, and one long-term safety study.<br />
<br />
The two pivotal programs will enroll approximately 500 patients per study at over 100 sites around the U.S. The primary endpoint of the pivotal studies is the cumulative incidence of gastric ulcers over the six-month treatment period for PA32540 versus 325 mg of enteric-coated aspirin. The long-term study will enroll approximately 400 patients and assess safety over a period of one year.<br />
<br />
Pozen is developing PA-325/40 for use in the secondary prevention of heart attacks and strokes in patients at risk for associated gastric ulcers. Aspirin is the No. 1 recommended agent for at-risk patients, with some 50 million Americans take daily aspirin therapy for secondary prevention of heart attacks and strokes.<br />
<br />
However, according to data presented at the American College of Gastroenterology and at the American Heart Association meeting, the use of low-dose aspirin for cardiovascular disease prophylaxis is associated with a 2- to 4-fold increase in gastro-intestinal (GI) complications, including gastric ulcers. Enteric coating is not a sufficient to reduce the risk of GI bleeding, and thus the majority of patients that should be taking 325mg aspirin are non-compliant or taking suboptimal low-dose (81mg) "baby" aspirin instead.<br />
<br />
Pozen&#8217;s PA-325/40 is designed to provide immediate-release omeprazole as a GI-protectant for patients taking full-dose 325mg daily aspirin therapy. If the phase III trials meet the primary endpoint of reduction in cumulative incidence of gastric ulcers, we expect PA-325/40 to be approved by the U.S. FDA with the full cardiovascular label claims of regular enteric-coated aspirin. This is a significant market opportunity in our view, considering less than 15% of the 50 million Americans on daily aspirin therapy are taking a GI-protectant such as omeprazole.<br />
<br />
Recently, data from a retrospective analysis of patients that use <strong>Sanofi-Aventis </strong>(<a href="http://www.zacks.com/stock/quote/sny">SNY</a>) / <strong>Bristol-Myers&#8217;</strong> (<a href="http://www.zacks.com/stock/quote/bmy">BMY</a>) Plavix (clopidogrel) showed an increased risk of major adverse cardiovascular events (MACE) by as much as 50% while taking a proton pump inhibitor (PPI) such as<strong> AstraZeneca&#8217;s </strong>(<a href="http://www.zacks.com/stock/quote/azn">AZN</a>) omeprazole (Prilosec) or esomeprazole (Nexium). The data included analysis of outcomes from 16,700 patients who underwent percutaneous coronary intervention and continued Plavix for 12 months after the procedure.<br />
<br />
Approximately 9,900 were not given a PPI at any time during Plavix treatment and 6,800 were given overlapping PPI therapy. The analysis showed a 12-month MACE event rate of about 25% among PPI users, compared with 18% of patients who were not given PPI (MACE hazard ratio of 1.50 for PPI users versus nonusers).<br />
<br />
The current Plavix label discourages use of a PPI due to this potential limiting effect on the drug&#8217;s effectiveness. The majority of Plavix use for secondary prevention of heart attacks and strokes is with enteric-coated aspirin.<br />
<br />
Strengthening this label warning by the U.S. FDA could work to greatly limit the potential uptake for Pozen&#8217;s PA-325/40 product. However, we note the retrospective analysis that potentially showed a reduced effectiveness for Plavix while on a PPI was with commercially available delayed release PPIs dosed at the same time as taking Plavix. Pozen is currently conducting a drug-drug interaction study with their immediate release omeprazole doses both at the same time and 12 hours apart from Plavix.<br />
<br />
The omeprazole used in PA-325/40 is an immediate release formulation, not the commercially available delayed-release found in Prilosec or Nexium. We suspect that dosing an immediate release omeprazole 12 hours apart (say at night) from Plavix (in the morning) will dramatically reduce the potential negative interactions between the two drugs.<br />
<br />
We are optimistic on the development plans for PA-325/40. Besides the potential use as a secondary preventative agent for cardiovascular disease, significant literature exists showing a potential reduction in risk for developing precancerous adenomas on high-dose aspirin regimen.<br />
<br />
Four separate government-funded randomized controlled trials concluded that aspirin is a benefit in the prevention of adenomas and significantly reduces the risk of colon cancer. However, the dangerous GI tolerability has greatly limited large outcome-based clinical studies or wide-spread use of high-dose aspirin in colon cancer prevention. We believe that Pozen&#8217;s PA-325/40, and phase II PA-650/40, have the potential to be a game-changer with respect to colon cancer prevention. This also helps mitigate the potential downside risk to pushing forward with development despite the recent negative Plavix/PPI headlines.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=POZN">Read the full analyst report on "POZN"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=SNY">Read the full analyst report on "SNY"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BMY">Read the full analyst report on "BMY"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AZN">Read the full analyst report on "AZN"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/pozen-initiates-new-phase-iii-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HZHI, Horizon Health International Aims for Millions in Sales with its E-Commerce System &#8211; Now is Developing Two New Websites to Speed Up Online Transactions</title>
		<link>http://www.straightstocks.com/stock-watch/hzhi-horizon-health-international-aims-for-millions-in-sales-with-its-e-commerce-system-now-is-developing-two-new-websites-to-speed-up-online-transactions/</link>
		<comments>http://www.straightstocks.com/stock-watch/hzhi-horizon-health-international-aims-for-millions-in-sales-with-its-e-commerce-system-now-is-developing-two-new-websites-to-speed-up-online-transactions/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 16:49:51 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[2009 Samson Industries]]></category>
		<category><![CDATA[604-998-3385]]></category>
		<category><![CDATA[advertisment services]]></category>
		<category><![CDATA[assistive technology]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[Calgary]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[Delbert G. Blewett]]></category>
		<category><![CDATA[disability products;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[e - commerce]]></category>
		<category><![CDATA[eBay US]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[ergonomic solutions]]></category>
		<category><![CDATA[Horizon Health International Corp.]]></category>
		<category><![CDATA[MEDIchair]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[On-line sales]]></category>
		<category><![CDATA[online shopping network]]></category>
		<category><![CDATA[online transactions]]></category>
		<category><![CDATA[order processing]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[Retail Stores]]></category>
		<category><![CDATA[Samson Industries]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[SunCity Ventures]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Workplace Medical Equipment Specialist]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.horizonhealthandsafety-canada]]></category>
		<category><![CDATA[www.horizonhealthandsafety-us]]></category>
		<category><![CDATA[www.horizonhealthandsafety.com]]></category>
		<category><![CDATA[www.medichair-calgary.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[Xplosivestocks.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4900</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

Friday November 20, 2009
DrStockPick.com Stock Report!
**************************************************************
 HZHI, Horizon Health International Corp., HZHI.PK
HZHI through its US and Canadian Subsidiaries is servicing all of North America through its E-Commerce System, providing services as a &#8216;Home, Office and Workplace Medical Equipment Specialist&#8217; offering a complete end-to-end shopping [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/hzhi-horizon-health-international-aims-for-millions-in-sales-with-its-e-commerce-system-now-is-developing-two-new-websites-to-speed-up-online-transactions/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>AstraZeneca Seeks FDA Approval &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/astrazeneca-seeks-fda-approval-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/astrazeneca-seeks-fda-approval-analyst-blog/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 16:43:23 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[acute coronary syndrome;]]></category>
		<category><![CDATA[American Heart Association;]]></category>
		<category><![CDATA[Astrazeneca]]></category>
		<category><![CDATA[Aventis]]></category>
		<category><![CDATA[Bristol]]></category>
		<category><![CDATA[Bristol Myers Squibb]]></category>
		<category><![CDATA[clopidogrel]]></category>
		<category><![CDATA[Eli Lilly]]></category>
		<category><![CDATA[European Medicines Agency]]></category>
		<category><![CDATA[Myocardial Infarction]]></category>
		<category><![CDATA[Plavix]]></category>
		<category><![CDATA[player]]></category>
		<category><![CDATA[stroke]]></category>
		<category><![CDATA[thrombosis]]></category>
		<category><![CDATA[U.S. Food and Drug  Administration]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[unstable angina]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27498/AstraZeneca+Seeks+FDA+Approval+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Recently, <strong>AstraZeneca plc </strong>(<a href="http://www.zacks.com/stock/quote/AZN">AZN</a>) announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its blood clot preventer Brilinta (ticagrelor). Brilinta is an oral reversible P2Y12 adenosine diphosphate receptor antagonist for arterial thrombosis aimed to compete with the blockbuster drug Plavix which is co-developed by <strong>Bristol-Myers Squibb</strong> (<a href="http://www.zacks.com/stock/quote/BMY">BMY</a>) and <strong>Sanofi-Aventis </strong>(<a href="http://www.zacks.com/stock/quote/SNY">SNY</a>). On Oct 26, 2009, AstraZeneca filed for approval of the drug with the European Medicines Agency (EMEA) and is awaiting validation of the application.<br />
 <br />
AstraZeneca is seeking an FDA approval of Brilinta primarily on the basis of data from PLATO (a study of Platelet Inhibition and Patient Outcomes), a late-stage 18,624 patient trial, that showed that Brilinta was more effective than Plavix in treating patients with acute coronary syndrome (ACS) in 43 countries. Brilinta treatment resulted in a reduction of cardiovascular events (CV death, MI or myocardial infarction, stroke) over clopidogrel (Plavix), without an increase in major bleeding. Brilinta is the first investigational antiplatelet that has demonstrated a reduction in CV death versus Plavix in ACS patients.<br />
 <br />
As a reminder, PLATO evaluated the efficacy, safety and tolerability of Brilinta versus Plavix. The trial design prospectively identified 66 subgroups including 33 efficacy and 33 safety subgroups. The findings from 62 of the 66 subgroups were consistent with the results in the overall study population.<br />
 <br />
ACS represents conditions that result from a reduction in blood flow to the heart muscle, including unstable angina and myocardial infarction. According to data from the American Heart Association, approximately 1.4 million people in the United States are affected by ACS annually.<br />
 <br />
We believe that if Brilinta gets FDA approval and enters the approximately $9 billion anticlotting medicine market, it would provide increased competition to Plavix, which is one of the largest selling drugs globally with sales of $5.6 billion in 2008. Plavix already has to contend with a new player in the market, <strong>Eli Lilly</strong>&#8217;s (<a href="http://www.zacks.com/stock/quote/LLY">LLY</a>) Effient. Moreover, Plavix will lose patent protection in 2011 resulting in huge loss of revenues for Bristol. If AstraZeneca can get Brilinta on the market before Plavix goes generic, it may help Brilinta maintain its market share and reduce the number of patients switching to generic clopidogrel.<br />
 <br />
Currently, we are Neutral on AstraZeneca.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AZN">Read the full analyst report on "AZN"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BMY">Read the full analyst report on "BMY"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=SNY">Read the full analyst report on "SNY"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=LLY">Read the full analyst report on "LLY"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/astrazeneca-seeks-fda-approval-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>11-20-09 Daily Small Cap Market News and Stock Highlights from SmallCapVoice.com</title>
		<link>http://www.straightstocks.com/investing-lessons/11-20-09-daily-small-cap-market-news-and-stock-highlights-from-smallcapvoice-com/</link>
		<comments>http://www.straightstocks.com/investing-lessons/11-20-09-daily-small-cap-market-news-and-stock-highlights-from-smallcapvoice-com/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 16:28:50 +0000</pubDate>
		<dc:creator>Stuart T. Smith</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[computer maker]]></category>
		<category><![CDATA[Dell Inc]]></category>
		<category><![CDATA[digital video]]></category>
		<category><![CDATA[Donald Baillargeon;]]></category>
		<category><![CDATA[Dow 30]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[European Central Bank]]></category>
		<category><![CDATA[financial advisor]]></category>
		<category><![CDATA[GRAMMY]]></category>
		<category><![CDATA[Grammy-winning singer and songwriter]]></category>
		<category><![CDATA[Hollywood technology]]></category>
		<category><![CDATA[imaging]]></category>
		<category><![CDATA[Jean Claude Trichet]]></category>
		<category><![CDATA[Lucas Energy Inc.]]></category>
		<category><![CDATA[Mary J. Blige]]></category>
		<category><![CDATA[Nasdaq Composite]]></category>
		<category><![CDATA[Oil And Gas]]></category>
		<category><![CDATA[online research]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Queen;]]></category>
		<category><![CDATA[registered broker]]></category>
		<category><![CDATA[retail]]></category>
		<category><![CDATA[service video technology]]></category>
		<category><![CDATA[smallcapvoice]]></category>
		<category><![CDATA[SmallCapVoice.com]]></category>
		<category><![CDATA[Standard & Poor]]></category>
		<category><![CDATA[stock broker]]></category>
		<category><![CDATA[The American Music Awards]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[video technology;]]></category>
		<category><![CDATA[wall street]]></category>
		<category><![CDATA[William Sawyer]]></category>

		<guid isPermaLink="false">http://smallcapvoice.com/blog/?p=3166</guid>
		<description><![CDATA[Stocks are lower as the dollar rises and Wall Street digests a week of mixed economic reports
Overseas markets declined. European Central Bank President Jean-Claude Trichet said the ECB plans to start pulling back some of its stimulus programs as the economy begins to recover.
With little U.S. economic news to help sway the market Friday, the [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/11-20-09-daily-small-cap-market-news-and-stock-highlights-from-smallcapvoice-com/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Helmerich &amp; Payne Profit Declines &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/helmerich-payne-profit-declines-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/helmerich-payne-profit-declines-analyst-blog/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 15:40:21 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Helmerich & Payne]]></category>
		<category><![CDATA[Nabors Industries]]></category>
		<category><![CDATA[natural gas market]]></category>
		<category><![CDATA[Patterson-UTI Inc.]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Venezuela]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27490/Helmerich+%26+Payne+Profit+Declines+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Contract drilling services provider <strong>Helmerich &#38; Payne, Inc</strong>. (<a href="http://www.zacks.com/stock/quote/HP">HP</a>) reported solid fourth quarter results, buoyed by improving rig counts on the back of rebounding commodity prices. Earnings per share, excluding gains from non-operating items, came in at 47 cents, marginally better than the Zacks Consensus Estimate of 44 cents.<br />
 <br />
However, as has been the case with the other contract drillers that have already reported &#8211; <strong>Patterson-UTI Inc.</strong> (<a href="http://www.zacks.com/stock/quote/PTEN">PTEN</a>) and<strong> Nabors Industries</strong> <a href="http://www.zacks.com/stock/quote/NBR">(NBR</a>) &#8211; earnings and revenue comparisons with the year-earlier period were quite ugly, severely hampered by lower rig utilization (especially in the U.S. land drilling market) amid weak demand for drilling services. Helmerich &#38; Payne&#8217;s adjusted earnings per share slumped approximately 58.4%, while revenues declined 38.0% to $362.2 million.<br />
 <br />
<u>U.S. Land Operations</u><br />
During the quarter, operating revenues totaled $269.1 million (74% of total revenue), down 38.5% year-over-year. Average rig revenue per operating day was $25,895, up 3.4%, while average rig margin per day increased 10.5% to $14,551. However, segment operating income fell 43.2% from the year-earlier quarter to $90.1 million, mainly reflecting lower utilization levels, which were down to 55% (from 98% in the fourth quarter of 2008).<br />
 <br />
<u>Offshore Operations<br />
</u>Helmerich &#38; Payne&#8217;s offshore revenues declined 5.6% year-over-year to $47.3 million. Daily average rig revenue fell 9.4% to $47,547, while average rig margin per day was down 7.7% to $20,679. Segment operating income, at $12.0 million, decreased 12.0%. Rig utilization, which was 89% in the same period of 2008, came down to 78%.<br />
 <br />
<u>International Land Operations</u><br />
International land operations recorded revenues of $43.1 million, as against $93.3 million in the previous-year quarter. Average daily rig revenue was $29,406, down 22.0%, while rig margin per day nosedived 71.2% year-over-year to $3,244. The segment incurred a loss of $6.3 million during the quarter, compared to a profit of $18.6 million in the fourth quarter of 2008. Activity levels declined significantly, falling to 41% from 97% a year ago. The company's decision earlier this year to delay booking revenue in Venezuela also contributed to the dismal international results.<br />
 <br />
<u>Capital Expenditure &#38; Balance Sheet</u><br />
During the quarter, Helmerich &#38; Payne spent approximately $142.3 million on capital programs. As of September 30, 2009, the company had more than $141.5 million in cash and long-term debt of $420 million (debt-to-capitalization ratio of 15.7%).<br />
 <br />
<u>Outlook </u><br />
Management indicated that drilling activity is picking up and hoped that the reported quarter represented the eventual bottoming of the North American natural gas driven land drilling operations. At the same time, it remained concerned about the current supply overhang in the natural gas market and noted an industry backlog of up to 1,500 uncompleted or deferred wells domestically.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=HP">Read the full analyst report on "HP"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PTEN">Read the full analyst report on "PTEN"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=NBR">Read the full analyst report on "NBR"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/helmerich-payne-profit-declines-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MoneyTV With Donald Baillargeon, 11/20</title>
		<link>http://www.straightstocks.com/investing-lessons/moneytv-with-donald-baillargeon-1120/</link>
		<comments>http://www.straightstocks.com/investing-lessons/moneytv-with-donald-baillargeon-1120/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 15:03:25 +0000</pubDate>
		<dc:creator>Stuart T. Smith</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[Brewer Investment Group Chief Market]]></category>
		<category><![CDATA[Brian Altounian;]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Coo]]></category>
		<category><![CDATA[Dean Janes;]]></category>
		<category><![CDATA[Dominion]]></category>
		<category><![CDATA[Dominion Medical Imaging device;]]></category>
		<category><![CDATA[Don Baillargeon;]]></category>
		<category><![CDATA[Donald Baillargeon;]]></category>
		<category><![CDATA[Executive Producer]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Flame Seal Products Inc.]]></category>
		<category><![CDATA[Health This Week;]]></category>
		<category><![CDATA[Hollywood technology]]></category>
		<category><![CDATA[Imaging3 Inc.]]></category>
		<category><![CDATA[Jim Hyerczyk]]></category>
		<category><![CDATA[Los Angeles]]></category>
		<category><![CDATA[Lucas Energy Inc.]]></category>
		<category><![CDATA[medical imaging]]></category>
		<category><![CDATA[medical imaging device]]></category>
		<category><![CDATA[Michael Kiser]]></category>
		<category><![CDATA[MoneyRap Radio;]]></category>
		<category><![CDATA[MoneyTV;]]></category>
		<category><![CDATA[Oil And Gas]]></category>
		<category><![CDATA[Platinum Studios Inc.;]]></category>
		<category><![CDATA[Securities Analyst]]></category>
		<category><![CDATA[smallcapvoice]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Western Europe]]></category>
		<category><![CDATA[William Sawyer]]></category>
		<category><![CDATA[www.moneytv.net]]></category>

		<guid isPermaLink="false">http://smallcapvoice.com/blog/?p=3163</guid>
		<description><![CDATA[LOS ANGELES, CA &#8212; (Marketwire) &#8212; 11/20/09 &#8212; Meteoric rise in stock price, Hollywood technology fosters interest in comics, fire prevention, forex, oil and gas; this week on MoneyTV, hosted by anchor Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what makes it happen, (http://www.moneytv.net), featuring informative interviews with company [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/moneytv-with-donald-baillargeon-1120/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Stock Market News for November 20, 2009 &#8211; Market News</title>
		<link>http://www.straightstocks.com/stock-watch/stock-market-news-for-november-20-2009-market-news/</link>
		<comments>http://www.straightstocks.com/stock-watch/stock-market-news-for-november-20-2009-market-news/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 14:04:47 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Bank of America Merrill Lynch;]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[chevron corp]]></category>
		<category><![CDATA[conocophillips]]></category>
		<category><![CDATA[Dell]]></category>
		<category><![CDATA[Dow 30]]></category>
		<category><![CDATA[energy producers]]></category>
		<category><![CDATA[Intel]]></category>
		<category><![CDATA[Merrill]]></category>
		<category><![CDATA[Nasdaq Composite]]></category>
		<category><![CDATA[Oecd]]></category>
		<category><![CDATA[Oil Prices]]></category>
		<category><![CDATA[Schlumberger Ltd]]></category>
		<category><![CDATA[semiconductor]]></category>
		<category><![CDATA[Sp 500]]></category>
		<category><![CDATA[Texas Instruments]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[wall street]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27493/Stock+Market+News+for+November+20%2C+2009+-+Market+News</guid>
		<description><![CDATA[<p align="justify">U.S. stocks tumbled Thursday as concerns about a subdued economic recovery played in the minds of investors.  Safer bets like dollar strengthened and oil prices slumped.  As investors turned to safe havens, Treasury prices rose, sending corresponding yields lower.  Yields on three-month bills, considered one of the safest bets, turned negative for the first time since December.  A Bank of America Merrill Lynch downgrade of semiconductor industry also added to the downward pressure.     </p>
<p align="justify">The spike in bond prices came even as the Treasury announced plans to auction a record $118 billion in new notes next week &#8211; an auction schedule of $44 billion 2-year notes on Monday, $42 billion 5-year notes Tuesday, and $32 billion 7-year notes on Wednesday.</p>
<p align="justify">The Dow, which had plunged as much as 170 points during the session, ended down 93.87 points, or 0.9%, to 10,332.44.  The broader Standard &#38; Poor's 500 index fell 14.90 points, or 1.3%, to 1,094.90, while the tech-heavy Nasdaq composite index dropped 36.32 points, or 1.7%, to 2,156.82.  Wall Street&#8217;s fear gauge, the CBOE Vix, jumped more than 4%.  Crude prices dropped $1.93 to $77.46. Gold prices rose to their fifth straight record close, up 70 cents to $1141.90.</p>
<p align="justify">As glimmers of a full-blown economic recovery fade, investors have increasingly become intolerant, locking in profits at every opportunity.  Also, a lack of conviction on part of the market to push beyond the current rally has been a dampener and concerns of an asset bubble build-up due to accommodative monetary policies have diminished risk appetites, sending daily average volume to levels of only about 1 billion.   </p>
<p align="justify">Nevertheless, to show not all is bad, the OECD raised its growth estimates for its 30-country members to 1.9% in 2010 from June's estimate of a 0.7% growth, and to a 2.5% GDP expansion in 2011.</p>
<p align="justify">Tech shares, already up 54.3% year-to-date, fell 1.7% Thursday, after Merrill's analyst slashed 2010 global growth targets, and downgraded ten companies in the semiconductor sector.  Intel (NASDAQ:INTC) shares fell 4.1%, and Texas Instruments (NYSE:TXN) retreated 3.4% after the downgrade.  Dell (NASDAQ:DELL) shares plunged 6.1% in premarket trading, after the company reported earnings that missed analysts&#8217; projections.</p>
<p align="justify">Among the S&#38;P 500 industry groups, energy producers, off 2.1%, were the biggest decliners.  ConocoPhillips (NYSE:COP) fell 1.9% and Chevron Corp. (NYSE:CVX) dropped 2% as crude prices fell for the first time in four days. Schlumberger Ltd. (NYSE:SLB) shares fell 3.3%.</p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/stock-market-news-for-november-20-2009-market-news/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Gap&#8217;s Earnings Improve &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/gaps-earnings-improve-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/gaps-earnings-improve-analyst-blog/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 14:00:00 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Gap Inc]]></category>
		<category><![CDATA[Old Navy]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27485/Gap%27s+Earnings+Improve+-+Analyst+Blog</guid>
		<description><![CDATA[<strong><br />
Gap Inc.</strong> (<a href="http://www.zacks.com/stock/quote/GPS">GPS</a>), a premier international specialty retailer, has reported healthy third quarter results despite challenging market conditions. The company reported net income of $307 million or 44 cents per share during the quarter compared to $246 million or 35 cents per share in the year-earlier quarter. <br />
<br />
The robust earnings were primarily driven by strong sales at its low-price Old Navy segment and the highest third quarter operating margins in a decade. Net sales during the quarter were $3.59 billion compared to $3.56 billion in the year-ago quarter, largely due to a 10% increase in comparable sales across 1,060 Old Navy stores that account for about 40% of the total sales. <br />
<br />
The Old Navy chain has benefited from the increasing preference among U.S. shoppers for lower-price and discount stores due to the continued challenging macroeconomic environment. Gross margins increased 380 basis points year-over-year to 42.5%. Operating margins during the quarter increased to 13.9% from 11.1% in the year-ago quarter due to effective cost-control measures and prudent inventory management policies. <br />
<br />
Gap is now focusing more on improving its business model by striking the right balance between its cost structure and merchandise by better aligning inventory with sales trends. The company reported a 9% decrease in year-over-year inventory per square foot. During the quarter, Gap repurchased approximately 4.1 million shares for $91 million, out of which 0.6 million shares were repurchased from individual members of the Fischer family. <br />
<br />
Subsequent to the end of the quarter, the management also authorized an additional $500 million under its share repurchase program, including a $20 million share repurchase from the Fischer family. At quarter end, Gap had $2.4 billion of cash and cash equivalents. Year-to-date, free cash flow of the company was $931 million. Gap defines free cash flow as net cash generated from operating activities less expenses relating to the purchases of property and equipment. <br />
<br />
During the quarter, Gap opened 13 stores and closed 15 stores, bringing the year-to-date figures to 36 and 42, respectively. For fiscal year 2009, the company expects to open about 50 stores and close 100 stores, including repositioning. With a strong performance in the fiscal 2009 third quarter, Gap is poised to regain its lost market share ahead of the holiday season supported by increased marketing campaigns and a focused approach to present a strong value proposition to customers.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=GPS">Read the full analyst report on "GPS"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/gaps-earnings-improve-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Dell Falls Short of Expectations &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/dell-falls-short-of-expectations-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/dell-falls-short-of-expectations-analyst-blog/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 13:51:13 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Americas]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Asia Pacific]]></category>
		<category><![CDATA[Brazil]]></category>
		<category><![CDATA[Brocade;]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Dell Inc]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Juniper]]></category>
		<category><![CDATA[Russia]]></category>
		<category><![CDATA[Storage Systems]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Windows 7;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27491/Dell+Falls+Short+of+Expectations+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Dell Inc.</strong> (<a href="http://www.zacks.com/stock/quote/dell">DELL</a>) reported third quarter 2010 EPS of 23 cents, below the Zacks Consensus Estimate of 27 cents.<br />
<em><strong><br />
Revenue<br />
</strong></em><br />
Revenue for the quarter was $10.75 billion, down 17.0% from $12.97 billion reported in the year-ago quarter and up 1.0% from $10.62 billion reported in the previous quarter. The company&#8217;s third quarter reported revenue was adversely affected by the timing of the Windows 7 launch and due to backlog buildup in the company&#8217;s SMB and consumer businesses.<br />
<br />
<em><strong>Revenue by Segment<br />
</strong></em><strong><br />
Large Enterprise</strong> posted revenue of $3.4 billion, an increase of 4.0% sequentially and decline of 23.0% year-over-year. In the last quarter, the company expended its networking partnership with Brocade and Juniper, and introduced products like PowerEdge 11g servers and expanded PowerVault storage systems.<br />
<br />
<strong>Public</strong> revenue for the quarter was $3.7 billion, down 3.0% on sequentially and 7.0% from the year-ago quarter. Shipments were down 12.0% on a sequential basis, due to seasonality in the U.S. public sector business.<br />
<strong><br />
Small and Medium Business</strong> revenue for the quarter was $3.0 billion, up 5.0% sequentially and down 19.0% from the year-ago quarter. Shipments increased 9% sequentially. The segment benefited from steadily improving demand in both the Americas and the Asia-Pacific region, as well as better performance in EMEA during the second half.<br />
<br />
Revenues for <strong>Consumer Business</strong> were down 10.0% year-over-year, but flat sequentially to $2.8 billion with shipments growing 4% sequentially.<br />
<br />
Dell&#8217;s total sales in China, India, Brazil and Russia increased 18.0% sequentially and 5.0% over last year. China, the second-largest revenue generating country for Dell, reported revenue increase of 20.0% sequentially and 8.0% from the year-ago quarter.<br />
<br />
<em><strong>Operating Results</strong></em><br />
<br />
Gross margin for the quarter was 17.3%, below 18.8% reported in the third quarter of 2009. The decline in gross margin took place as gross profit declined at a higher rate than revenue. <br />
<br />
In addition, operating expenses declined 10.0% from the year-ago quarter, as a result of a decline in both SG&#38;A and R&#38;D expenses. This translated into an operating margin of 4.5% versus 6.7% in the year-ago quarter. Tax rate for the third quarter was 34.5%, compared to 28.0% in the year-ago quarter.<br />
<br />
Earnings per share during the quarter were $0.17, down from $0.37 reported in the year-ago quarter and $0.24 reported in the previous quarter. The EPS for the quarter included a pre-tax expense of expense of $123.0 million or $0.05 per share and $40.0 million or $0.01 per share for amortization of intangibles. Excluding that, the EPS for the quarter comes to $0.23.<br />
<br />
<em><strong>Balance Sheet &#38; Cash Flow</strong></em><br />
<br />
Dell&#8217;s cash conversion cycle improved by a day to negative 36 days. Cash flow from operations declined to $801.0 billion from $1.0 billion reported in the previous quarter. The company ended the quarter with $13.12 billion in cash and short-term investments versus $11.99 billion in the previous quarter. Long-term debt stood at $3.44 billion at the end of the quarter versus $3.39 billion in the previous quarter.<br />
<em><strong><br />
Guidance<br />
</strong></em><br />
Dell did not provide any guidance for the fourth quarter, but expects seasonal improvement in demand from the consumer end market. However, Public sector demand may be lower. The company expects fourth quarter revenue to improve over the third quarter.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=DELL">Read the full analyst report on "DELL"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/dell-falls-short-of-expectations-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Dollar, the Euro, and being Bullish on Gold</title>
		<link>http://www.straightstocks.com/investing-lessons/the-dollar-the-euro-and-being-bullish-on-gold/</link>
		<comments>http://www.straightstocks.com/investing-lessons/the-dollar-the-euro-and-being-bullish-on-gold/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 13:22:14 +0000</pubDate>
		<dc:creator>Contrarian Profits</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[contrarian profits]]></category>
		<category><![CDATA[Mediterranean]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[Oil Market]]></category>
		<category><![CDATA[Oil Price]]></category>
		<category><![CDATA[oil rising]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[William Rees-Mogg;]]></category>

		<guid isPermaLink="false">http://www.contrarianprofits.com/?p=21107</guid>
		<description><![CDATA[The dollar nevertheless remains the world’s leading reserve currency, with the euro in second place. Investors are naturally anxious to protect themselves against markets, including currency markets, which have shown such a high degree of volatility. 

The Chinese, who have the greatest number of dollars in their currency reserves, have already suffered substantial losses. 

In what amounts to a crisis of the dollar, the euro is in second place as a reserve currency, but there are potential threats to the future of the euro, due to the weak productivity of the Mediterranean economies.]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/the-dollar-the-euro-and-being-bullish-on-gold/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zacks Bull and Bear of the Day Highlights: Principal Financial, Sohu.com, Bank of America, Wal-Mart and Sears Holding Corp. &#8211; Press Releases</title>
		<link>http://www.straightstocks.com/stock-watch/zacks-bull-and-bear-of-the-day-highlights-principal-financial-sohu-com-bank-of-america-wal-mart-and-sears-holding-corp-press-releases/</link>
		<comments>http://www.straightstocks.com/stock-watch/zacks-bull-and-bear-of-the-day-highlights-principal-financial-sohu-com-bank-of-america-wal-mart-and-sears-holding-corp-press-releases/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 13:10:10 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Bank Of America]]></category>
		<category><![CDATA[Banking]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[brand advertising revenue]]></category>
		<category><![CDATA[broadline retailer]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[Kmart]]></category>
		<category><![CDATA[Leonard Zacks;]]></category>
		<category><![CDATA[local food bank]]></category>
		<category><![CDATA[Online Games]]></category>
		<category><![CDATA[Principal Financial;]]></category>
		<category><![CDATA[Salvation Army;]]></category>
		<category><![CDATA[Sears Holding Corp.]]></category>
		<category><![CDATA[unemployment insurance]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Wal Mart]]></category>
		<category><![CDATA[Zacks Equity Research]]></category>
		<category><![CDATA[Zacks Investment Research Inc.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27484/Zacks+Bull+and+Bear+of+the+Day+Highlights%3A+Principal+Financial%2C+Sohu.com%2C+Bank+of+America%2C+Wal-Mart+and+Sears+Holding+Corp.+-+Press+Releases</guid>
		<description><![CDATA[<p align="left"><strong>For Immediate Release</strong></p>
<p align="left">Chicago, IL &#8211; November 20, 2009 &#8211; Zacks Equity Research highlights <strong>Principal Financial </strong>(<a href="http://www.zacks.com/stock/quote/PFG">PFG</a>) as the Bull of the Day and <strong>Sohu.com </strong>(<a href="http://www.zacks.com/stock/quote/SOHU">SOHU</a>) the Bear of the Day. In addition, Zacks Equity Research provides analysis on <strong>Bank of America </strong>(<a href="http://www.zacks.com/stock/quote/BAC">BAC</a>), <strong>Wal-Mart </strong>(<a href="http://www.zacks.com/stock/quote/WMT">WMT</a>) and <strong>Sears Holding Corp.</strong>(<a href="http://www.zacks.com/stock/quote/SHLD">SHLD</a>).</p>
<p align="left">Full analysis of all these stocks is available at <a href="http://at.zacks.com/?id=5506">http://at.zacks.com/?id=5506</a></p>
<p align="left">Here is a synopsis of all five stocks:</p>
<p align="left"><a href="http://www.zacks.com/newsroom/commentary/index.php?type_id=6">Bull of the Day</a>:</p>
<p align="left">We are upgrading our recommendation on the shares of <strong>Principal Financial </strong>(<a href="http://www.zacks.com/stock/quote/PFG">PFG</a>) to Outperform. The company's third quarter operating earnings were much ahead of the Zacks Consensus Estimate, driven primarily by the sequential improvement in domestic as well as global equity markets.</p>
<p align="left">We believe that Principal's strong franchise within the pension sector, which is aided by its diversification both in terms of products and geography, positions it well to benefit from the gradual recovery of the credit market. However, rising unemployment is reducing the number of participants in existing employee benefit plans.</p>
<p align="left">Though we are concerned about higher delinquencies in its commercial mortgage portfolio, we expect the company to benefit from its decent capital level and cost containment measures.</p>
<p><a href="http://www.zacks.com/newsroom/commentary/index.php?type_id=7">Bear of the Day</a>:</p>
<p align="left">While <strong>Sohu.com&#8217;s </strong>(<a href="http://www.zacks.com/stock/quote/SOHU">SOHU</a>) third-quarter earnings beat the Zacks Consensus Estimate and were in line with the company s own guidance, the outlook for the fourth quarter was far below expectation. The company's operating expenses have been steadily going up, which we fear could limit the growth in earnings.</p>
<p align="left">Moreover, recent delays in game launches, weak ad spending, which is hurting the brand advertising revenue and intense competition pose a threat. Strength in its online games and portal business are expected to be the strongest drivers for growth beyond 2010.</p>
<p align="left">Currently, we see limited upside for Sohu's revenue and earnings growth in the near term. We downgrade the stock to Underperform from our previous Neutral rating and set a six-month price target of $45.00.</p>
<p>Latest Posts on the Zacks <a href="http://www.zacks.com/stock/news/AnalystBlog">Analyst Blog</a>:</p>
<p align="left"><em>Initial Jobless Claims Flat(-ish)</em></p>
<p align="left">With the pace of hiring as slow as it is, this hole in the safety net will have to be repaired as soon as possible. With no income, and more than six job seekers for every available job, those people are going to be in a world of hurt. Most Americans have very little in the way of savings to fall back on, especially outside of IRA&#8217;s and 401k plans. Tapping those would expose people to a 10% penalty and it would be considered taxable income for them. Yet many of them will probably be forced to do so, even if unemployment insurance is extended to them.</p>
<p align="left">It is not just for humanitarian reasons that benefits should be extended. Without an income, people will have to do their banking at the local food bank, not at <strong>Bank of America </strong>(<a href="http://www.zacks.com/stock/quote/BAC">BAC</a>), and even the local food bank needs a bailout these days. People will be hard-pressed to shop at even the Salvation Army, let alone <strong>Wal-Mart </strong>(<a href="http://www.zacks.com/stock/quote/WMT">WMT</a>).</p>
<p align="left">Extending benefits is one of the most effective forms of economic stimulus there is. It is far more effective than extending lavish tax credits to move-up homebuyers with incomes up to five times the national median. Unfortunately, the unemployed to not have as effective a lobby as the used home dealers (aka Realtors).</p>
<p align="left"><em>Sears Reports 3Q Loss</em> <br />
<strong><br />
Sears Holding Corp.</strong>(<a href="http://www.zacks.com/stock/quote/SHLD">SHLD</a>), the fourth largest broadline retailer in the U.S., reported a third-quarter loss of $127 million or $1.09 per share compared to a loss of $146 million or $1.16 per share in the year-earlier quarter. Although Sears managed to reduce its quarterly loss year over year, this was the second consecutive quarterly loss for the company.</p>
<p align="left">The quarterly figures included non-recurring items such as severance charges related to store closings, impairment charges, and pension plan expenses. Excluding the one-time charges, net loss was $94 million or 81 cents per share during the third quarter versus a net loss of $114 million or 90 cents per share in the year-ago quarter.</p>
<p align="left">Sears reported total revenues of $10.2 billion during the quarter compared to $10.7 billion in the year-earlier quarter. The decrease in year-over-year sales was primarily due to a decline in comparable store sales partially offset by the effect of foreign currency translation. Domestic comparable store sales decreased 2.3% during the quarter, with the Sears Domestic division accounting for a 4.6% decrease partially offset by a 0.5% increase in the Kmart division.</p>
<p align="left">Get the full analysis of all these stocks by going to <a href="http://at.zacks.com/?id=5507">http://at.zacks.com/?id=5507</a>.</p>
<p align="left"><strong>About the Bull and Bear of the Day</strong></p>
<p align="left">Every day, the analysts at Zacks Equity Research select two stocks that are likely to outperform (Bull) or underperform (Bear) the markets over the next 3-6 months.</p>
<p align="left"><strong>About the Analyst Blog</strong></p>
<p align="left">Updated throughout every trading day, the <a href="http://www.zacks.com/stock/news/AnalystBlog">Analyst Blog</a> provides analysis from Zacks Equity Research about the latest news and events impacting stocks and the financial markets.</p>
<p align="left"><strong>About Zacks Equity Research</strong></p>
<p align="left">Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.</p>
<p align="left">Continuous analyst coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.</p>
<p align="left">Zacks <a href="http://at.zacks.com/?id=5508">"Profit from the Pros"</a> e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today by visiting <a href="http://at.zacks.com/?id=5508">http://at.zacks.com/?id=5508</a>.</p>
<p align="left"><strong>About Zacks </strong></p>
<p align="left">Zacks.com is a property of <a href="http://www.zacks.com/">Zacks Investment Research</a>, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the <a href="http://www.zacks.com/rank/index.php">Zacks Rank</a>, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at <a href="http://at.zacks.com/?id=5509">http://at.zacks.com/?id=5509</a>.</p>
<p align="left">Visit <a href="http://www.zacks.com/performance">http://www.zacks.com/performance</a> for information about the performance numbers displayed in this press release.</p>
<p align="left">Follow us on Twitter: <a href="http://twitter.com/zacksresearch">http://twitter.com/zacksresearch</a></p>
<p align="left">Join us on Facebook: <a href="http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts">http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts</a></p>
<p align="left">Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.</p>
<p align="left">Contact:<br />
Mark Vickery<br />
Web Content Editor<br />
312-265-9380<br />
Visit: <a href="www.zacks.com">www.zacks.com </a></p>
<p align="left"> </p>
<p align="left"> </p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/zacks-bull-and-bear-of-the-day-highlights-principal-financial-sohu-com-bank-of-america-wal-mart-and-sears-holding-corp-press-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zacks Analyst Blog Highlights: Bank of America, MGIC, Fannie Mae, Freddie Mac and Gymboree Corp. &#8211; Press Releases</title>
		<link>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-bank-of-america-mgic-fannie-mae-freddie-mac-and-gymboree-corp-press-releases/</link>
		<comments>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-bank-of-america-mgic-fannie-mae-freddie-mac-and-gymboree-corp-press-releases/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 12:42:27 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Bank Of America]]></category>
		<category><![CDATA[big banks]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[Fannie Mae]]></category>
		<category><![CDATA[Freddie Mac]]></category>
		<category><![CDATA[Gymboree Corp]]></category>
		<category><![CDATA[Jack]]></category>
		<category><![CDATA[Janie]]></category>
		<category><![CDATA[Leonard Zacks;]]></category>
		<category><![CDATA[Mortgage Insurers]]></category>
		<category><![CDATA[Puerto Rico]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Investment Research Inc.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27481/Zacks+Analyst+Blog+Highlights%3A+Bank+of+America%2C+MGIC%2C+Fannie+Mae%2C+Freddie+Mac+and+Gymboree+Corp.+-+Press+Releases</guid>
		<description><![CDATA[<p align="left"><strong>For Immediate Release</strong></p>
<p align="left">Chicago, IL &#8211; November 20, 2009 &#8211; Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: <strong>Bank of America </strong>(<a href="void(0)">BAC</a>), <strong>MGIC </strong>(<a href="void(0)">MTG</a>), <strong>Fannie Mae </strong>(<a href="void(0)">FNM</a>), <strong>Freddie Mac </strong>(<a href="void(0)">FRE</a>) and <strong>The Gymboree Corp.</strong> (<a href="void(0)">GYMB</a>).</p>
<p align="left">Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5513">http://at.zacks.com/?id=5513</a></p>
<p align="left"><strong>Here are highlights from Thursday&#8217;s Analyst Blog: </strong></p>
<p align="left"><strong>Mortgage Delinquencies: Record High</strong></p>
<p align="left">The delinquency rate is going up much faster than foreclosures are being started. With unemployment high and rising, it is hard to see a lot of those delinquencies getting cured. Either the lenders will have to let people live indefinitely in their houses without paying (unlikely that the banks would be so generous) or we will see another huge wave of foreclosures coming.</p>
<p align="left">The absolute number of houses that are either in foreclosure or 90 days or more past due now exceeds the number of existing homes available for sale. That is a huge overhang of shadow inventory (although some of it is out of the shadows and currently listed for sale) that should continue to put pressure on housing prices, even with all the extraordinary government support trying to prop up housing prices.</p>
<p align="left">While unemployment is one serious driver of mortgage foreclosures because it affects the ability to pay, falling home prices are another driver. An underwater home is a home that is at high risk of going into foreclosure. It is simply economically irrational to continue to make payments on a $500,000 mortgage that is secured by a property that is only worth $400,000. This, then, continues the vicious cycle, where falling prices lead to foreclosures, which leads to more distressed supply, which leads to further pressure on home prices that in turn leads to yet more foreclosures.</p>
<p align="left">The entire mortgage complex is not yet out of the woods. That complex includes the big banks like <strong>Bank of America </strong>(<a href="void(0)">BAC</a>), the mortgage insurers like <strong>MGIC </strong>(<a href="void(0)">MTG</a>) as well as <strong>Fannie Mae </strong>(<a href="void(0)">FNM</a>) and <strong>Freddie Mac </strong>(<a href="void(0)">FRE</a>). My inclination is to avoid all of them.</p>
<p align="left"><strong>Gymboree Beats, but Outlook Down</strong></p>
<p align="left"><strong>The Gymboree Corp.</strong> (<a href="void(0)">GYMB</a>) reported its fiscal third quarter results after the closing bell on Wednesday. The company posted earnings of $34.8 million, a growth of 12.6% from $30.9 million recorded in the year-ago period. Earnings per share came in at $1.15, which topped the Zacks Consensus Estimate of $1.13.</p>
<p align="left">Gymboree is a specialty retailer offering apparel and accessories for children under the Gymboree, Gymboree Outlet, Janie and Jack and Crazy 8 Brands, as well as play programs under the Gymboree Play &#38; Music brand. At the end of October 2009, the company operated a total of 951 stores across the U.S., Canada and in Puerto Rico.</p>
<p align="left">The company reported a nearly 2% increase in total sales to $269.1 million during the quarter, compared to $264.1 million in the year-ago quarter. The expansion was primarily driven by the addition of 78 new stores in the last one year period, partially offset by a 4% decline in same-store sales. During the quarter, the company opened a total of 25 new stores including six Gymboree stores, four Gymboree Outlets and 15 Crazy 8 stores.</p>
<p align="left">Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5515">http://at.zacks.com/?id=5515</a>.</p>
<p align="left"><strong>About Zacks Equity Research</strong></p>
<p align="left">Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.</p>
<p align="left">Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.</p>
<p align="left">Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: <a href="http://at.zacks.com/?id=5517">http://at.zacks.com/?id=5517</a></p>
<p align="left"><strong>About Zacks </strong></p>
<p align="left">Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at <a href="http://at.zacks.com/?id=5518">http://at.zacks.com/?id=5518</a>.</p>
<p align="left">Visit <a href="http://www.zacks.com/performance">http://www.zacks.com/performance</a> for information about the performance numbers displayed in this press release.</p>
<p align="left">Follow us on Twitter: <a href="http://twitter.com/zacksresearch">http://twitter.com/zacksresearch</a></p>
<p align="left">Join us on Facebook: <a href="http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts">http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts</a></p>
<p align="left">Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.</p>
<p align="left">Contact:<br />
Mark Vickery<br />
Web Content Editor<br />
312-265-9380<br />
Visit: <a href="www.zacks.com">www.zacks.com </a></p>
<p align="left"> </p>
<p align="left"> </p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-bank-of-america-mgic-fannie-mae-freddie-mac-and-gymboree-corp-press-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zacks Analyst Blog Highlights: Toyota Motors, Petroleo Brasileiro S.A., ExxonMobil Corp., Chevron Corp., and Royal Dutch Shell PLC &#8211; Press Releases</title>
		<link>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-toyota-motors-petroleo-brasileiro-s-a-exxonmobil-corp-chevron-corp-and-royal-dutch-shell-plc-press-releases/</link>
		<comments>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-toyota-motors-petroleo-brasileiro-s-a-exxonmobil-corp-chevron-corp-and-royal-dutch-shell-plc-press-releases/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 12:26:57 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Brazil]]></category>
		<category><![CDATA[BRL]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[chevron corp]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[energy giant]]></category>
		<category><![CDATA[ExxonMobil Corp.]]></category>
		<category><![CDATA[I.R.I.S. s.a. TG3Z3510AFCS Headset]]></category>
		<category><![CDATA[Leonard Zacks;]]></category>
		<category><![CDATA[Natural Gas]]></category>
		<category><![CDATA[natural gas liquids production]]></category>
		<category><![CDATA[natural gas volumes]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[Oil And Gas Production]]></category>
		<category><![CDATA[oil-equivalent barrels]]></category>
		<category><![CDATA[Petrobras S.A.]]></category>
		<category><![CDATA[Petroleo Brasileiro S.A.]]></category>
		<category><![CDATA[Royal Dutch Shell plc]]></category>
		<category><![CDATA[Toyota Motors;]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Investment Research Inc.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27480/Zacks+Analyst+Blog+Highlights%3A+Toyota+Motors%2C+Petroleo+Brasileiro+S.A.%2C+ExxonMobil+Corp.%2C+Chevron+Corp.%2C+and+Royal+Dutch+Shell+PLC+-+Press+Releases</guid>
		<description><![CDATA[<p align="left"><strong>For Immediate Release</strong></p>
<p align="left">Chicago, IL &#8211; November 20, 2009 &#8211; Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: <strong>Toyota Motors </strong>(<a href="void(0)">TM</a>), <strong>Petroleo Brasileiro S.A. </strong>(<a href="void(0)">PBR</a>), <strong>ExxonMobil Corp.</strong> (<a href="void(0)">XOM</a>), <strong>Chevron Corp. </strong>(<a href="void(0)">CVX</a>) and <strong>Royal Dutch Shell PLC </strong>(<a href="void(0)">RDS.A</a>).</p>
<p align="left">Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5513">http://at.zacks.com/?id=5513</a></p>
<p align="left"><strong>Here are highlights from Thursday&#8217;s Analyst Blog: </strong></p>
<p align="left"><strong>Toyota&#8217;s 1st Sales Gain in 15 Months</strong></p>
<p align="left"><strong>Toyota Motors </strong>(<a href="void(0)">TM</a>) has posted its first year-over-year monthly sales gain across the globe in 15 months during October. The company&#8217;s sales rose 4% to more than 630,000 vehicles. In the U.S., the company&#8217;s sales fell 3.5%.</p>
<p align="left">However, in the domestic market Toyota&#8217;s sales grew 15% helped by tax breaks for purchases of environment-friendly cars. In China, the company saw a staggering rise of 40% in sales. Toyota returned to profitability in the second quarter of fiscal 2010 ended Sep 30, 2009, after reporting losses since the third quarter of fiscal 2009.</p>
<p align="left">The company posted a profit of ¥21.8 billion ($232 million) or ¥6.96 per share (7 cents) per share. This profit was attributed to government incentive programs across the world &#8211; such as the U.S. &#8220;Cash for Clunkers"&#8211; that helped the company recoup its market share. Consolidated revenue in the quarter dipped 24% to ¥4.54 trillion ($48 billion).</p>
<p align="left">Automotive revenue fell 24% to ¥4.11 trillion ($44 billion) while Financial Services revenue shrank 17% to ¥307 billion ($4 billion). This was on the back of a decline in vehicle sales in each region as well as a negative impact from the appreciation of yen. Sales volume declined 16% to 1.64 million units due to a decrease in volume in all the regions except North America.</p>
<p align="left"><strong>Petrobras Profit Exceeds Ests</strong></p>
<p align="left">Brazilian energy giant <strong>Petroleo Brasileiro S.A. </strong>(<a href="void(0)">PBR</a>), or Petrobras S.A. announced encouraging third quarter results, helped by strong performance from the Supply segment. Earnings per ADR came in at R$1.66 (96 cents), comfortably beating the Zacks Consensus Estimate of 80 cents. However, on a year-over-year basis, Petrobras&#8217; earnings per ADR was down approximately 28.7%, hurt by lower prices of oil and natural gas. Still, they were better than the high double-digit earnings decline suffered by other majors such as <strong>ExxonMobil Corp.</strong> (<a href="void(0)">XOM</a>), <strong>Chevron Corp. </strong>(<a href="void(0)">CVX</a>), and <strong>Royal Dutch Shell PLC </strong>(<a href="void(0)">RDS.A</a>).</p>
<p align="left">Total oil and gas production during the third quarter of 2009 reached 2,534 million oil-equivalent barrels per day, from 2,524 million in the previous quarter and 2,437 million in the same period of 2008. Compared to the third quarter of 2008, Brazilian oil and natural gas liquids production increased 4.8%, while international production was up 24.6%. However, Brazilian natural gas volumes were down 3.3% from the year-ago period, while international output during the quarter was down 6.0% year over year.</p>
<p align="left">During the third quarter of 2009, the average sales price of oil in Brazil decreased 36.4% from the year-earlier period to $64 per barrel. Average sales price of international oil was down 16.9% year-over-year, reaching $57.16 per barrel. Regarding natural gas, average international sales price decreased 21.5% from the third quarter of 2008, while domestic price was down 61.5%.</p>
<p align="left">Refining costs per barrel in Brazil was down 2.6% to $3.37 and internationally, it fell 45.2% to $3.51. Lifting cost per barrel moved down 24.5% in Brazil to $22.86, while overseas costs rose 9.4% to $5.6. Petrobras exported an average of 724,000 barrels of oil per day, 10.2% higher compared to the same period last year.</p>
<p align="left">Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5515">http://at.zacks.com/?id=5515</a>.</p>
<p align="left"><strong>About Zacks Equity Research</strong></p>
<p align="left">Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.</p>
<p align="left">Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.</p>
<p align="left">Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: <a href="http://at.zacks.com/?id=5517">http://at.zacks.com/?id=5517</a></p>
<p align="left"><strong>About Zacks </strong></p>
<p align="left">Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at <a href="http://at.zacks.com/?id=5518">http://at.zacks.com/?id=5518</a>.</p>
<p align="left">Visit <a href="http://www.zacks.com/performance">http://www.zacks.com/performance</a> for information about the performance numbers displayed in this press release.</p>
<p align="left">Follow us on Twitter: <a href="http://twitter.com/zacksresearch">http://twitter.com/zacksresearch</a></p>
<p align="left">Join us on Facebook: <a href="http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts">http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts</a></p>
<p align="left">Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.</p>
<p align="left">Contact:<br />
Mark Vickery<br />
Web Content Editor<br />
312-265-9380<br />
Visit: <a href="www.zacks.com">www.zacks.com </a></p>
<p align="left"> </p>
<p align="left"> </p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-toyota-motors-petroleo-brasileiro-s-a-exxonmobil-corp-chevron-corp-and-royal-dutch-shell-plc-press-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Audit the Fed – Amendment to a $200 billion bill frightens currency traders!</title>
		<link>http://www.straightstocks.com/investing-lessons/audit-the-fed-%e2%80%93-amendment-to-a-200-billion-bill-frightens-currency-traders/</link>
		<comments>http://www.straightstocks.com/investing-lessons/audit-the-fed-%e2%80%93-amendment-to-a-200-billion-bill-frightens-currency-traders/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 12:20:35 +0000</pubDate>
		<dc:creator>Contrarian Profits</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Chuck Butler]]></category>
		<category><![CDATA[contrarian profits]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[House Financial Services Committee]]></category>
		<category><![CDATA[regular analyst]]></category>
		<category><![CDATA[Ron Paul]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[Thanksgiving]]></category>
		<category><![CDATA[The Daily Reckoning]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.contrarianprofits.com/?p=21105</guid>
		<description><![CDATA[So what was it that spooked the markets… Well… The only thing I can find was the report yesterday about falling Housing Starts that Chris told you about… Did you know that about 14% of US homeowners were either delinquent on their mortgage or in some stage of foreclosure? That is the highest rate since the group started collecting the data in 1972!

But there was something else that was announced as the day went on, that I think probably spooked the markets more than anything else… And that is a key House panel approved two amendments to a sweeping financial-overhaul bill that would give federal watchdogs new authority to audit the Federal Reserve, and would establish a fund of as much as $200 billion to help dissolve large, troubled institutions. Rep. Ron Paul (R., Texas) offered the amendment seeking to subject the Fed to audits.]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/audit-the-fed-%e2%80%93-amendment-to-a-200-billion-bill-frightens-currency-traders/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Velocity of US money supply at long last edging up</title>
		<link>http://www.straightstocks.com/investing-lessons/velocity-of-us-money-supply-at-long-last-edging-up/</link>
		<comments>http://www.straightstocks.com/investing-lessons/velocity-of-us-money-supply-at-long-last-edging-up/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 09:54:55 +0000</pubDate>
		<dc:creator>Prieur du Plessis</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[I-Net Bridge]]></category>
		<category><![CDATA[investment postcards]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://www.investmentpostcards.com/?p=13955</guid>
		<description><![CDATA[This post discusses the trend in the velocity of US money supply and the implications for the economy.]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/velocity-of-us-money-supply-at-long-last-edging-up/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zoellick on the world economy and new hotspots</title>
		<link>http://www.straightstocks.com/investing-lessons/zoellick-on-the-world-economy-and-new-hotspots/</link>
		<comments>http://www.straightstocks.com/investing-lessons/zoellick-on-the-world-economy-and-new-hotspots/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 09:40:07 +0000</pubDate>
		<dc:creator>Prieur du Plessis</dc:creator>
				<category><![CDATA[China]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Barack Obama]]></category>
		<category><![CDATA[Financial Times]]></category>
		<category><![CDATA[International Bank for Reconstruction and Development]]></category>
		<category><![CDATA[investment postcards]]></category>
		<category><![CDATA[Managing Editor]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Robert Zoellick]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://www.investmentpostcards.com/?p=13925</guid>
		<description><![CDATA[In this three-part video interview, Robert Zoellick, president of the World Bank, discusses a range of topical issues concerning the global economy, new economic hotspots, the Chinese currency peg and lessons from the crisis.]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/zoellick-on-the-world-economy-and-new-hotspots/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Squanderville vs. Thriftville</title>
		<link>http://www.straightstocks.com/investing-lessons/squanderville-vs-thriftville/</link>
		<comments>http://www.straightstocks.com/investing-lessons/squanderville-vs-thriftville/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 09:24:39 +0000</pubDate>
		<dc:creator>Prieur du Plessis</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[I.O.U.S.A.]]></category>
		<category><![CDATA[investment postcards]]></category>
		<category><![CDATA[obama]]></category>
		<category><![CDATA[One Nation;]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Squanderville;]]></category>
		<category><![CDATA[Thriftville;]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Warren Buffett]]></category>

		<guid isPermaLink="false">http://www.investmentpostcards.com/?p=13929</guid>
		<description><![CDATA[Using animation, Warren Buffett eloquently explains in just more than two minutes why trade imbalances lead to serfdom. Put differently, and in the context of the US / China talks, "Thriftville" owns "Squanderville" in the endgame.]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/squanderville-vs-thriftville/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nordstrom Inc. &#8211; Momentum &#8211; Zacks Rank Buy</title>
		<link>http://www.straightstocks.com/stock-watch/nordstrom-inc-momentum-zacks-rank-buy/</link>
		<comments>http://www.straightstocks.com/stock-watch/nordstrom-inc-momentum-zacks-rank-buy/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 05:00:00 +0000</pubDate>
		<dc:creator>Michael Vodicka</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[fashion retailer]]></category>
		<category><![CDATA[JWN]]></category>
		<category><![CDATA[Nordstrom Inc.]]></category>
		<category><![CDATA[Nordstrom Rack]]></category>
		<category><![CDATA[pence]]></category>
		<category><![CDATA[Rack store]]></category>
		<category><![CDATA[Retail Sector]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/commentary/12810/Nordstrom+Inc.+-+Momentum+-+Zacks+Rank+Buy</guid>
		<description><![CDATA[<b>Nordstrom Inc. </b> (<a href="http://www.zacks.com/stock/quote/JWN">JWN</a>) continues to trade near its 52-week high on the heels of better than expected Q3 results.  
<p ALIGN="left">
<b>Company Description</b>
</p><p ALIGN="left">
Nordstrom, Inc operates as a specialty fashion retailer for men, woman and children in the United States. The company was founded in 1901 and has a market cap of $7.38 billion. 
</p><p ALIGN="left">
The retail sector has been weak for the last year as consumers continue to struggle with overbearing debt and high unemployment. But in spite of the challenges shares of Nordstrom have posted big gains as the company adjusts to the challenging environment. This dynamic showed up on Nov 13 when Nordstrom posted better than expected third-quarter results.
</p><p ALIGN="left">
<b>Third-Quarter Results</b>
</p><p ALIGN="left">
Same-store sales were down 1.2% from last year, but net sales were up 3.5% to $1.87 billion. Earnings came in one penny ahead of the Zacks Consensus Estimate at 38 cents per share. The company has beat in each of the last four quarters by an average of 3 cents, or 8%.
</p><p ALIGN="left">
Nordstrom noted that its Nordstrom Rack store, a value oriented extension of the its main store, saw increased demand, with same-store sales up 3% from last year. The company also noted that its 90 basis point expansion in gross margin was largely offset by a jump in performance related compensation. 
</p><p ALIGN="left">
<b>Estimates Rising</b>
</p><p ALIGN="left">
The good quarter pushed estimates higher. The current-year estimate is up 6 cents in the last week to $1.82, while the next-year estimate is up 9 cents to $2.17, a 19% growth projection.
</p><p ALIGN="left">
<b>Valuation</b>
</p><p ALIGN="left">
Based upon the current-year estimate, this stock trades with a P/E multiple of 18X, a slight premium to the overall market.
</p><p ALIGN="left">
<b>The Chart</b>
</p><p ALIGN="left">
Shares of JWN are up big over the last 4 months after bottoming out just above $18 in early July. Shares have been hovering near the 52-week high for the last few weeks ahead of prime-time holiday spending season. 
</p><p ALIGN="left">
</p><p ALIGN="left">
<img src="http://www.zacks.com/images/upload_dir/1258661926.JPG" width="607" height="309"/>

<a href="http://www.zacks.com">Zacks Investment Research</a><br /></p>]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/nordstrom-inc-momentum-zacks-rank-buy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>China, the Renminbi, and Global Imbalances: A Quantitative View</title>
		<link>http://www.straightstocks.com/investing-lessons/china-the-renminbi-and-global-imbalances-a-quantitative-view/</link>
		<comments>http://www.straightstocks.com/investing-lessons/china-the-renminbi-and-global-imbalances-a-quantitative-view/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 04:45:12 +0000</pubDate>
		<dc:creator>Menzie Chinn</dc:creator>
				<category><![CDATA[China]]></category>
		<category><![CDATA[Economics]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[108/228 Card T-1 with cable - Refurbished. - - Phone;]]></category>
		<category><![CDATA[Beijing]]></category>
		<category><![CDATA[Emporia Telecom Isoetec IDS]]></category>
		<category><![CDATA[obama]]></category>
		<category><![CDATA[ordinary and processing trade]]></category>
		<category><![CDATA[ORT]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.econbrowser.com/archives/2009/11/china_the_renmi.html</guid>
		<description><![CDATA[<p>President Obama's trip to China has returned to scrutiny the role of China's currency and macroeconomic policies in perpetuating global imbalances. <a href="http://www.latimes.com/business/la-fi-currency19-2009nov19,0,6482321.story">[0]</a> <a href="http://blogs.wsj.com/chinarealtime/2009/11/19/on-yuan-what%E2%80%99s-in-a-chinese-phrase/">[1]</a> <a href="http://www.bloomberg.com/apps/news?pid=20601080&#38;sid=adVRNNmrjIDc">[2]</a> </p>

<br />

<img alt="china01.gif" src="http://www.econbrowser.com/archives/2009/11/china01.gif" />


<br /><b>Figure 1:</b> Log real value of RMB (blue, left axis), and Chinese trade balance in billions USD at annual rates (red, right axis) from Chinese statistical sources, and twelve month trailing moving average (maroon). Source: IMF, <i>International Financial Statistics</i>, ADB, NBER and author's calculations.

<p>Various observers have continued to ascribe a central role to real RMB appreciation to effect global rebalancing. I think it's useful to remember that, given a Chinese trade balance in excess of 260 billion USD, appreciation can only have a certain impact. From <a href="http://www.ssc.wisc.edu/~mchinn/NBER_China_Dec08_final.pdf">Cheung, Chinn and Fujii (forthcoming)</a>:</p>

<blockquote><p>...using a single equation error correction model, allowing for coefficient shifts with Chinese accession to WTO, leads to a statistically insignificant estimate of the price elasticity. In the 2000-06 period, the implied price elasticity is zero. Using this point estimate, then a 10% appreciation would actually lead to a shrinkage of the trade balance from 400.9 billion to 355.2 billion. This estimate of 45.7 billion (2000$) is somewhat less than the $88.6 billion current dollars reported in Marquez and Schindler (forthcoming) <a href="http://www.federalreserve.gov/pubs/ifdp/2006/861/default.htm">[working paper version]</a>.</p></blockquote>

<p>The export equations take the form:</p>

<p><i> &#916; exp <sub>t</sub> = &#952; <sub>0</sub> + &#961; exp <sub>t-1</sub> + &#952; <sub>1</sub> y<sup>*</sup> <sub>t-1</sub> + &#952; <sub>2</sub> r  <sub>t-1</sub> + &#952; <sub>3</sub> k <sub>t-1</sub> + 
&#963; <sub>1</sub> &#916; exp <sub>t-1</sub> + 2 lags of first differenced right hand side variables + quarterly dummies + WTO dummy + v <sub>t</sub> </i>
</p>
<p>Where <i>exp</i> is log exports, <i>y<sup>*</sup></i> is log RoW GDP, <i>r</i> is the real exchange rate, and <i>k</i> is the Chinese capital stock. The import equations take the form:</p>

<p><i> &#916; imp <sub>t</sub> = &#946; <sub>0</sub> + &#966; imp <sub>t-1</sub> + &#946; <sub>1</sub> y <sub>t-1</sub> + &#946; <sub>2</sub> r  <sub>t-1</sub> + &#947;<sub>1</sub> &#916; imp <sub>t-1</sub> + 1 lag of first differenced right hand side variables + quarterly dummies + WTO dummy + u <sub>t</sub> </i>
</p>
<p>Where <i>imp</i> is log imports, <i>y</i> is log GDP. </p><p>Separate regressions are run for ordinary and processing trade, over the 1993Q4-07Q1 period. The adjusted R<sup>2</sup>'s range from 0.77 to 0.92.</p>

<p>If we take the <a href="http://www.piie.com/publications/chapters_preview/4167/01iie4167.pdf">Goldstein-Lardy</a> misalignment estimates of 20% to heart, then a 20% appreciation would lead to an approximately 91.4 billion (2000$) reduction in the Chinese trade balance. As best as I can tell, the export prices from China, and to China (as proxied by unit value indices for Hong Kong) have probably stayed constant relative to 2000; hence the nominal impact is around 90 billion USD (with considerable uncertainty surrounding this point estimate).</p>

<p>This leaves a large Chinese trade surplus in place, around 170 billion even before the rebound in the Chinese surplus anticipated as the world aggregate demand recovers. Now, to the extent that Chinese reserve accumulation is due to a current account surplus and capital inflows, one could hope that a revaluation would have an additional knock-on effect by deterring capital inflows (the argument would be revaluation would eliminate expectations of appreciation that would provide capital gains on holding RMB). That is, recall the balance of payments <i>identity</i>:</p>

<p><i>CA + KA + ORT &#8801; 0</i></p>

<p>Where CA is the current account, KA is private capital account, and ORT is official reserves transactions.</p>

<p>Figure 2, drawn from <a href="http://prasad.aem.cornell.edu/doc/policy/ChinaReservesNote.July09.pdf">Prasad and Sorkin (2009)</a> shows that net inflows were not a major factor, at least in 2008.</p>

<img alt="china02.gif" src="http://www.econbrowser.com/archives/2009/11/china02.gif" />


<br /><b>Figure 2</b> from <a href="http://prasad.aem.cornell.edu/doc/policy/ChinaReservesNote.July09.pdf">Eswar Prasad and Isaac Sorkin, "Sky's the Limit? National and Global Implications of China's Reserve Accumulation," mimeo (July 2009)</a>.

<p>This suggests to me that rebalancing requires as much or more Chinese fiscal stimulus and a concerted effort to encourage private consumption via enhancing the social safety net, in addition to RMB revaluation. (This can be seen in a Mundell Fleming framework, as applied to China <a href="http://www.econbrowser.com/archives/2007/03/internal_and_ex.html">[3]</a>). And it also requires determined action from the US side as well (see <a href="http://www.econbrowser.com/archives/2009/10/the_naitonal_sa.html">here</a>). If only we'd conducted a sane fiscal policy in 2001-08 <a href="http://www.econbrowser.com/archives/2006/10/the_us_macroeco.html">[4]</a>, our range of action would now be wider in this respect.</p>



]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/china-the-renminbi-and-global-imbalances-a-quantitative-view/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Maturing debt markets anchor emerging economies’ resilience, V-shaped recovery</title>
		<link>http://www.straightstocks.com/investing-lessons/maturing-debt-markets-anchor-emerging-economies%e2%80%99-resilience-v-shaped-recovery/</link>
		<comments>http://www.straightstocks.com/investing-lessons/maturing-debt-markets-anchor-emerging-economies%e2%80%99-resilience-v-shaped-recovery/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 03:24:23 +0000</pubDate>
		<dc:creator>Jason G. Wulterkens</dc:creator>
				<category><![CDATA[Frontier Markets]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Absa Capital]]></category>
		<category><![CDATA[Africa]]></category>
		<category><![CDATA[Antoine van Agtmael]]></category>
		<category><![CDATA[Antoinette Sayeh]]></category>
		<category><![CDATA[Argentina]]></category>
		<category><![CDATA[bank supervisors]]></category>
		<category><![CDATA[Basel]]></category>
		<category><![CDATA[Botswana]]></category>
		<category><![CDATA[capital raising solutions]]></category>
		<category><![CDATA[central Asia]]></category>
		<category><![CDATA[Central Banks]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[chairman and CIO]]></category>
		<category><![CDATA[CIO]]></category>
		<category><![CDATA[Daniel Broby]]></category>
		<category><![CDATA[Development Bank]]></category>
		<category><![CDATA[director]]></category>
		<category><![CDATA[Ecuador]]></category>
		<category><![CDATA[Emerging Markets Management LLC]]></category>
		<category><![CDATA[Global Quantitative Management]]></category>
		<category><![CDATA[Globalizing Financial Systems]]></category>
		<category><![CDATA[Gross national product]]></category>
		<category><![CDATA[Hashemite University in Jordan]]></category>
		<category><![CDATA[head]]></category>
		<category><![CDATA[Head of African Research]]></category>
		<category><![CDATA[insurance industries]]></category>
		<category><![CDATA[International Monetary Fund]]></category>
		<category><![CDATA[investment banking group]]></category>
		<category><![CDATA[jason g wulterkens]]></category>
		<category><![CDATA[Jason Toussaint]]></category>
		<category><![CDATA[Jordan]]></category>
		<category><![CDATA[Jpmorgan]]></category>
		<category><![CDATA[Kenya]]></category>
		<category><![CDATA[London]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[Mohamed Bahaa]]></category>
		<category><![CDATA[Nigeria]]></category>
		<category><![CDATA[Northern Trust]]></category>
		<category><![CDATA[observer]]></category>
		<category><![CDATA[Pakistan]]></category>
		<category><![CDATA[Per Daniel Broby]]></category>
		<category><![CDATA[Philip Turner]]></category>
		<category><![CDATA[Razia Khan]]></category>
		<category><![CDATA[secretariat group]]></category>
		<category><![CDATA[senior investment strategist]]></category>
		<category><![CDATA[Silk Invest]]></category>
		<category><![CDATA[Standard Chartered Bank Group]]></category>
		<category><![CDATA[Stephen van Coller]]></category>
		<category><![CDATA[sub-Saharan Africa]]></category>
		<category><![CDATA[Tanzania]]></category>
		<category><![CDATA[then-BIS head of the secretariat group]]></category>
		<category><![CDATA[Ukraine]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://frontiermarkets.wordpress.com/?p=1033</guid>
		<description><![CDATA[The following appeared in the November issue of Business Diary Botswana:
Despite the IMF&#8217;s recent projection that Botswana’s economy will contract 10.3% this year, the lender expects a 4.1% uptick next year such that emergency funding would not be required.  Back in June the country tapped a $1.5bn &#8220;budget support loan&#8221; from the African Development [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=frontiermarkets.wordpress.com&#38;blog=3702668&#38;post=1033&#38;subd=frontiermarkets&#38;ref=&#38;feed=1" />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/maturing-debt-markets-anchor-emerging-economies%e2%80%99-resilience-v-shaped-recovery/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Are negative yield money funds next?</title>
		<link>http://www.straightstocks.com/investing-lessons/are-negative-yield-money-funds-next/</link>
		<comments>http://www.straightstocks.com/investing-lessons/are-negative-yield-money-funds-next/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 00:13:47 +0000</pubDate>
		<dc:creator>Richard Shaw</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Chrysler]]></category>
		<category><![CDATA[Inc]]></category>
		<category><![CDATA[Lehman]]></category>
		<category><![CDATA[Moody's Investors Service]]></category>
		<category><![CDATA[QVM Group LLC]]></category>
		<category><![CDATA[Richard Shaw]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://www.qvmgroup.com/invest/?p=6798</guid>
		<description><![CDATA[The U.S. policies have driven short-term interest rates to Japan-like levels, creating &#8220;free&#8221; money for banks, creating a massive carry-trade speculative investment funds flow,  financially crippling low and middle income senior citizens who have historically relied on bank deposits to supplement their meager Social Security checks, and pushing very hard on investors to leave the [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/are-negative-yield-money-funds-next/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>PWRM, HZHI, HCEI, CVAT, PSFT, TAXS, CSRH, AQNM, DrStockPick.com Stock Report!</title>
		<link>http://www.straightstocks.com/stock-watch/pwrm-hzhi-hcei-cvat-psft-taxs-csrh-aqnm-drstockpick-com-stock-report/</link>
		<comments>http://www.straightstocks.com/stock-watch/pwrm-hzhi-hcei-cvat-psft-taxs-csrh-aqnm-drstockpick-com-stock-report/#comments</comments>
		<pubDate>Thu, 19 Nov 2009 21:45:12 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[(718) 951-8021]]></category>
		<category><![CDATA[(818) 718-0905]]></category>
		<category><![CDATA[(951) 657-8832]]></category>
		<category><![CDATA[+1 866 824 8854]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[advertisment services]]></category>
		<category><![CDATA[Agri Process Innovations Inc.]]></category>
		<category><![CDATA[ALS]]></category>
		<category><![CDATA[Amplification Technologies Inc.]]></category>
		<category><![CDATA[Aquentium Inc.;]]></category>
		<category><![CDATA[assistive technology]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[Beijing]]></category>
		<category><![CDATA[beverage]]></category>
		<category><![CDATA[BioMedReports.com]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cavitation Technologies Inc.]]></category>
		<category><![CDATA[Chair and Keynote Speaker]]></category>
		<category><![CDATA[chemical industries]]></category>
		<category><![CDATA[chemical sensors]]></category>
		<category><![CDATA[chief scientific officer]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Congress]]></category>
		<category><![CDATA[Consorteum Holdings Inc.;]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[crude oil refining;]]></category>
		<category><![CDATA[CSRH]]></category>
		<category><![CDATA[CVAT]]></category>
		<category><![CDATA[diagnostic tests]]></category>
		<category><![CDATA[disability products;]]></category>
		<category><![CDATA[Distribution Inc]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[drug development]]></category>
		<category><![CDATA[e - commerce]]></category>
		<category><![CDATA[end-product]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Energy Drinks]]></category>
		<category><![CDATA[environmental friendly technology]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[ergonomic solutions]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[Food Safety]]></category>
		<category><![CDATA[General Counsel for TAXS]]></category>
		<category><![CDATA[green technologies;]]></category>
		<category><![CDATA[Healthy Coffee International Inc.]]></category>
		<category><![CDATA[Healthy Coffee USA Inc.]]></category>
		<category><![CDATA[high-energy physics]]></category>
		<category><![CDATA[Homeland Security]]></category>
		<category><![CDATA[Horizon Health International Corp.]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[Indiana]]></category>
		<category><![CDATA[InGaAs/InP technologies]]></category>
		<category><![CDATA[International Congress]]></category>
		<category><![CDATA[Internet-driven international business model]]></category>
		<category><![CDATA[Ira Goldknopf]]></category>
		<category><![CDATA[Jack Mayer]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Krishna Linga]]></category>
		<category><![CDATA[leader in the development]]></category>
		<category><![CDATA[light level imaging]]></category>
		<category><![CDATA[Mark Taggatz;]]></category>
		<category><![CDATA[medical diagnostics]]></category>
		<category><![CDATA[medical imaging]]></category>
		<category><![CDATA[Michael Sharp]]></category>
		<category><![CDATA[Michael Wallace]]></category>
		<category><![CDATA[mining]]></category>
		<category><![CDATA[motivational speaker]]></category>
		<category><![CDATA[neurodegenerative disease;]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[New Zealand]]></category>
		<category><![CDATA[news portal;]]></category>
		<category><![CDATA[non-chemical sanitation equipment]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[online transactions]]></category>
		<category><![CDATA[Palm Springs]]></category>
		<category><![CDATA[Pilipinas]]></category>
		<category><![CDATA[PK Healthy Coffee INTL]]></category>
		<category><![CDATA[platform semiconductor]]></category>
		<category><![CDATA[platform semiconductor technology]]></category>
		<category><![CDATA[Power 3 Medical Products Inc.]]></category>
		<category><![CDATA[Power3 Medical Products Inc.;]]></category>
		<category><![CDATA[PowerSafe Technology Corp.]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[President & COO]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[PSFT]]></category>
		<category><![CDATA[PWRM]]></category>
		<category><![CDATA[Quent Rickerby;]]></category>
		<category><![CDATA[Retail Stores]]></category>
		<category><![CDATA[Savi Ranch Parkway business complex]]></category>
		<category><![CDATA[scientific instrumentation]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[semiconductor]]></category>
		<category><![CDATA[speaker]]></category>
		<category><![CDATA[spectroscopy]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[Sweden]]></category>
		<category><![CDATA[TaxMasters Inc.]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[vegetable oil refining]]></category>
		<category><![CDATA[Waste To Energy]]></category>
		<category><![CDATA[workflow management software application]]></category>
		<category><![CDATA[Workplace Medical Equipment Specialist]]></category>
		<category><![CDATA[www.amplificationtechnologies.com]]></category>
		<category><![CDATA[www.apinnovations.com]]></category>
		<category><![CDATA[www.aquentium.com]]></category>
		<category><![CDATA[www.consorteum.com]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.HCEI.biz]]></category>
		<category><![CDATA[www.HealthyCoffee.com]]></category>
		<category><![CDATA[www.horizonhealthandsafety-canada]]></category>
		<category><![CDATA[www.horizonhealthandsafety-us]]></category>
		<category><![CDATA[www.power3medical.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[www.txmstr.com]]></category>
		<category><![CDATA[Xplosivestocks.com]]></category>
		<category><![CDATA[Yorba Linda]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4883</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

Thursday November 18, 2009
DrStockPick.com Stock Report!
PWRM, HZHI, HCEI, CVAT, PSFT, TAXS, CSRH, AQNM
**************************************************************
 HCEI, Healthy Coffee International Inc., HCEI.PK
HCEI is well positioned in the market place at the intersection of three mega-billion dollar industries: coffee, wellness and energy drinks, and has quickly established offices [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/pwrm-hzhi-hcei-cvat-psft-taxs-csrh-aqnm-drstockpick-com-stock-report/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Grainger Boosted by Acquisitions &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/grainger-boosted-by-acquisitions-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/grainger-boosted-by-acquisitions-analyst-blog/#comments</comments>
		<pubDate>Thu, 19 Nov 2009 21:10:14 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Alliance Energy Solutions]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Grainger]]></category>
		<category><![CDATA[Imperial Supplies]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[Panama]]></category>
		<category><![CDATA[Puerto Rico]]></category>
		<category><![CDATA[turn-key energy-efficient]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[value added services]]></category>
		<category><![CDATA[W W Grainger Inc.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27477/Grainger+Boosted+by+Acquisitions+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>W.W. Grainger Inc.</strong> (<a href="http://www.zacks.com/stock/quote/gww">GWW</a>) reported a 3% year-over-year drop in October sales. (October this year had one less selling day compared to October 2008.) The company benefited from a 2% positive contribution from the businesses in Japan and India, 1% from the acquisition of Imperial Supplies and 2% from favorable foreign currency translation. Excluding the impact of acquisitions and currency exchange, Grainger&#8217;s daily sales in October were down 8% from last year. <br />
<br />
The company witnessed a 7% decline in daily sales in the U.S., as demand remained weak across all end markets. These results include sales from Imperial Supplies, which the company acquired in mid-October. Excluding this acquisition, U.S. daily sales were down 8%.<br />
<br />
In the Canadian (Acklands-Grainger) division, daily sales were up 5% due to favorable foreign exchange. However, the division&#8217;s daily sales were down 7% in local currency due to continued weakness in the Canadian economy.<br />
<br />
Sales of Grainger&#8217;s other businesses increased 177%, primarily driven by incremental sales from acquisitions in Japan and India, along with sales growth in Mexico, Puerto Rico, China and Panama.<br />
<br />
Grainger anticipates November sales to be flat or up modestly from last year&#8217;s level. The company expects sales to be in a range of down 2% to up 1% for the fourth quarter. Full-year sales are expected to come in 9% to 10% below the 2008 level. The company forecasts fourth quarter EPS of $1.13-$1.23 and full-year EPS of $5.10-$5.20.<br />
<br />
Further, Grainger provide guidance for 2010. The company is forecasts 2010 revenue to be up 4%-9% year-over-year. Earnings for 2010 are anticipated in the range of $5.30 to $5.80 per share. Grainger expects a 3% sales contribution and 5 cents per share of earnings growth from acquisitions made in 2009.<br />
<br />
<em><strong>Acquisition</strong></em><br />
<br />
Grainger announced an all-cash acquisition of Alliance Energy Solutions. The company expects the acquisition to be accretive to earnings by approximately 1-2 cents per share in 2010.<br />
<br />
Alliance Energy Solutions is a provider of turn-key energy-efficient retrofits. Grainger said that this is its first service-based acquisition in the U.S. With this acquisition, Grainger can provide value added services to complement its deep product line around lighting products. The company did not disclose other terms of the deal.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=GWW">Read the full analyst report on "GWW"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/grainger-boosted-by-acquisitions-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Etrion Corp. (TSX: ETX) and SunPower Corp. (NASDAQ:SPWRA) Team Up to Deliver Four Italy-based Solar Plants</title>
		<link>http://www.straightstocks.com/investing-lessons/etrion-corp-tsx-etx-and-sunpower-corp-nasdaqspwra-team-up-to-deliver-four-italy-based-solar-plants/</link>
		<comments>http://www.straightstocks.com/investing-lessons/etrion-corp-tsx-etx-and-sunpower-corp-nasdaqspwra-team-up-to-deliver-four-italy-based-solar-plants/#comments</comments>
		<pubDate>Thu, 19 Nov 2009 20:47:51 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Bank]]></category>
		<category><![CDATA[Centrobanca]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[clean energy sources;]]></category>
		<category><![CDATA[Electricity Sales]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Entrion]]></category>
		<category><![CDATA[Etrion Corporation]]></category>
		<category><![CDATA[Faenza]]></category>
		<category><![CDATA[fixed-tilt systems]]></category>
		<category><![CDATA[Italy]]></category>
		<category><![CDATA[maintenance services]]></category>
		<category><![CDATA[Marco Northland]]></category>
		<category><![CDATA[Mario Riello]]></category>
		<category><![CDATA[Milan]]></category>
		<category><![CDATA[Sales Director]]></category>
		<category><![CDATA[solar manufacturer]]></category>
		<category><![CDATA[SunPower Corp.]]></category>
		<category><![CDATA[SunPower European]]></category>
		<category><![CDATA[Tracker technology;]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19419</guid>
		<description><![CDATA[Canadian energy company Etrion Corporation (TSX: ETX) and U.S.-based solar manufacturer SunPower Corp. (NASDAQ:SPWRA) (NASDAQ:SPWRB) today announced an agreement to build four solar power plants in the Puglia region of southern Italy. 
SunPower has more than 500 megawatts of solar power plants installed or under contract around the world, including Italian power plants in Milan [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/etrion-corp-tsx-etx-and-sunpower-corp-nasdaqspwra-team-up-to-deliver-four-italy-based-solar-plants/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Will UNL Beat UNG?</title>
		<link>http://www.straightstocks.com/investing-lessons/will-unl-beat-ung/</link>
		<comments>http://www.straightstocks.com/investing-lessons/will-unl-beat-ung/#comments</comments>
		<pubDate>Thu, 19 Nov 2009 20:43:53 +0000</pubDate>
		<dc:creator>IndexUniverse Staff</dc:creator>
				<category><![CDATA[Exchange Traded Funds]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[international energy agency]]></category>
		<category><![CDATA[Month Oil Fund;]]></category>
		<category><![CDATA[Natural Gas]]></category>
		<category><![CDATA[natural gas contango]]></category>
		<category><![CDATA[natural gas futures]]></category>
		<category><![CDATA[natural gas market]]></category>
		<category><![CDATA[natural gas market flip]]></category>
		<category><![CDATA[Natural Gas Stocks]]></category>
		<category><![CDATA[natural gas surplus]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[Record-low natural gas prices]]></category>
		<category><![CDATA[U.S.  12-Month Natural Gas Fund]]></category>
		<category><![CDATA[U.S. Natural Gas Fund]]></category>
		<category><![CDATA[U.S. Oil Fund]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[United States Commodity Funds;]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">tag:www.indexuniverse.com://e115a7b314c85a1cd719e889f2a7bcac</guid>
		<description><![CDATA[<p>Can USCF's new fund tackle the natural gas contango?</p>

<p>United States Commodity Funds' <a href="http://www.unitedstates12monthnaturalgasfund.com/" target="_blank">new ETF</a>, the U.S. 12-Month Natural Gas Fund (NYSEArca: UNL), began trading yesterday, offering investors another easy access point to the natural gas market. But let's hope it sees smoother sailing than its controversial cousin, the U.S. Natural Gas Fund (NYSEArca: UNG).</p>
<p>Not only have regulators vociferously blamed UNG for distorting the commodity markets earlier this year, the fund has also performed dismally to date, dropping a whopping 61.24 percent since the beginning of the year. And it's not because investors have lost their taste for the fund: Last month, UNG still saw <a href="http://www.nsx.com/content/etf-product-list" target="_blank">brisk inflows</a> of $308 million, even as its net assets dropped $263 million.</p>
<p>Record-low natural gas prices have played their part in slashing UNG's returns, of course, but the big anvil weighing the fund down is the market's nasty case of contango. For the better part of the year, the front-month NYMEX natural gas futures contract has stayed cheaper than those with later delivery dates. And since UNG buys only the front-month contract, selling it near its expiration date to purchase the next-nearest month's contract, the fund has been stuck in a wicked cycle of "sell low, buy high" for months now.</p>
<p>UNL, on the other hand, may be able to avoid some (but not all) of the same pricing sting. Instead of focusing solely on the front-month contract, UNL purchases an equally weighted basket of futures contracts with delivery dates in each of the next 12 months. Two weeks from rollover time, the fund sells the front-month contract and buys the one 12 months out, essentially pushing the basket forward in time.</p>
<p>Given that currently UNG must absorb losses across 100 percent of its contracts during rollover, while UNL only experiences losses in 1/12<sup>th</sup> of its portfolio, this methodology should protect the latter somewhat from contango's vicious sting. But it can't make UNL entirely immune, considering the furthest-out contracts are still priced substantially above the front-month contract: Yesterday, the December 2009 contract closed at $4.254, while the December 2010 contract closed 45.7 percent higher, at $6.199.</p>
<p>Also consider that at 0.75 percent, UNL's expense ratio is a mite bigger than UNG's (0.60 percent), so when the contango lessens, any cost savings from choosing the former over the latter would naturally erode. And should the natural gas market flip to backwardation, UNL's staggered buying strategy would actually put it at a disadvantage to UNG.</p>
<p>But backwardation's not likely to happen in natural gas—at least, not anytime soon. To see inversion occur, we'd need to start seeing shortages in the physical commodity, yet natural gas stocks just hit <a href="http://www.google.com/hostednews/ap/article/ALeqM5iDCJNIq2-ICfA19vji2PGra_p7aQD9C2MBHG1" target="_blank">an all-time high</a>. In fact, the International Energy Agency <a href="http://www.reuters.com/article/latestCrisis/idUSLA022008" target="_blank">recently predicted</a> that even if demand rebounds, due to an extra-cold winter and economic recovery, we'll still see a natural gas surplus that will depress prices until 2015.</p>
<p>Will UNL ultimately outperform UNG until then? Obviously only time will tell, but we may be able to divine some clues from USCF's other 12-Month Oil Fund (NYSEArca: USL) and its UNG-analogous partner, the U.S. Oil Fund (NYSEArca: USO). Despite oil's price recovery, the commodity has also experienced heavy contango recently, and year-to-date, USL is up 38.84 percent, while USO is only up 22.87 percent.</p>
<p>Still, while I'm always happy to have more tools in the box, when it comes to natural gas, I'm not yet sure whether a flathead or a Phillips screwdriver would be better.</p>
<p> </p><div><a href="http://www.indexuniverse.com/blog/6897-will-unl-beat-ung.html?Itemid=3" target="_blank">Permalink</a> &#124; &#169; Copyright 2009 <a href="http://www.indexuniverse.com" target="_blank">Index Publications LLC.</a> All rights reserved</div>]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/will-unl-beat-ung/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Massey Acquires Coal Reserve &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/massey-acquires-coal-reserve-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/massey-acquires-coal-reserve-analyst-blog/#comments</comments>
		<pubDate>Thu, 19 Nov 2009 20:16:27 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Appalachian Fuels LLC]]></category>
		<category><![CDATA[coal mining assets]]></category>
		<category><![CDATA[Dante Coal]]></category>
		<category><![CDATA[Fayette County]]></category>
		<category><![CDATA[Mammoth]]></category>
		<category><![CDATA[Massey]]></category>
		<category><![CDATA[Massey Energy]]></category>
		<category><![CDATA[Nicholas Energy]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[West Virginia]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27473/Massey+Acquires+Coal+Reserve+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Massey Energy Company</strong> (<a href="http://www.zacks.com/stock/quote/mee">MEE</a>) has fully acquired 15 million tons of coal reserves in West Virginia from rival Appalachian Fuels LLC, which went bankrupt recently, for over $6 million. Massey has also acquired permits needed to develop infrastructure and plans to begin production at the Dante Coal Reserves site. The transaction was completed on November 13, 2009.<br />
<br />
Massey secured rights to the reserves through an auction in the bankruptcy of Appalachian Fuels. The acquisition was announced last month and completed on Nov. 13. The company expects the value of the reserves to increase significantly as conditions in the metallurgical coal market improve. The acquisition is Massey's second from Appalachian. In September, Massey bought 23 million tons of reserves and other assets in West Virginia's Fayette County from Appalachian for $5.1 million.<br />
<br />
Massey Energy is the fourth largest coal company in the US and the largest in Central Appalachia. The company is continuously making acquisitions of coal mining assets and reserves. The Dante Coal acquisition has raised the company&#8217;s current total coal reserves to 2.3 billion tons. Of the total current reserves, 1.0 billion ton is metallurgical coal. The company had recently acquired the mining assets from Appalachian.<br />
<br />
At more than $5.1 million, the assets include 23 million tons of coal reserves, permitted deep and surface mines, a permitted preparation plant and some mining equipment. These assets are located in Fayette County, West Virginia, close to Massey's existing Mammoth and Nicholas Energy resource groups.<br />
<br />
Over half of the acquired reserves are metallurgical coal in the Powellton and Eagle Coal Seams. Massey plans to resume mining metallurgical coal in the Powellton Seam in the near term. However, it has no immediate plans to start the other idled deep and surface mines acquired in the transaction. The coal produced will be processed at Massey's Mammoth preparation plant. Massey expects the acquisition to be immediately accretive to earnings.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=MEE">Read the full analyst report on "MEE"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/massey-acquires-coal-reserve-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HCEI, Healthy Coffee Projects Seven Figure per Month Sales by November 2010</title>
		<link>http://www.straightstocks.com/stock-watch/hcei-healthy-coffee-projects-seven-figure-per-month-sales-by-november-2010/</link>
		<comments>http://www.straightstocks.com/stock-watch/hcei-healthy-coffee-projects-seven-figure-per-month-sales-by-november-2010/#comments</comments>
		<pubDate>Thu, 19 Nov 2009 19:59:24 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[(949) 209-8850]]></category>
		<category><![CDATA[advertisment services]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[corporate site]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[Energy Drinks]]></category>
		<category><![CDATA[Establishing Offices Worldwide]]></category>
		<category><![CDATA[Healthy Coffee International Inc.]]></category>
		<category><![CDATA[Healthy Coffee USA Inc.]]></category>
		<category><![CDATA[Internet-driven international business model]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[New Zealand]]></category>
		<category><![CDATA[Pilipinas]]></category>
		<category><![CDATA[PK Healthy Coffee INTL]]></category>
		<category><![CDATA[Rick Aguiluz]]></category>
		<category><![CDATA[Savi Ranch Parkway business complex]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Sweden]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[www.HCEI.biz]]></category>
		<category><![CDATA[www.HealthyCoffee.com]]></category>
		<category><![CDATA[www.healthycoffee.us]]></category>
		<category><![CDATA[Xplosivestocks.com]]></category>
		<category><![CDATA[Yorba Linda]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4880</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Thursday Nov 19, 2009
DrStockPick.com Stock Report!
**************************************************************
 HCEI, Healthy Coffee International Inc., HCEI.PK
HCEI’s proprietary formulas combine the health benefits of Ginseng, Reishi Mushroom, and other top quality ingredients with the world’s finest coffee beans to create a line of deliciously healthy instant gourmet coffee drinks.
HCEI [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/hcei-healthy-coffee-projects-seven-figure-per-month-sales-by-november-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Patterson Meets Expectations &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/patterson-meets-expectations-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/patterson-meets-expectations-analyst-blog/#comments</comments>
		<pubDate>Thu, 19 Nov 2009 19:07:34 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Columbus Serum]]></category>
		<category><![CDATA[companion-pet veterinarian]]></category>
		<category><![CDATA[dental]]></category>
		<category><![CDATA[Patterson Companies Inc.;]]></category>
		<category><![CDATA[Software Sales]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27463/Patterson+Meets+Expectations+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Patterson Companies, Inc.</strong> (<a href="http://www.zacks.com/stock/quote/PDCO">PDCO</a>) reported fiscal second-quarter earnings per share of 41 cents, meeting the Zacks Consensus Estimate. However, earnings were better than the year-ago figure of 40 cents.<br />
 <br />
<strong><em>Sales</em></strong><br />
 <br />
Total sales in the reported quarter increased 7% year over year to roughly $815 million. In terms of business segments: Dental Supply revenues were approximately flat year over year at $537.2 million. Veterinary Supply sales increased 30% year over year to $160.7 million. Growth can be attributed to strong demand for the company&#8217;s own products and the acquisition of Columbus Serum in October 2008. <br />
 <br />
Rehabilitation Supply revenues increased 18% year over year to $117.1 million primarily due to the company&#8217;s internal sales growth and acquisitions.<br />
 <br />
In terms of products: Consumable and printed products sales increased 9.1% year over year to $538.7 million. Equipment and software sales increased 4.5% year over year to $210.0 million. Other category of revenues registered a growth of 2.4% year over year to $66.3 million. <br />
 <br />
<strong><em>Margins</em></strong><br />
 <br />
Patterson witnessed a contraction in margins. Gross margin declined 70 basis points (bps) year over year to 32.7%. Operating margin declined 50 bps year over year to 10.4%.<br />
 <br />
<strong><em>Balance Sheet &#38; Cash Flow</em></strong><br />
 <br />
Patterson ended the quarter with cash and short-term investments of roughly $170.2 million, an increase of approximately 8% in the first half of the fiscal year. The company had an outstanding long-term debt of roughly $525 million at the end of the second quarter. Cash flow from operations was $8.6 million for the quarter.<br />
 <br />
<strong><em>Outlook</em></strong><br />
 <br />
Patterson reaffirmed its earnings per share guidance between $1.70 and $1.80 for full fiscal 2010. <br />
 <br />
Patterson Companies, Inc. is a distributor of dental, companion-pet veterinarian and rehabilitation supply markets in the U.S. and Canada.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PDCO">Read the full analyst report on "PDCO"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/patterson-meets-expectations-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
